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Summary  
In Germany, as in almost all industrial countries, active pharmaceutical substances can 
now be found in virtually all water bodies and occasionally also in drinking water. Even 
though the concentrations in question tend to be very low, there are initial signs of their 
impact on aquatic life. There is no evidence as yet of any acute consequences for human 
health. It is, however, impossible to rule out long-term consequences from these minimal 
concentrations or unexpected effects from the interaction between various active ingredi-
ents (cocktail effect). At special risk here are sensitive segments of the population such as 
children and the chronically ill. There is thus a need for action on precautionary grounds. 
The main actors in the health system are largely unaware of the problem posed by drug 
residues in water. Although knowledge cannot be equated with awareness – given the exis-
tence of the ‘not wanting to know' phenomenon – the first step is to generate a consoli-
dated knowledge base. Only by creating awareness of the problem can further strategies be 
implemented to ultimately enlighten and bring about behavioural change. At stake here is 
the  overall  everyday  handling  of  medications,  including  prescription,  compliance,  and 
drug-free disease prevention down to the doctor-patient relationship. The latter, namely, is 
often characterised by misunderstandings and a lack of communication about the – sup-
posed – need to prescribe drugs. 
The first part of the strategy for the general public involves using various channels and 
media to address three different target groups. These were identified by ISOE in an empiri-
cal survey as reacting differently to the problem under review: 
·  ‘The Deniers/Relativists' 
·  ‘The Truth-Seekers' 
·  ‘The Hypersensitives' 
The intention is to address each target group in the right tone and using the most suitable 
line  of  reasoning  via  specific  media  and with the  proper  degree of differentiation.  The 
‘Truth-Seekers' play an opinion-leading role here. They can be provided with highly differ-
entiated information through sophisticated media which they then pass on to their dialogue 
partners in an appropriate form. 
The second part of the strategy for the general public relates to the communication of 
proper disposal routes for expired drugs. The goal is to confine disposal to pharmacies so 
that on no account are they flushed down the sink or toilet. Based on an analysis of typical 
errors in existing communications media on this topic, ISOE prepared recommendations for 
drafting proper information materials. 
In addressing pharmacists, the first priority is to convey hard facts: to this end we propose 
a PR campaign to place articles in the main specialist media. At the same time, the subject 
should  feature  in  training  and  continuing  education  programmes.  Another  aim  is  to 
strengthen the advisory function of the pharmacies. The environmentally sensitive target 
group would indeed react positively to having their attention drawn to the issue of drug 
residues in water. For all other customers, the pharmacists can and should act as consult-
ants: they emphasise how important it is to take medication as instructed (compliance) and Communication Strategies 
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use suitable pack sizes, and warn older customers in particular about the potential hazards 
of improper drug intake. 
The first stage of the communications strategy for doctors likewise revolves around knowl-
edge. Here, however, it is important to take into account their self-image as scientists while 
in fact having little grasp of this specific area. The line to take is that of ‘discursive self-
enlightenment'. This means that the issue of drug residues in water cannot be conveyed to 
doctors by laymen but must be taken up and imparted via the major media of the medical 
profession and by medical association officials (top-down). 
The second stage, namely that of raising doctors’ awareness of the problem, is likely to 
encounter strong resistance from some of the medical profession. They may fear a threat of 
interference in treatment plans from an environmental perspective and feel the need to 
emphasise that doctors are not responsible for environmental issues. As shown in empirical 
surveys by ISOE, such a defensive reaction is ultimately down to an underlying taboo: peo-
ple are loath to discuss the over-prescription taking place in countless doctors' surgeries. 
And it is a fact that this problem cannot be tackled from the environmental perspective, 
although the goals of water protection are indeed consistent with the economic objectives 
of restraint in the deployment of drugs. Any communications measure for this target group 
has to bear in mind that doctors feel restricted by what they see as a ‘perpetual health re-
form' no matter which government is in power. On no account are they prepared to tolerate 
any new form of regulation, in this case for environmental reasons. 
An entirely different view of the problem is taken by ‘critical doctors' such as specialists in 
environmental health and those with a naturopathic focus. They are interested in the prob-
lem because they see a connection between the quality of our environment and our health. 
What is more, they have patients keen to be prescribed as few drugs as possible and who 
are instead interested in ‘talking medicine'. So, any communication strategy intent on tack-
ling the difficult problem of oversubscribing drugs needs to look carefully at the experi-
ences of these medical professionals and also at a ‘bottom-up strategy'. 
Implementation of strategic communications should be entrusted to an agency with experi-
ence in ‘issue management'. Knowledge of social marketing and the influencing of behav-
iour  are  further  prerequisites.  All  important  decisions  should  be  taken  by  a  consensus 
committee (‘MeriWa'
1 round table), in which the medical profession, pharmacists and con-
sumers are represented. 
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Preliminary comments  
In order to reduce drug residues in the environment, an awareness of the problem needs to 
be promoted amongst those responsible in the health system and amongst the population. 
The will to take sustainable action must also be strengthened. In this handbook, we there-
fore present communication strategies designed to help prevent environmental risks in the 
handling of pharmaceuticals. These preventative measures concern the overall handling of 
medications, from prescription through usage down to disposal. The German Federal Envi-
ronment Agency or other institutions can only raise awareness and bring about changes in 
behaviour within this field by addressing the major players in the health system. 
These include doctors, pharmacists and users of pharmaceutical drugs. Appropriate meas-
ures of communication are required to suitably address each of these target groups. As we 
have seen from the results of various empirical surveys, the general public knows virtually 
nothing about the problem. There is also a risk of individual aspects being misunderstood, 
dramatized or vehemently repelled. 
This is why forward-looking strategic communication with elements that interlink and build 
on each other makes sense. Communication of this kind is referred to as ‘issue management'. 
The handbook presents communication strategies which are geared to the above-mentioned 
target groups and designed to promote the sustainable handling of pharmaceuticals. Special 
attention is given here to the fact that, to some extent, the motivation to undertake preven-
tative action has to be drawn from what is only a vague grasp of the facts. This places spe-
cial demands on communication. 
The handbook consists of four sections: 
1.  Background information on the state of research and the legislative framework 
2.  Basic information on risk awareness 
3.  Recommendations on how to draft communication material explaining how to dispose 
of expired drugs 
4. The centrepiece of the handbook: recommendations outlining the specific strategies for 
the general public, doctors, pharmacists and hospitals 
The handbook is primarily directed at the staff of the German Federal Environment Agency 
working in specialist departments such as Wastewater, Disposal, Chemical Risk Assessment, 
and Communications. It may, however, also be used by all interested parties in the um-
brella organisations of doctors and pharmacists as well as by health insurance companies 
and consumer advice bureaus. 
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1  Background and problem definition 
Pharmaceutical drugs are for many people an indispensable part of a healthy life free of 
complaints. However, the early 1990s saw the somewhat incidental discovery in Berlin's 
drinking water sources of what was at the time a commonly used drug for reducing blood 
lipid levels. The downside of using pharmaceutical drugs became very apparent: following 
drug intake, the active ingredients and their metabolites are for the most part excreted with 
the urine and end up in the water cycle. Our sewage plants are not as yet capable of fully 
eliminating these substances. Trace concentrations of active pharmaceutical ingredients are 
thus now ubiquitous in the aquatic environment: numerous studies describe over 100 dif-
ferent substances in almost all of Germany's surface waters, in groundwater influenced by 
such surface waters, and occasionally even in drinking water. There are circa 3,000 active 
ingredients available on the German market alone. The only reason why a mere fraction of 
these have been found in the environment is due above all to the lack of specific methods 
for detecting what are generally highly complex molecules. 
Given these findings, the environmental relevance of pharmaceutical drugs in the water 
cycle is today undisputed. The degree and nature of the risk to the environment or to hu-
man beings does, however, remain unclear. The main reason for the on-going debate is the 
high degree of scientific uncertainty about possible hazards for the environment or hu-
mans. So far, the only certainty is deemed to be that individual active ingredients are capa-
ble of impacting negatively on aquatic life. On the other hand, as far as we are currently 
aware, acute risks to human health from polluted drinking water can virtually be ruled out. 
Nonetheless, the nagging question still remains as to the chronic effects that may arise 
from a lifelong intake of active drug ingredients, albeit in sub-therapeutic doses. 
Pitted against these uncertainties in scientific risk assessment are two certainties in the way 
societies approach the problem. On the one hand, drug residues in water bodies are unde-
sirable – and still more so in drinking water. As basis for life itself and as the most essen-
tial of all foods, water is not only of factual but also of strong symbolic significance. Peo-
ple do not want drug residues in their drinking water, regardless of whether they represent 
a proven health risk or not. On the other hand, individuals and society as a whole associate 
pharmaceutical drugs with considerable benefits – at least in the case of human therapeu-
tics. In case of doubt, this means that based on ethical considerations, if nothing else, 
health protection is always likely to take precedence over environmental protection. 
At the European level, this deliberative stance is reflected in the current laws for market 
authorisation of human therapeutics. Legislation allows effective risk-mitigation measures 
only within a tightly restricted framework. To sustainability strengthen risk prevention, it is 
therefore necessary to identify and implement measures (also those beyond the legislative 
approach) that are capable of effectively reducing the entry of active pharmaceutical ingre-
dients into the environment. These include the development of innovative active pharma-
ceutical ingredients with a better environmental performance, along with more advanced 
technical measures to protect water bodies. Another key sphere of action is the actual han-
dling of drugs themselves, i.e. the way they are prescribed, sold, used and disposed of.  Communication Strategies 
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A modified approach to handling pharmaceutical drugs holds great potential for strength-
ening risk prevention (cf. ISOE 2009; start 2008; Keil 2009). However, to activate this po-
tential it is necessary to fully inform important actors within the health system and make 
them aware of the problem. This calls for target-group-specific communication measures 
that reach out to the medical profession, pharmacists and users of pharmaceutical drugs, 
respectively.  
This handbook presents communication strategies that have been tailored to these target 
groups with the intention of promoting sustainable handling of pharmaceuticals. Special 
consideration has been given to the fact that the motivation to act rests on a somewhat 
shaky knowledge base. This difficult situation places special demands on communication. 
 
1.1   The environmental relevance of pharmaceuticals for human use: an overview 
The occurrence of active pharmaceutical ingredients in the environment is largely a side-
effect of their intended use. In order for the substances to work properly, they must mani-
fest a minimum degree of stability. A sufficient number of intact drug molecules must 
reach the diseased cell before being broken down into various metabolites by the biochemi-
cal processes taking place in the body. Active substances are generally optimised to achieve 
the required stability and this has two consequences. On the one hand, the active ingredi-
ents do not fully metabolise in the body and, instead, are predominantly excreted via the 
urine, in some cases in an unmodified state. In this way they end up in domestic sewage. 
On the other hand, the desired stability of the molecules prevents their biological degrada-
tion in our sewage plants (which are based on the activated sludge system): elimination 
rates of between zero and 100 per cent are observed, depending on the active ingredient at 
stake (cf. Ternes et al. 2004, 2005). On being released into the rivers and lakes with the 
discharge  from  sewage  plants,  the  stable  molecules  then  can  find  their  way  into  the 
groundwater and ultimately back to human beings via the drinking water.  
These diffuse inputs via domestic sewage represent the main source of active pharmaceuti-
cal ingredients in the environment. In contrast to this, pharmaceutical production plants, 
hospitals and other medical facilities (e.g. nursing homes) are considered point sources. 
Whereas polluted industrial effluents play a secondary role, at least in Europe (cf. Larsson 
et al. 2007; Thomas et al. 2007), current studies put the contribution of hospitals towards 
the overall annual volume released into the environment at 10 to 20 per cent (Feldmann et 
al. 2008; Schuster et al. 2008; Alder et al. 2006). Another source of input on top of those 
named is improper disposal of expired drugs via the toilet or wash basin/sink. Figure 1 
illustrates the materials cycle. 
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Fig. 1: Input paths of active ingredients from pharmaceuticals for human use entering the environment 
(start 2008: 14) 
 
1.1.1  Occurrence of active pharmaceutical ingredients in the environment 
The current state of knowledge on the occurrence of pharmaceuticals in the environment 
has been extensively documented in a large number of publications (see for example Küm-
merer 2008; LANUV NRW 2007; German Council of Environmental Experts 2007; Schulte-
Oehlmann  et  al. 2007).  The  following  therefore  assembles  merely  those  facts  crucial  to 
gaining an insight into the problem. Communication Strategies 
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In Germany there is only limited availability of consumption figures for pharmaceuticals as 
manufacturers are not obliged to publish their production volume. The health insurance 
companies have access to data on annual prescription rates; nonetheless, these figures do 
not reflect the non-prescription drug (OTC) market which is also experiencing growth due 
to internet trade. The data available at present dates from 1996–2001 and was published by 
the German Federal Environment Agency on the basis of data from the Institute of Medical 
Statistics (IMS Health AG). According to this data, a total of 38,000 tons of pharmaceuticals 
was dispensed by pharmacies and hospitals in 2001 (UBA 2005). This volume was spread 
over 2,671 different active ingredients. The data showed painkillers (analgesics) and anti-
inflammatories to be amongst the active substance groups with the highest sales figures 
(ca. 2,500 tons), followed by antibiotics (approx. 500 tons), anticonvulsants (approx. 200 
tons) and medication to reduce blood pressure (antihypertensives, beta-receptor blockers, 
approx. 150 tons).  
Where large quantities of an active ingredient are consumed, it is an indicator of the sub-
stance’s widespread presence in the environment. Correspondingly, the occurrence in the 
environment of pain-relieving and anti-inflammatory agents such as diclofenac and ibupro-
fen, antibiotics such as roxythromycine and sulphamethoxazole, anticonvulsants such as 
carbamazepine and primidone, and hypertensives such as metoprolole and sotalole has been 
proved particularly frequently. Added to this is another group of substances that are not 
strictly speaking pharmaceuticals but belong to the so-called diagnostics such as x-ray con-
trast agents like iopromide or amidotrizoic acid. On average, the concentrations measured lie 
between a few billionths to several millionths of a gram per litre (nano or micrograms per 
litre). Similar findings exist internationally for most of the industrialised countries. 
The concentrations of active ingredients in rivers and lakes are normally far higher than in 
groundwater (cf. BLAC 2003). This is due to the fact that the substances in surface waters 
strongly  degrade  before  reaching  aquifers:  biologically  via  microorganisms  and  photo-
chemically via solar radiation. Furthermore, they can become adsorbed to suspended matter 
and particles. The following table gives examples of environmentally relevant data for se-
lected active pharmaceutical ingredients. These are the maximum values based on single 
measurements. Communication Strategies 
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Maximum concentrations in µg/l 
Active  
ingredient 
Indication group 
Consumption 
(2001) in kg  Surface  
water
  Groundwater
  Drinking 
water 
Amidotri-zoic acid  x-ray contrast agents  60,700  0.950
  0.650
  0.085 
Carbamazepine  Anticonvulsants  87,600  1.810  0.110  0.030 
Cyclophosphamide       Cytostatics  385  0.100  **  0.008 
Diclofenac  Antirheumatics  85,800  2.000  0.030  0.001 
Ethinyl-estradiole  Hormone  50  0.005
  0.002  0.023 
Ibuprofen  Antirheumatics  344,880  1.500  0.510  0.003 
Ifosfamide  Cytostatics  170  0.180  **  No findings 
Iopromide  Radiocontrast agents  64,100  8.5
  0.22
  0.086
 
Metoprololl  Anti-hypertensives  93,000  1.800  0.030  No findings 
Primidone  Anticonvulsants  10,000  0.560  No findings  No findings 
Roxythromycine  Antibiotics  9,550  0.060  0.026  No findings 
Sotalole  Antihyper-tensives  26,600  0.850  0.560  No findings 
Sulphamethoxazole  Antibiotics  53,600  0.380  0,030  No findings 
Table: Data on the occurrence of active pharmaceutical ingredients in the aquatic environment (non-
representative single measurements) (** below the detection limit; sources: BLAC 2003; LANUV NRW 2007 and 
bibliographical references therein) 
If a certain active ingredient is not found in the environment, this may essentially be due 
to the following: either there is no specific technique to prove its existence or it is degraded 
in the human body to such an extent that mainly metabolites rather than the original sub-
stance are excreted. Since the structure of these metabolites is generally unknown, they 
normally escape the search lights of an environmental analysis. For a comprehensive risk 
assessment, transformation products of this kind are of special importance since virtually 
nothing is known about their toxicological properties. It is not only metabolites that are at 
stake here but also some unknown products which occur during the course of natural deg-
radation processes or in technical wastewater treatment and drinking water processing. 
 
1.1.2  Occurrence of pharmaceutical active ingredients in drinking water 
Two thirds of Germany's drinking water is sourced from groundwater. The rest comes from 
surface waters (rivers, lakes or reservoirs), bank filtration and enriched groundwater. Bank 
filtrate is a mixture of groundwater and river water extracted via wells close to the banks 
of rivers or lakes. Enriched groundwater is obtained via artificial means by percolating 
surface waters (generally pre-purified river water or treated wastewater) through appropri-
ate springs or ponds. In both cases, passage through the soil leads to at least partial degra-
dation of pollutants. Surface waters and bank filtrate are generally far more polluted with 
pharmaceutical drug residues than groundwater. This poses something of a risk for water-
works, which extract water from both these raw water sources, in that the drinking water 
could also contain traces of active substances. In Germany, however, many of these water-Communication Strategies 
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works deploy activated carbon filtration (often coupled with ozonation) for the treatment of 
drinking  water.  With  the  exception  of  a  few  x-ray  contrast  agents,  the  procedure  has 
proved effective in removing active pharmaceutical ingredients and other micropollutants 
(Ternes et al. 2005). 
In actual fact, the occurrence of active pharmaceutical ingredients in German drinking wa-
ter samples has so far only been proven in isolated cases. A current review of the literature 
(LANUV NRW 2007) substantiates the occurrence so far of 15 different active pharmaceuti-
cal ingredients in drinking water (cf. also Table above). As to be expected, the concentra-
tions measured, amounting to a few billionths of a gram per litre (a few nanograms), are 
far lower than those in surface water or groundwater.  
 
1.1.3  Potential risk for humans and the environment 
Very little is yet known about the possible risks to the environment posed by pharmaceuti-
cal drug residues. Ecotoxicological studies are only available for a few substances. The rea-
son for this is not just the vast array of substances but above all the fact that significant 
results can only be achieved through long-term studies. However, the ascertainment of 
chronic  effects  in  such  studies  calls  for  considerable  investment  in  terms  of  time  and 
money. Most of the active pharmaceutical ingredients investigated to date are only acutely 
toxic for aquatic life in concentrations that far exceed current values measured in water 
bodies (for an overview of the current status of ecotoxicological knowledge cf. German 
Advisory Council on the Environmental 2007; LANUV NRW 2007).  
One example, however, shows that even the concentrations typically found in water bodies 
may pose a risk for aquatic life: the active ingredient 17a-ethinylestradiol (EE2) is deployed 
in most hormonal contraceptives and occurs in the aquatic environment in concentrations of a 
few nanograms per litre (see Table). It has been shown that, due to its high oestrogenic po-
tency, EE2 is a substantial contributor to the feminisation of male fish in habitats close to 
sewage treatment plant outlets (Jobling et al. 1998). Given the current state of knowledge, 
it is impossible to rule out particularly sensitive reactions to a certain active substance in 
the proven concentrations by other animal species or plants. This is shown by the much 
discussed example of the anti-inflammatory ‘diclofenac’, which in Pakistan and India led to 
the near-total extinction of three types of vulture (Oaks et al. 2004). They had fed on the 
carcases of cattle that had previously been treated with the drug.  
In terms of human health toxicity, active pharmaceutical ingredients are amongst the most 
stringently tested substances. During the drug licensing process, an active ingredient is 
tested not just for its therapeutic efficacy but also for a variety of undesirable side-effects 
to patients.
2 The overwhelming expert view is that the incidence of such side-effects and a 
potential threat to health through consumption of contaminated drinking water may be 
largely ruled out (Webb et al. 2003). This can be illustrated using a simple piece of arithme-
tic. It was possible to identify the above-mentioned active ingredient ‘carbamazepine’, de-
                                         
2
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ployed  in  anticonvulsants  and  antidepressants,  in  individual  drinking  water  samples  in 
maximum concentrations of 30 nanograms per litre (cf. Table). If they consumed two litres 
of water a day over a 70-year life span, a human being would only ingest a few thou-
sandths of the recommended daily dose of the drug (around 600 milligrams). 
 
1.1.4  Fundamental problems of risk assessment 
Risk assessment based solely on a comparison with therapeutic doses does, however, only 
cover part of the potential risk. It fails to take into account possible unknown effects of 
micro doses. For example, the possible chronic effects of ingesting sub-therapeutic doses of 
active ingredients throughout a lifetime remain largely unexplored. The possible effects 
from substance mixtures is likewise unexplored. The risk assessment of chemicals generally 
involves evaluation of individual substances. In the environment, however, living things 
are simultaneously exposed to many substances. According to current knowledge, the ef-
fects of the individual substances accumulate in as far as they manifest the same mecha-
nism of action (cf. Kortenkamp 2007; Sumpter et al. 2006). Exactly how such ‘cocktail ef-
fects' can be adequately accounted for in risk assessment so far remains unclear. Risk as-
sessment is further complicated by the numerous degradation products from pharmaceuti-
cal ingredients which originate in the human body, sewage plants or water bodies. Virtu-
ally nothing is known about their toxicological properties. 
 
1.2  Current European legislation 
1.2.1  Drug authorisation procedures 
An environmental risk assessment (ERA) for the authorisation of new human therapeutics 
in Europe was made obligatory as early as 1993 (Directive 93/39/EG). This directive has 
also been applicable to generics since 2004 (Directive 2004/27/EG on amending the Com-
munity Code 2001/83/EG). Pharmaceuticals approved before this directive came into effect 
do not need to undergo a retrospective ERA. However, as of 1.12.2006, there is a uniform 
technical standard for the ERA in place which has to be initiated by the drug manufacturer. 
It takes the form of a guideline for the ERA itself, drawn up by the European Medicines 
Agency (EMA). It is used both for Europe-wide and for national drug authorisation. In 
Germany, the Federal Environment Agency in collaboration with the Federal Institute for 
Drugs and Medical Devices (BfArM) is carrying out the ERA. Since the guideline has only 
been available since the end of 2006, very few active pharmaceutical ingredients have so 
far been tested according to these regulations during the authorisation procedure. 
Directive 2004/27/EG defines two types of risk that may accompany the use of a pharma-
ceutical drug. On the one hand there are risks to public health or the health of patients 
relating to the quality, safety and efficacy of a drug. On the other hand, undesirable effects 
on the environment are also seen as risks. Of crucial importance here: the environmental 
risks are not part of the decisive risk-benefit analysis for authorizing a drug. This means 
that even if an environmental risk is ascertained during the ERA, it is not possible to ex-
pressly refuse authorisation of the drug. In such a case, the only course of action available 
is to request preventative measures. However, the actual options open to the authorities Communication Strategies 
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responsible are currently very restricted in this respect. In practice, they are confined to 
including in the package leaflet and in specialist information for doctors and pharmacists a 
reference to the need for proper disposal of unused drugs. The legal situation is different 
for veterinary pharmaceuticals: here, authorisation may be refused or made subject to cer-
tain conditions if an environmental risk is assessed (Directive 2004/28/EC on amending the 
Community Index 2001/82/EC). 
 
1.2.2  Protection of drinking water and water bodies 
At present, there are no binding thresholds for active pharmaceutical ingredients in surface 
waters and groundwater, neither at European level nor in Germany. In principle, however, 
it is indeed legally possible to set such thresholds, for instance in the European Water 
Framework Directive. Nor have any European thresholds for active pharmaceutical ingredi-
ents so far been set for drinking water (in the Drinking Water Directive 98/83/EG), whether 
for human-use or veterinary drugs. To date, the German Directive on the Quality of Water 
for Human Consumption does not define any binding limit values for active pharmaceuti-
cal ingredients. For these and other as yet non-evaluated substances, the German Drinking 
Water Commission merely recommends a precautionary limit of 0.1 microgram per litre –a 
threshold that, however, is non-binding and toxicologically unsubstantiated. 
 
1.2.3  Disposal of expired pharmaceuticals 
Apart from a few exceptions such as cytostatics, medications are not legally classified as 
hazardous  waste  (cf.  Directive  for  Implementation  of  the  European  Waste  Catalogue  of 
10.12.2001, BGBl. I S. 3379). For this reason it is basically legitimate to dispose of expired 
or unused drugs along with household waste. From an environmental perspective, this can 
be seen as unproblematic, since according to the Technical Directive on Urban Waste dat-
ing from 1993 (Federal Gazette No. 99a from 29.5.1993), all urban waste have to undergo 
pre-treatment as of 1.6.2005. This means almost entirely thermal energy recovery in waste 
incineration plants. This is likely to have greatly reduced the risk of future groundwater 
pollution from active pharmaceutical ingredients in landfill leachate.  
Directive 2004/27/EG
3 provides for the setting up of collection systems for unused or ex-
pired pharmaceutical drugs in order to guarantee proper disposal of the substances (Article 
127b). All member states were required to make such systems available by October 2005. In 
Germany a system by which pharmacies took back expired drugs was installed. The inten-
tion with this system was that manufacturers of pharmaceutical drugs and other medical 
products should honour their obligations as per the Packaging Ordinance for the Recycling 
of Valuable Substances (e.g cardboard and paper from pharmaceutical packaging). It is in 
fact a special solution for the sector, which was not part of the ‘dual system' regulation. 
According to the main operator of the take-back system – VfW Remedica – a good three 
quarters of all pharmacies in Germany participated in the scheme in 2008.  
                                         
3
   Directive 2004/27/EC of the European Parliament and of the Council amending Directive 2001/83/EC on the 
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Subsequent to the fifth amendment to the Packaging Ordinance which came into effect on 
1 January 2009, all packaging must today be registered and licensed with ‘Duales System'. 
This does away with the exemption of expired drugs and their repackaging, on which the 
take-back system was based. According to VfW Remedica, under the new regulations, the 
cost of disposing of expired pharmaceutical drugs can no longer be generated, as now the 
drug manufacturers pay Duales System directly instead of VfW Remedica. As a result, the 
latter initially halted disposal of expired drugs as of 1 June 2009. 
The question as to how Germany will organise the disposal of expired drugs in future cur-
rently remains unresolved. In negotiations between the pharmaceutical industry, pharmacy 
associations  and  VfW  Remedica,  a  fee-paying  system  for  pharmacies  is  now  emerging 
(status as of February 2010). It is not yet possible to predict whether this means that the 
safest option and the one favoured by the Federal Agency for the Environment and others 
(cf. start 2008, namely that of returning expired drugs via the pharmacy) can be maintained.  
 
1.2.4  The role of the precautionary principle  
The precautionary principle enjoys special significance when it comes to ‘pharmaceuticals in 
the environment'. The precautionary principle has been one of the most important legal 
tenets in European environmental legislation since the Maastricht treaties of 1992 (Treaty on 
European Union, 92/C 191/01, Article 174). It legitimises decisions and the measures based 
on them, even in cases where something is known to have potentially harmful effects on 
humans and the environment but the risk cannot be scientifically proven with sufficient 
certainty (European Commission 2000). Put another way: without knowing for certain the 
likelihood and extent of possible damage, the aim is to avoid it from the outset.  
This is the case when it comes to possible risks for the environment or human beings from 
active pharmaceutical ingredients in the water cycle. In order to ascertain a risk, it is neces-
sary to establish a relationship between a cause and any harmful impact observed. In risk 
assessment for chemicals in general and for active pharmaceutical ingredients in particular, 
however, there are only rare cases where this is possible. The reasons for this are essentially 
two-fold. On the one hand the range of substances is vast. This means that negative impacts 
can not necessarily be traced back to one in particular. The effects can also be triggered by 
the combined and simultaneous impact of several substances. On the other hand, there may 
be long periods between a cause and evidence of its impact. It is extremely difficult to ascer-
tain by scientific methods a causal relationship in chronic reactions of this kind.  
The precautionary principle is based on the normative requirement to create room for ma-
noeuvre and safety margins, even for risks possibly emerging as such sometime in the future 
as opposed to the here and now (Calliess 2006; von Schomberg 2005). The regulations cur-
rently in place for the EU – particularly the mandatory ERA when authorizing a new active 
pharmaceutical ingredient – are to be viewed in the context of the precautionary principle. 
As shown in empirical studies (cf. Ch. 4.2 Population-specific Strategy), it is particularly 
important to refer to the precautionary principle when designing communication strategies 
for the sustainable handling of pharmaceutical drugs. Given the uncertainties involved in Communication Strategies 
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assessing the risks, the main difficulty with concrete preventative measures is, however, to 
guarantee commensurability (Keil 2008). It is also vital to avoid any conflict of aims be-
tween the individual actors. For the issue ‘Pharmaceuticals in the environment' this means 
that preventative measures' at the de facto and communication level must not be allowed 
to detract in any way from the quality of medical care.  
 Communication Strategies 
Pharmaceutical Drugs and the Environment 
 
  19 
2  Risk awareness in society 
What features and characteristics determine the degree to which a risk is perceived as threat 
by individuals and by society? Are different types of risk perceived in different ways? The 
following brief outline provides an insight into the theory behind risk perception to allow a 
better  understanding  of  risks  and  the  importance  of  adapted,  target-group-specific  risk 
communication. These basic principles should enable better appreciation of target group 
characteristics when developing risk communication (cf. Population-specific Strategy). 
 
2.1  Fundamentals of risk perception 
Exactly how a risk is perceived does of course depend on the risk itself, but subjective and 
social factors also play a role. Flight, fighting, feigning death, and inquisitive experimenta-
tion (Renn et al. 2007) are considered evolutionary responses to danger, i.e. developed over 
the course of human evolution. As society developed, further graduations of such (some-
what archaically rooted) responses emerged and became part of cultural and social assess-
ment. Psychologically measurable characteristics that influence individual risk perception 
and are subject to these cultural evaluations are referred to as psychometric traits (Junger-
mann/Slovic 1993; Zwick/Renn 2002). They include aspects such as the personal benefit 
arising from the desired effects of the risk source. Take, for instance, mobile communica-
tions, with mobile reachability on the one hand and the possible exposure to radiation on 
the other. What counts when subjectively assessing a risk is whether people are putting 
themselves at risk voluntarily, how much they know about the risk, and to what degree 
they can influence it. Another crucial factor is whether the risks and rewards are fairly dis-
tributed in society. This reflects the important fact that sections of society are indeed pre-
pared to bear certain risks as long as the reward is high enough and the risk not unfairly 
distributed, and providing they can personally influence the risk to themselves. 
The subjective rating of a risk also depends on the characteristics of the risk source. These 
include (according to: Renn et al. 2007: 78; Jungermann/Slovic 1993) 
–  the degree to which people become accustomed to the source of risk, 
–  the potential for catastrophe inherent in the risk source, 
–  the probability of fatal consequences should a risk actually materialise, 
–  undesirable consequences for the next generations, 
–  a sensory perception of the danger in question, 
–  the sense of being able to reverse the consequences of a risk. 
Depending on their characteristics, risks are perceived within so-called mental pigeonholes, 
namely as a direct threat, a stroke of fate, a challenge to personal resources, a gamble, or 
an  early  warning  of  slow-onset  hazards.  These  ‘mental  pigeonholes'  are  systematically 
linked with risks of different types (cf. Renn et al. 2007: 80ff.). Examples are technical risks 
(e.g. nuclear power plants) as an immediate threat, natural catastrophes as a stroke of fate, 
risks associated with sport or financial investment as a challenge on personal resources, 
and BSE, genetically modified products, or radiation from mobile communications as slow-
onset hazards. Communication Strategies 
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2.2  Target-group specific perception 
With typological differentiation it is possible to ascertain how the different social groups 
perceive risk. Empirical studies (for mobile communications example: Büllingen/ Hillebrand 
2005) have demonstrated the need for target-group-specific risk communication. This means 
that instead of directing risk communication at the unspecific, homogeneous population, it 
should be addressing groups with their differing perceptions and ways of dealing with risk. 
The target groups thus defined can reflect the above-mentioned characteristics of subjective 
risk assessment along with personality traits (e.g. attitudes, values, behaviour) and people’s 
socio-demographic situation.  
With the help of such typologies, it is possible to pinpoint the information channels and 
media most likely to reach the groups, and ascertain how receptive they are to the subject, 
how strong their need for information, and the kind of information that needs to be con-
veyed. 
Perception of the risk under review here, namely that posed by active pharmaceutical in-
gredients in the environment, is influenced by the following: 
–  Pharmaceuticals represent a strong social benefit. 
–  The specific risk is not (as yet) obvious via sensory perception. 
–  The individual has virtually no means of controlling the risk. 
–  The risk potentially has undesirable consequences for future generations. These are not 
known but merely hypothetical. 
–  Water is an indispensable staple food. Hence there is virtually no question of voluntari-
ness in exposing oneself to this risk. 
 
Target-group-specific risk communication 
Risks trigger very different reactions and coping patterns in different social groups. It is therefore fair 
to assume that these reactions substantially determine whether and how strongly a risk is perceived 
as such, as well as affecting people‘s willingness to change their behaviour accordingly.  
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3  Analysis of communication materials concerning the disposal of unused  
or expired drugs 
The German public still knows very little about the problem of water pollution from drug 
residues. Nevertheless, in Germany, and internationally, there are plenty of examples for 
communication intended to alert people to this issue and to promote an understanding of 
suitable solutions. They differ greatly in the information they provide and how they impart 
it. Of course, communication in this context also depends on the respective national systems 
for disposing of unused or expired drugs. Although the scope of this handbook cannot ex-
amine all of these individually, an analysis of several sample communication materials is 
very revealing when it comes to developing an appropriate module within the communica-
tion strategy. 
The analysis drew on materials which are accessible online, mainly flyers or posters along 
with several TV commercials. The selection of print media was confined to documents in 
German and English. The commercials also included Spanish, Portuguese and French ads. 
All in all, materials from Germany, Australia, France, Canada, Austria, Portugal, Switzer-
land, Spain and the USA were evaluated. 
The main goal is to derive recommendations from the existing examples for a communica-
tion strategy in Germany.  
 
3.1  Actors: who communicates with whom? 
The  material  was  predominantly  commissioned  by  public  institutions.  These  included 
governments,  public  authorities  or  environment  ministries  at  different  federal  levels. 
Another important group of actors is comprised of semi-private initiatives founded espe-
cially to tackle the disposal of unused or expired drugs. Examples are RUM (Return Un-
wanted Medicine) in Australia or SMAP x T DISPOSAL in the USA. Also amongst the origina-
tors  are  non-governmental  organisations  –  mainly  environmental  associations.  Private-
sector companies such as Sanofi Aventis represent a marginal group. 
 
3.2  Subject matter of the materials: action guidelines and background information  
The materials differ greatly in what they communicate. On the one hand they provide ac-
tion guidelines, recommending either disposal of unused or expired drugs via domestic 
waste, returning them to pharmacies, or participating in take-back/collection programmes. 
Over and above this, a small number also suggest how to demonstrate greater awareness 
when handling pharmaceuticals. Furthermore, the recommended guidelines are often justi-
fied in different ways. In the case of American information material, safety aspects play a 
particularly important role. The focus is on preventing risk to children and addicts from 
unused or expired drugs in the household or through improper disposal. 
The examples differ further in the amount of information offered. Some merely suggest 
how to dispose or not to dispose of unused or expired drugs. Others provide comprehensive 
background information on the problems posed by drug residues in the environment, in-
cluding entry paths, cause-and-effect mechanisms, and scientific uncertainties. 
 Communication Strategies 
Pharmaceutical Drugs and the Environment 
 
  22 
 
3.3  Implications and recommendations arising from the analysis 
Analysis of the materials
4 shows the importance of thinking through such information me-
dia and using a professional approach to prepare them in order to avoid typical errors and 
enable constructive communication of the problem. The main priority is to word the key 
message clearly and concisely. It needs to be highlighted by an appropriate layout so that it 
is seen and understood at a glance. Visuals should not (merely) illustrate but should them-
selves take the form of action guidelines or provide signals for taking action. Background 
information placing the problem in context should be brief and secondary to the key mes-
sage. It should be simply and intelligibly worded. It is always preferable to use an active form 
of address instead of the passive tense. It can prove helpful to use a question and answer 
format, using intuitive questions that people ask themselves: ‘What do I do with the old 
drugs? Can I pour cough mixture down the toilet? Does the packaging go in the yellow sack? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
               
                                         
4
   Cf. links in Sources of communication materials, p. 67f. and graphic materials in Annexes, p. 69ff. 
Potential content to be conveyed via communication media  
￿  Environmental relevance of drug residues 
￿  Improper disposal as an entry path  
￿  Action guidelines for proper disposal 
￿  Safe storage and disposal of pharmaceutical drugs  
￿  A responsible approach to pharmaceutical drugs vis-à-vis prescription, purchase and alternatives 
to medication  Communication Strategies 
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Rules for constructive communication via flyers, info sheets and internet information 
￿  In the case of flyers or internet messages, people often only notice and look at the title page or 
home page. The main message – concisely worded – thus has to catch the eye immediately and be 
intuitively clear. 
–  Here it may prove helpful to apply the ’call from the kitchen‘ rule: the message must be 
understood when shouted from the kitchen to someone elsewhere in the home. 
–  It is important to avoid a distracting array of logos on the title page and blanket/generally 
worded headings. 
￿  The most important background information should follow the key message, lending meaning to 
actions. 
–  Here again, it should be readily understandable just by skimming the text. For this reason, any 
factual information should not be overly differentiated – instead they can be placed in the inter-
net by way of supplementary information. 
–  The background information should use short, simple sentences that are easily accessible to 
laypeople. Convoluted sentences or scientific jargon should be avoided. 
–  The message must be logically compelling for all segments of the population. It is thus 
important not to moralise or declare ecological imperativess. 
￿  The aim is to create a visual/text ensemble that interacts to convey intuitively, i.e. in a non-
roundabout way, the right action to take. 
–  The graphic material must serve the declared communication goal. The pictures should impart 
the message so effectively as to be clear even without the text. Meaningless illustrations with 
no real reference to the message must be avoided. The text should be made to seem redundant. 
–  The illustrations must be of a professional quality, striking, attractive and immediately 
understandable. They may also use emotion, working with devices such as humour, as long as 
the humour supports the forcefulness of the message and is not likely to be misunderstood. 
–  The ratio of illustrations to text must be pleasing to the eye. The text should be set in an open, 
airy layout, making it easy to absorb, and avoiding the impression of a solid block of text that 
puts people off reading. Communication Strategies 
Pharmaceutical Drugs and the Environment 
 
    25 
4  Recommendations 
4.1  Overarching activity: institutionalisation and issue management 
4.1.1  Background to the problem 
Many tasks presenting themselves on the strategic communication side can be delegated to 
scientists, communication and PR agencies, or professionals in the field. Areas in question 
include specialist articles, campaigns, personal communication and the lobbying of panels 
and expert committees. There is, however, a risk of the communication work fragmenting 
into many single activities, whereas a coherent communication strategy calls for overall 
co-ordination by a resolution panel.  
Such co-ordination can be achieved by drawing on the so-called public affairs approach, 
with the issue management tool that has proved so useful in policy advisory work. “Public 
affairs is the strategic management of decision-making processes in dialogue between poli-
tics, business & industry. It makes for the sustainable inclusion of companies, associations, 
interest  groups  and  organisations”.  (de|ge|  pol  2005:  9,  English  translation  by  Maxine 
Demharter). Issue management is used for the systematic planning and control of commu-
nication processes (Dujic/Johanssen 2006). It allows a topic to be strategically positioned in 
public opinion and in different political and institutional arenas. With issue management, 
undesirable developments in the communication process can be prevented, and, if need be, 
responded to actively and in good time.  
 
4.1.2  Guidance 
Issue management takes place via steering bodies such as a round table discussion with the 
major stakeholders and actors affected by the issue. This body should be institutionalised 
for a limited period (at least two years) and run on its own budget. This steering body may, 
for example, be affiliated to the Federal Ministry for the Environment, Nature Conservation 
and Nuclear Safety (BMU), with the Federal Environment Agency (UBA) in a co-ordinating 
capacity.  
The umbrella organisations of the medical profession and the pharmacists are not organised 
on a strictly top-down basis. Decisions always have to pass through a number of state su-
pervisory boards. We therefore propose allowing sufficient time for the approval processes. 
 
MeriWa – Round table on ”Drug residues in water“  
￿  Setting up the round table at the initiative of the UBA/BMU; getting relevant stakeholders on board  
￿ Round table co-ordination by the UBA 
￿ Round table composed of decision-makers from 
–  Pharmacists‘ associations 
–  Doctors‘ associations and specialist organisations (environmental health doctors) 
–  Consumer protection organisations  
–  Joint Federal Committee (G-BA) 
–  Water industry 
–  Environmental associations 
–  Pharmaceutical manufacturers 
￿  Further tasks arise from the specific strategies (co-ordination work). Communication Strategies 
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4.2  Population-specific strategy 
The population-specific strategy is sub-divided into the two modules ‘Target-group-specific 
awareness-raising' and ‘Disposal'. These are outlined below. 
 
4.2.1 Module: Awareness-raising  
Background to the problem – conflict inherent in the issue 
The population knows very little about the risk of water pollution from active pharmaceuti-
cal ingredients. This became apparent from initial qualitative empirical surveys conducted 
for the start project (Götz et al. 2012, forthcoming). The results reveal scant media coverage 
of the problem, leading to very low awareness of the issues at stake. Added to this is the fact 
that the topic is highly fraught with conflicts. It is relatively easy to convey the right and 
wrong ways to dispose of unused and expired drugs. However, the fact that active pharma-
ceutical ingredients can be excreted into the environment is linked with fear and taboos: 
·  People who, due to chronic illness, are dependent on medication for survival might 
worry about limitations being imposed on their supply of such drugs. 
·  Certain segments of the population (social milieus or lifestyle groups) might be con-
cerned that the great benefits of pharmaceuticals for life expectancy, lifestyle and stan-
dard of living could become subordinated to environmental policies and no longer be as 
readily available.  
·  The unnecessary use of drugs as a consequence of inappropriate prescription practice is 
largely a taboo topic. If addressed publically, it triggers emotional reactions, as shown very 
clearly in the focus groups for the start project. 
·  Furthermore,  empirical  research  has  revealed  the  extremely  varied  levels  of  problem 
awareness in the different demographic groups. 
 
Heterogeneous pattern of risk awareness and risk processing 
The qualitative empirical survey conducted for the start
5 project used a group process to 
confront people with information about water pollution from pharmaceutical residues. The 
participants were given a series of texts, each disclosing greater detail than the one before, 
and  then discussed  them.  In  this  way it was possible  to  simulate  a  process  of  gradual 
enlightenment, which commenced with a single headline on the issue and ended with com-
prehensive articles. The different forms of reaction were analysed and reduced to five pat-
terns of risk perception and processing. These form the basis for a target group strategy. 
Figure 2 gives an overview of the patterns which are now outlined below (cf. Götz et al. 
2012, forthcoming, for more details of methods and a description). 
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   In 2008, four focus groups were conducted with consumers on the subject of medical products in the envi-
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Fig. 2: Risk perception and mental processing patterns 
 
Immunisation pattern: ”I don't want to hear about it!“ 
The term ‘immunisation' is intended to indicate a mind-set with which individuals and 
groups of people fence themselves off from the disquieting revelation or go into denial 
about the risk. 
This pattern adopts the following cope of strategy: other, supposedly far more important or 
hazardous phenomena are highlighted (e.g. problematic conditions in other countries). Peo-
ple express environmental pessimism and resignation (“everything's already contaminated") 
while emphasising their own perceived powerlessness in the face of this situation. Further-
more, the facts are often misinterpreted or even reframed in a beneficial or positive light 
(the ‘toughening up' theory: “What doesn't kill you only makes you stronger." This is fol-
lowed by media scolding in which information is rejected, pointing out the political or fi-
nancial interests of the respective medium. The news as such is then declared a scandalisa-
tion strategy on the part of the media which tend to ‘make the most' of this kind of thing, 
or else spotlight one issue one day and something else the next. Representatives of this 
pattern openly and explicitly express an attitude of not wanting to know (“The best tactic 
is to deny its existence!"). 
 
Relativisation pattern: ”There are far worse things“ 
‘Relativisation' characterises an attitude whereby the new, possibly unsettling information 
on drug residues in the environment/water is put into perspective by comparing it to other 
problems. This is a way of taking the edge off the problem along the lines of: “There are far 
worse things". Communication Strategies 
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They often base their reasoning on their faith in the quality of German drinking water, 
arguing on the basis that this is one of the best monitored foodstuffs. However, this knowl-
edge is initially used to dispute any facts about possible emissions. 
The fact that only very small concentrations of active substances in the water have been 
proven and the potential risk posed to human health has not yet been shown is selectively 
highlighted to call into question the need for immediate action. Similarly to the ‘Immunisa-
tion' pattern, the problem is put into perspective by emphasising worse conditions abroad, 
or other, supposedly more serious, environmental problems. Here again, media chastise-
ment initially plays an important role in relativising the new information. People in this 
group are motivated by an optimistic view of progress dictating that uncertainties and risks 
of this kind are all part of social progress and that the same (technological) progress will in 
turn tackle and resolve these problems.  
 
Reflection pattern: "It's a difficult question" 
People who fit the ‘Reflection' pattern begin by thinking rationally about the initial facts 
received, neither rejecting nor feeling threatened by them. Instead, they feel somewhat af-
fected by the problem and begin to think about it. This leads to critical reflection of their 
personal behaviour and rational assessment of the logic behind the problem (excretion of 
pharmaceuticals). Their characteristic response is thus one of matter-of-fact appraisal. The 
risk is basically described as logically compelling and plausible, and is not called into ques-
tion. This ultimately creates a belief in the need for research into the environmental rele-
vance of pharmaceuticals. 
When representatives of this pattern reflect on the consequences of active substance inputs, 
it triggers a process of deliberation: while the need to take certain drugs is recognised, the 
use of others is seen more in terms of an unhealthy way of life (lifestyle medicine). People 
are aware of the conflict that exists between the common practice of symptomatic medical 
treatment with the goal of restoring fitness for work as quickly as possible and the more 
gradual  and  hence  more  expensive  preventative  treatment  and  rehabilitation.  They  are 
quick to draw on personal experience in this respect, constantly finding arguments against 
conventional medicine and current approaches to the treatment of disease. It is also typical 
here to see people weighing up whether drug residues in the environment represent an ac-
ceptable or unacceptable risk. Given the cost to society of a nationwide thrust to improve 
sewage treatment, there is some deliberation about the acceptability of a residual risk. The 
argument that pharmaceuticals provide substantial benefits also plays a role here. 
 
Apprehension pattern: "It's alarming" 
People who match this pattern have a strong need for factual enlightenment from reliable 
sources. They are alarmed, and uncertain as to which information is credible, which is why 
they call for state regulation. Many put forward the departure from classical medicine as a 
strategic solution. Communication Strategies 
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Attitudes towards the risk range from fatalism through horror down to total rejection of 
classical medicine and a switch to alternative medicine instead. People who react along 
these lines have a strong need for information and clarification as they know nothing 
about the risk and its origins. They do, however, tend to doubt the credibility of informa-
tion sources. This, together with a desire for reliability, leads to the call for state regulation. 
People demand that every possible approach (research, obligations on the part of the phar-
maceutical industry, sewage treatment, consumer education, etc.) be pursued in order to 
achieve the most effective outcome. A certain degree of fatalism becomes apparent from 
the fact that respondents fail to weigh up the benefits of pharmaceutical drugs against risk 
potential. Furthermore, in this pattern one often finds sharp criticism of common prescrip-
tion practices and the doctor-patient relationship. From the reasoning around alternative 
medicine, it becomes clear that this is a means of bridging the comprehension gap when it 
comes to the complex, uncertain nature of the risk. Several participants, for example, use 
the analogy of homeopathic micro-doses to help them understand the possible impact of 
minor drug residues in water on fish.  
 
Threat pattern: ”I need to do something about it right away!" 
The ‘Threat' pattern ultimately defines the most ardent response to information about the 
problem under review here. People are frightened and dismayed, and quickly lapse into 
spontaneous actionism with the desire to implement measures on the spot. Such a response 
is probably very much due to the heat of the moment, so that tangible action in the longer 
term becomes less likely. 
The reasoning is initially coloured by a sense of being shocked and overwhelmed. Instead 
of leading this group towards contemplation or reflection, however, it results in the need to 
undertake something practical right away – also in the private sphere; warning acquaintan-
ces, for example, or immediately setting up an action group. People find compelling and 
legitimate reasons for such actionism by referring to the need for precautionary measures. 
But on the other hand, they feel powerless in the face of the risk and towards any influen-
tial actors involved. From this perspective they are prompted to follow the only course of 
action open to them: to take things into their own hands. This group thus offers good start-
ing points for implementing action guidelines. As long as such guidelines are not forth-
coming from outside, however, there is a risk of these people taking premature and inap-
propriate action on their own initiative such as propagating the idea of no longer drinking 
tap water. 
The five perceptual and mental processing patterns have been condensed into three target 
groups for practical strategic purposes. The ‘Disinterested' group could not be proven here 
due to the explicit quota system for the focus groups which prescribed interest in the topic. 
We know from other empirical projects that there is always such a disinterested group. 
Since it is extremely difficult to address, we are not including it as a target group here: 
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￿ Deniers and relativists 
￿ Keen learners 
￿ Hypersensitives 
 
Communication strategy  
The primary goal of the communication strategy is make the population aware that there is 
a problem with pharmaceutical drug residues in water in order to reduce input in the me-
dium term. This process of raising people's awareness should take place without triggering 
a sense of alarm, which could lead to over-reaction on the part of the Hypersenstives. 
Given that drug residues are meanwhile measured in water bodies around the world, the pre-
cautionary principle represents a good line of reasoning to take with the general public. In 
addressing the environmental problem at the early stages, the main focus should be on main-
taining what is generally accepted to be the high quality of German water. 
The practical objective is to avoid pharmaceuticals being used where there is no therapeutic 
need. Appropriate measures create synergies for reducing costs in the health service. 
 
Measure 
It  is important  that  an  experienced  agency  be  commissioned  to  design  a target-group-
specific communication campaign with which to make the general public aware of the 
problem. The tendering process must ensure that the agency can produce references for 
awareness-raising projects vis-à-vis a social problem or the ‘effecting of social change' (cf. 
Kotler/Roberto 1991). This means they must be familiar with the methods and strategies of 
social  marketing  and  issue  management.  The  focus  here  is  not  on  image-building  and 
product advertising, nor attracting the maximum amount of attention. The objective of the 
communication strategy is to help create adequate public awareness of the issue ‘drug resi-
dues in water' with the ultimate goal of reducing inputs.  
The campaign should be comprised of logical steps on the way to achieving the communi-
cation target. These could take the following form:
6 
·  A set of requirements defined by the client for the agency (agencies): Is an overall cam-
paign called for, or just partial products? 
·  Participation in a briefing session
7 by the applicant agencies: the essence of the briefing 
is discussed in the following step. 
·  Research and analysis: here, the agency must form its own impression of the situation. 
This includes looking at important research material such as the results and handbook 
from the start project. 
·  Participation in a pitch; decision in favour of an agency 
                                         
6
   In line with Schmidbauer/Knödler-Bunte 2004. 
7
   A briefing session provides the opportunity to give the Agency the information it needs to make a tender. Communication Strategies 
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·  Target definition: the overall goal is to make the general public aware of the ‘drug resi-
dues in water' issue (the different target groups should ultimately perceive and appreci-
ate  the  problem).  Awareness  and  sensitisation  should  be  achieved  without  causing 
alarm, as this could make the Hypersensitives over-react. An additional objective is to 
get people to recognise their own scope for action within an overall social strategy and 
transfer  it  to  their  everyday  lives  (moving  from  ‘knowing'  to  ‘doing').  Medium-term 
goal: to reduce the input of active pharmaceutical ingredients by avoiding the use of 
therapeutically unnecessary pharmaceutical drugs. 
·  Sub-goals and verifiable intermediate steps need to be laid down in working towards the 
overall goal. The client must carry out constant checks. We recommend ‘keeping the 
agency on a tight leash'. 
·  Target  group  selection  (see  ‘Heterogeneous  Models'  section):  Deniers  and  Relativists, 
Keen Learners, Hypersensitives  
·  Motivation  and  communication  mechanism:  the  agency  must  provide  evidence  of  a 
communicative and psychological mechanism with which people and target groups can 
be reached, convinced and encouraged to act. 
·  Positioning: the agency must determine the best way of ensuring that the originator or 
the message appears distinctive, confident and unique amidst the array of competing 
messages and design configurations (Logo? Slogan? Colour? Language?). 
·  Creative guiding principle: this is the Agency's creative act par excellence – a design 
concept  based  on  the  motivation  and  communication  mechanism  (emotive  colour 
scheme, tone, storyline, etc.) 
·  Action planning: this is all about developing a detailed, consistent action concept for 
achieving the declared goals (e.g. kick-off event, media planning, accompanying PR ac-
tivities, co-operation with supporting organisations and institutions, etc.). 
·  Success monitoring: Are intermediate steps being achieved? Have the sub-goals and 
overall objective been achieved? 
·  Documentation: not just the successes or failures of the campaign are documented but 
the entire process, from briefing to completion. 
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Implications for practical implementation 
The following boxes describe the key lines of reasoning for the three target groups: 
 
Reasoning for the ’Deniers and Relativists‘ target group  
￿  Any information on the problem of measurable pollution tends to trigger feelings of powerlessness 
and hopelessness within this group. The aim is therefore to provide cognitive and emotional help 
in facing up to the problem. 
￿  Given the strong sense of powerlessness prevailing in this target group, the only effective way of 
communicating the facts of ’drug residues in the environment/water‘ is to ’diffuse them‘ into a 
problem that can be tackled and for which solutions can be found, thus embedding the issue in a 
pragmatic context. 
￿  The core traits of the risk under review here, namely complexity and uncertainty, are precisely 
what this target group is unable to cope with. It is therefore vital to focus on presenting the cer-
tainties in a simple form. 
￿  Proposals for action must relate to simple everyday options free from any finger-pointing. A good 
place to begin is with ’disposal‘. At the same time it is important to address possible future action 
on the part of the actors perceived to hold the power, namely government and industry: ”The ones 
at the top have an obligation“. And so the burden needs to be shared, with separate responsibili-
ties. 
￿  It is possible to work against denial and relativisation by pointing out the strong relevance of the 
issue in other countries and the measures in place to tackle it (Sweden, USA). 
￿  Part of the target group use the tabloid media while at the same time condemning them as unreli-
able, resulting in turn in general media scolding. This contradictory behaviour can be addressed 
with a PR policy which ensures that information concerning facts and options for action are al-
ways conveyed complete with reputable references and using figures from renowned institutions, 
even in the popular media. 
Media:  
￿  Press work via the tabloids, popular scientific pay TV programmes and print media, special inter-
est magazines on health & family affairs, pharmacy magazines (Apotheken-Umschau)  
￿  Brief special information geared to specific target groups via a web portal on the subject (pub-
lished by: UBA/BMU) 
 
   
Reasoning for the ’Keen learners‘ target group 
￿  This minority amongst the population is ready and willing to get to grips with the hard facts of the 
issue. 
￿  The way to satisfy this group‘s need for facts is to provide independent data conveyed by reput-
able originators or media so that they can form their own opinion. This concerns both their per-
sonal handling of pharmaceutical drugs and the process of weighing up the acceptability of resid-
ual risk. 
￿  Parts of this group are prepared to change the way they use medication and alternative methods 
of treatment. This, however, is more of a long-term rethinking process and should be viewed in 
synergy with desirable changes in the health system. Communication Strategies 
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￿  It is fair to say that the members of this group act as disseminators and opinion leaders. Important 
information and messages do not generally reach the recipient directly from the originator and 
become subsequently implemented. Instead, opinion leaders rated especially competent in the 
field come into play, with their interpretations then being taken on board by others. 
Media:  
￿  Press work via serious newspapers such as ”Süddeutsche Zeitung, Frankfurter Allgemeine Zei-
tung, Frankfurter Rundschau, Welt, Spiegel, DIE ZEIT“, and their online magazines, science maga-
zines such as ”Zeit Wissen“, popular science TV programmes, radio discussions  
￿  Separate, target-group-specific background information via a web portal dedicated to the topic  
(published by: UBA/BMU) 
 
Reasoning for the ’Hypersensitives‘ target group 
￿  Communication with the target group is determined by the strong potential threat they see in this 
risk. This primarily means: no over-dramatic messages. 
￿  The credibility of information and its source plays an important role for this target group: since 
these people know virtually nothing about the subject and barely understand it, the first step must 
be enlightenment in layman‘s terms. Giving the wrong messages can, however, lead to the group 
becoming anxious and uncertain, and ultimately drawing the wrong conclusions.  
￿  This group responds to visible means of tackling the problem. On the one hand this means factual 
enlightenment, but also regulation in the sense of ”this is what can be done”. The possibility of 
overcoming the problem via technical means meets with strong approval to some degree, as in the 
case of sewage treatment. 
￿  What cannot be communicated or only with great difficulty is uncertainty about the effects of the 
risk, or contradictory research results. The group, like the first target group, finds this very difficult 
to deal with. 
￿  People‘s openness towards non-conventional medicine could be a starting point for measures re-
sulting in synergies with the healthcare sector such as a different approach towards the use of 
medication. But here gain, the credibility of the originator is of the utmost importance. 
￿  This group is keen to take personal responsibility (albeit in vague terms), and this can be utilised if 
properly channelled. The use of hand-outs describing suitable and meaningful measures for their 
personal environment and everyday life can do the job here. 
Media:  
￿  Press work: ”Tageszeitung“, alternative press, ”Öko-Test“, publications by environmental agen-
cies and organisations, radio features, talks and panel discussions initiated by consumer associa-
tions and adult education centres, consumer magazines such as ”Test“, etc. 
￿  Separate, target-group-specific background information via a web portal dedicated to the topic  
(published by: UBA/BMU) 
 
It is important to pay special attention to the 50 to 70-year-olds in the target groups. Some 
take medication on a regular basis as they are already suffering from chronic ailments. 
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Flanking measures for the ’Awareness‘ module  
￿  Such a strategy needs to be accompanied by steps to raise doctors‘ awareness of the issue. It is 
only once they are fully informed and understand the relevance of the problem that they can react 
appropriately to patients raising the issue with them (cf. Doctor-specific strategy). 
 
 
4.2.2  ’Disposal' module 
Background to the problem 
In Germany there is a significant incidence of unused or expired drugs being improperly 
disposed of via the wash basin/sink and toilet. A representative survey from the start pro-
ject provided evidence of this (cf. Götz/Keil 2007). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 3: Disposal of unused or expired drugs via the toilet/basin  
(representative survey from the start project (cf. start 2008) 
The main reason for this improper behaviour is that Germany lacks a standard regulation 
for the disposal of unused or expired drugs, plus the fact that there is barely any active 
consistent  communication  of  the  appropriate  means  of  drug  disposal  already  available. 
There are incidences where recommendations on the part of disposal services, municipali-
ties, and Länder differ considerably (see Ch. 3). These range from taking the drugs along to 
Disposal of tablets via the toilet 
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collection points for harmful or hazardous waste, through disposal along with household 
waste, down to returning them to the pharmacy. The uncertainty thus triggered amongst 
the population is gaining new significance given the Germans' strong readiness to recycle. 
The established routines of waste separation are evidently being indiscriminately trans-
ferred to drug waste. This means, for example, that in order to dispose of a medicine bottle 
in the glass container, it first has to be emptied of its liquid drug – leaving only the plug-
hole or toilet as possible alternatives. This behaviour is heightened through the general 
public's unawareness of what water pollution through drug residues can actually mean. 
Therefore it seems to be an argument for the nation-wide and, if possible, Europe-wide 
introduction of uniform and binding disposal standards for unused and expired drugs. The 
recommended course of action is the procedure already established in Germany and other 
countries such as France, namely that of returning pharmaceutical drugs that are no longer 
required to the pharmacies. 
The German take-back system, so far managed by disposal services and financed by the 
pharmaceutical  industry,  is  currently  undergoing  reorganisation  (cf.  Pharmacist-specific 
strategy) following a change in the law. There are, however, signs that pharmacies will 
continue to accept leftover medication voluntarily and at no charge to customers, but in 
future at their own expense. Surveys amongst pharmacists, both for this project and for 
start, have shown that the pharmacists are basically prepared to continue taking back un-
used and expired drugs in future as an additional customer service. 
However, to further raise acceptance amongst pharmacists it makes sense to simplify the 
take-back system for staff. So far, employees have been separating the individual recycla-
bles at the pharmacy itself.
8 In future, we feel that this should be left up to the operators of 
the take-back system. With the new system currently under discussion, this will presumably 
be the case. Pharmacies are to collect medication, complete with packaging, in special bags 
for subsequent collection by the disposal service. 
As the law stands, pharmaceuticals, barring a few exceptions, are not classed as hazardous 
waste and so can in principle be disposed of along with household waste. Given the fact 
that in Germany today almost 100 per cent of household waste is incinerated, this type of 
disposal is actually unproblematic. Even though this solution is literally ‘closest' to con-
sumers' hearts, certain aspects also attract criticism. From a precautionary perspective, the 
possible risk to third parties such as children at play is something that needs to be taken 
seriously. These days, a mere seven per cent of Germans always throw their unused or ex-
pired drugs out with the rubbish. Should this figure increase significantly in future, so too 
will the risk of medication occasionally getting into the wrong hands. Pointers as to how 
this might be prevented – for example, wrapping old tablets in newspaper – are difficult to 
communicate and hardly practicable. Furthermore, in most member countries of the Euro-
pean Union, collection systems have been set up in recent years, partly because of current 
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legislation. The favoured German solution of getting rid of unused or expired drugs along 
with the household waste would run counter to a standard solution for Europe. 
The German Federal Environment Agency recommends disposal at collection points for 
hazardous waste as a second option besides the pharmacies. 
 
 
 
 
 
 
 
 
 
Fig. 4: Disposal of pharmaceutical drugs along with the household waste (cf. start 2008) 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Disposal of pharmaceutical drugs at the pharmacy (cf. start 2008) 
 
Communication strategy 
According to the studies by ISOE, only around a third of German citizens always take the 
medication they no longer need back to the pharmacy. A broad-ranging, professionally 
planned and designed campaign is called for in order to inform the general public and thus 
raise this figure. The originator should be a recognised actor with a serious image, for in-
stance the Federal Environment Agency or the Ministry of the Environment – possibly in 
conjunction with the pharmacies.  
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Measure 
It has long been possible to dispose of unused or expired pharmaceutical drugs at pharma-
cies and so provides good scope for easy communication. Patients or consumers
9 should be 
given the express message that all unused or expired drugs – whether prescription or non-
prescription – should be taken back to the pharmacy. This should be backed up by a stan-
dard reference on drug packaging and on the package leaflet indicating the correct disposal 
of pharmaceuticals. Although already provided for in the appropriate EU guidelines and 
also in the German Pharmaceuticals Act, this measure has not yet been rigorously imple-
mented. Before starting the communication campaign, the UBA/BMU should contact the 
pharmaceutical manufacturers instructing them to print clear pointers for disposal on the 
packaging. 
Here again, it is necessary to plan a suitable campaign to professional standards or have it 
planned by experts. This becomes particularly apparent upon analysing the existing mate-
rial (see Ch. 3): almost all material manifests serious technical communication errors. Thus 
it is advisable to use an agency selected in a tendering process to plan the details of the 
campaign. 
In choosing an agency it is important to clarify whether it is experienced in communica-
tion that influences behaviour. It must have understood that this is not about advertising or 
communicating an image. On the other hand, neither it is about a particularly complex 
switch  in  behaviour  like  that  commonly  found  in  environmental  communication  (e.g. 
switching from the car to the bicycle). 
This campaign should likewise be comprised of logical steps on the way to achieving the 
communication target. The main parameters are outlined below, beyond which the proce-
dure follows the same cues as in the procedure for the ‘Awareness-raising' module: 
·  Goals: the first goal is to motivate people to handle leftover pharmaceuticals in the 
proper way. The correct and most simple method is to hand them in at the pharmacy. 
The aim therefore is to encourage a certain behaviour that is familiar to most, seems ob-
vious, is easy to put into practice and therefore encounters minimal barriers. Those fa-
miliar with the correct way of doing things but who are not practising it should be in-
spired to move on from just knowing to actually doing. Those confused by the latest 
provisions should regain a sense of clarity. And those few who have never heard of dis-
posal via the pharmacy should learn about it for the first time. A second, equally impor-
tant goal of the campaign is to reach a point by which those who dispose of leftover 
pharmaceuticals improperly via household sewage – the toilet or wash basin/sink – no 
longer do so in future. In addition, all those who might be tempted do so in future 
should be made aware that this is the wrong way and therefore desist. A generalised 
form of communication should be used to convey this preventative social norm: “Let's 
not throw leftover pharmaceuticals into the water system!"
10 Since highly diverse and 
non-uniform information and communication campaigns have already been conducted 
                                         
9
   With over-the-counter lifestyle medical drugs it makes sense to speak of consumers. 
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start project on 5 March 2008 Communication Strategies 
Pharmaceutical Drugs and the Environment 
 
    39 
on a regional scale, it is important to refer – succinctly – to the disposal routes these 
campaigns already recommended (i.e. household waste and hazardous waste collection 
services) next to that of returning the drugs to the pharmacy. 
·  Target groups: ISOE's analysis of the data from the representative survey did not reveal 
any socio-demographic differences influencing the right or wrong way to dispose of 
pharmaceuticals. As such, all segments of the population should be addressed, especially 
consumers who feel responsible for disposing of pharmaceuticals in their household. Ac-
cording to the start representative survey, these tend to be women.
11 In addition, the use 
of pharmaceuticals increases with age and thus also the amount of unused or expired 
drugs. In a nutshell this means that a campaign has to be commonly understood, be tai-
lored to those members of the household responsible for disposal (in particular women), 
and must also take older people into account. 
 
Implications for practical implementation 
The main message should be: 
￿ Pharmaceuticals must not be disposed of via the wash basin /sink or the toilet. 
￿  Return all unused or expired pharmaceuticals to the pharmacy. 
￿  This applies both to prescription and over-the-counter drugs. 
￿  This way we can maintain the high quality of our drinking water. 
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   In seeking to address a female target group, one needs to weigh up whether or not it serves to cement the 
already asymmetrically distributed household responsibility for the environment (cf. Empacher et al. 2002 
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4.3  Specific strategy for pharmacists 
4.3.1  Background to the problem 
Thanks to their training, pharmacists see themselves as the true specialists when it comes to 
evaluating the ingredients of pharmaceutical drugs. For this reason they take the issue of 
water pollution from active pharmaceutical ingredients seriously and regard it as being 
within their scope of expertise and responsibility. They do, however, complain that their 
services as important actors within the health system are enjoying less and less recognition. 
The main reasons for this are that the mail order trade in pharmaceutical drugs is on the 
increase, with ever more sources of medical consultancy becoming available on the inter-
net. Registered pharmacists, on whom particular attention is focused here, see themselves 
as direct trustworthy sources of advice for their customers when buying prescription phar-
maceuticals and OTC products. They are able to answer questions about health that cannot 
be posed to mail order pharmacies or discussed with the doctor (cf. remarks on the doctor-
patient relationship in Ch. 4.4.1).  
Up until the summer of 2009, private households in many locations were able to dispose of 
their unused or expired drugs at the pharmacy (although not a mandatory service), as the 
Packaging Ordinance provided for the taking back of pharmaceutical packaging by the 
manufacturers. The taking back of unused or expired drugs implied in this policy was an 
additional service, cross-financed by fees for the disposal of medical packaging from phar-
macies.  This  led  to  a  reliable  separation  of  packaging  from  residual  content:  up  until 
1.1.2009, pharmaceutical manufacturers were bound to take back pharmaceutical packag-
ing and, in doing so, to dispose of leftover drugs in the proper way via waste incineration. 
There was, however, no rigorously communicated standard practice in this respect: the tak-
ing back of unused or expired drugs was a service on the part of pharmacies. On the other 
hands,  various  waste  disposal  companies,  environment  agencies  and  (private)  consumer 
information  initiatives  were  recommending  disposal  of  pharmaceuticals  via  household 
waste, hazardous waste, or even the wash basin and toilet (cf. Deffner/Götz 2008).  
The unused or expired drugs and packaging were disposed of via a so-called reverse logis-
tics system
12, by which the different recyclable fractions (cardboard, glass, blister packs and 
leftover drugs) were collected. The operators of the reverse logistics system provided the 
pharmacies with the appropriate waste containers and collected them on a monthly basis. 
The service was cost-neutral for the pharmacies, the costs being borne by the pharmaceuti-
cal  manufacturers.  However,  changes  were  made  to  the  Packaging  Ordinance  as  of 
1.1.2009. The aim of this fifth amendment was to improve disposal of sales packaging in 
households (BMU 2008), but its effect on unused or expired drugs was negative. In order to 
guarantee disposal, drug manufacturers have to obtain a fee-based licence for the packag-
ing from ‘Duales System' (cf. e.g. Günkel 2009 and BMU 2009). Since the pharmaceutical 
companies were already footing the bill for the reverse logistics system, this meant a dou-
bling in costs. The result was that those operating the reverse logistics system no longer 
received remuneration from the drug manufacturers for the disposal service and so ceased 
to run the service at pharmacies in early June 2009. Medium-sized drug manufacturers are 
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currently continuing to finance the system, whereas the large groups are not doing so. The 
situation has been in limbo ever since. ZAV (Waste Disposal Association) is calling for re-
gional solutions to be created by the state ministries of the environment. The largest re-
verse logistics operator Vfw-Remedica continued to collect the unused or expired drugs up 
until the end of 2009 – albeit upon payment of a 200-euro flat rate per pharmacy. Besides 
this, alternative systems such as the ‘Medi-Tonne' in Berlin (Ärztekammer 2010; BSR 2009) 
are being tested on a regional scale. 
The pharmacists themselves are in favour of disposal taking place predominantly via the 
pharmacies. This is in line with their professional self-image, even if they do see room for 
improvement to the overall process. The current regulation or handling attracts a number 
of criticisms: firstly, there is and never has been a rigorously communicated norm for pri-
vate households as to how drugs should be properly disposed of (household waste, phar-
macy, hazardous waste). On the other hand, the criteria of the Packaging Ordinance turned 
separation of recyclables at the pharmacies into a very involved process. 
So far there is no obligation for mail order pharmacies to take back unused or expired 
drugs, a fact which one cannot afford to ignore. Given the global operation of companies, it 
is necessary to impose standards here for the disposal or return of unused or expired drugs. 
 
4.3.2  Communication strategy 
The communication strategy consists of three modules: knowledge transfer and continuing 
education, disposal system, and strengthening of pharmacist consultancy. 
 
Module 1 – Knowledge transfer  
In line with change communication, this module has been devised in terms of ‘change 
processes' (cf. fig. 6). It is the initial aim of the communication to impart knowledge and 
hence orientation. Such knowledge increases acceptance of the subject matter and paves 
the way for the ensuing measures. Once the measures have been introduced and accepted, 
they give way to long-term action thanks to the preparatory communication. In this case, a 
sustainable handling of drugs is achieved.  
At the first stage, pharmacists must be given the opportunity to acquire factual knowledge 
that they can use in their everyday work in their capacity as disseminators.  
 
 
 
 
 
Fig. 6: Communication to accompany change processes  
(based on IMAKA (o.J.)) Communication Strategies 
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Measures 
Recognised pharmacist-specific media (print and online) should be used in order to achieve 
the highest possible level of acceptance and to spread information on the facts and options 
for action. The representatives of the round table ‘Drug Residues in Water' (MeriWa) should 
be used as a channel through which to set the issue on the regional and national agendas 
of the pharmacists' associations and have it taken up in curricula for continuing education. 
This should be managed via personal and institutional communication.  
Factual knowledge can be improved by getting relevant reports and studies into the spe-
cialist press. This includes surveys on the nature and concentration of the major active 
ingredients so far detected in surface water, groundwater and drinking water. Moreover, 
reports on the significance of entry paths and root causes (human and veterinary medicine, 
human excretions versus improper disposal, etc.) should be published. There should also be 
broader coverage of the key adverse impacts proven thus far such as those on aquatic life 
and hypotheses for possible harm to human beings. Opinion leaders of relevant committees 
and from appropriate institutions should be used to multiply the number of topics in the 
equation. 
It is also important to clarify the significance of the precautionary principle of environ-
mental policy for the actual substance of the problem. This needs to be highlighted as a 
formal component of German and European legislation, as the precautionary principle also 
has to be heeded by actors in the health system. The self-perception of pharmacists, which 
differs from that of doctors, can be tapped into here. Whereas the latter place healing right 
at the top of their value hierarchy, environmental protection tends to be very much a part 
of pharmacists' professional self-image. They see a logical connection between environ-
mental and health protection and so this is an area that invites direct communication. 
A basic knowledge about pharmaceuticals in the environment can be integrated in pharma-
cists' basic training. In order to establish it firmly in practice, the subject can then be in-
corporated into their specialist training. Knowledge transfer with a view to practical scope 
for action can then take place as an on-going process in the form of continuing training. 
This has been provided for since 2002 via a certificate of continuing education, for which 
150 credits have to be obtained as proof of attendance at certain events, seminars, etc. The 
certificate serves quality assurance for patient care (ABDA 2008). It is therefore important 
for credits also to be awarded for continuing education on the subject of drug residues in 
the environment. This would mean more frequent exposure to a perception of the informa-
tion on offer, with knowledge and its dissemination not merely dependent on personal 
commitment. A broader knowledge base can be created by dealing with the subject in con-
nection with water abstraction and treatment, and with the methods and problems of prov-
ing that pollution has occurred.  
Continuing education events are designed and offered by various institutions such as the 
Federal Union of German Associations of Pharmacists (ABDA) or the respective Regional 
Chamber of Pharmacists – mostly in conjunction with private providers. Accreditation is 
the domain of the regional chambers of pharmacists. In order to come up with an appropri-Communication Strategies 
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ate offering, it is therefore necessary to recruit the assistance of the regional chambers and 
the ABDA or rather its Academy of Further Education. 
 
Implications for practical implementation 
￿  Creation of a publication strategy with press mailing list through which to convey facts and get 
papers published; also invitations to specialist journalists to become active  
Examples of media which should be taken into account: 
Deutsche Apotheker Zeitung (DAZ):  
Deutscher Apotheker Verlag, Dr. Roland Schmiedel GmbH & Co., Stuttgart 
Neue Apotheken Illustrierte (NAI):  
Editor: ABDA – Bundesvereinigung Deutscher Apothekerverbände, Eschborn,  
Govi-Verlag Pharmazeutischer Verlag GmbH 
Pharmazeutische Zeitung (PZ):  
Editor: ABDA – Bundesvereinigung Deutscher Apothekerverbände, Berlin 
Apotheke ad-hoc:  
Online Info: www.apotheke-adhoc.de 
￿ ￿ ￿ ￿  Information platform on the internet: to distribute the Handbook and suitably prepared e-learning 
documents for multipliers within the pharmacists‘ umbrella organisations  
￿ ￿ ￿ ￿  Awareness strategy: the precautionary principle is considered an essential element of environ-
mental policy with ’directive‘ status. It is the basis for measures such as the disposal of expired 
drugs via pharmacies being accepted by the general public and for customers to receive suitable 
advice on how to handle drugs and perhaps consume less of them. The communication should 
likewise take place via the media named above (and others) along lines that follow the basic rules 
of targeted communications. 
￿ ￿ ￿ ￿  Continuing education strategy: design of teaching modules for integration in continuing educa-
tion programmes. Content: risk posed by active pharmaceutical ingredients in water and general 
data on water abstraction and pollution. The accreditation of such courses takes place via the 
regional chambers of pharmacists. 
Academy of Further Education of the German Chamber of Pharmacists: ABDA – Federal Union of 
German Associations of Pharmacists, Pharmacy Division – Continuing Education Unit 
Media: ’PZ Prisma – Materialien zur Weiterbildung‘, is published quarterly by Govi Verlag 
 
 
Module 2 – Disposal of unused or expired drugs 
This strategy is primarily concerned with supporting pharmacists in motivating their cus-
tomers to return every single unused or expired drug to the pharmacy. The focus here is 
not on separating recyclables. It is far more important to communicate what effect it has 
on the environment if drugs are improperly disposed of. We recommend that a regulation 
be found to act as a national standard. 
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Measure 
Re-organisation means that the reverse logistics system is geared to dealing with far larger 
quantities of leftover drugs than before. The system has been simplified. This includes the 
downstream separation of recyclables in the sorting centres, as already offered by Vfw-
Remidica. This takes the burden off the expensive, highly qualified staff in the pharmacies. 
It also involves shorter collection cycles to relieve the storage problem. The system must be 
soundly financed via the pharmacies. At a final project workshop on 24 March 2010 in 
Dessau, a proposal was made to set up an EU fund in the long term for this purpose. All 
relevant actors would pay into this fund (pharmaceutical industry, pharmacies, mail order 
pharmacies and/or internet retailers) in order to finance the costs of disposal via the phar-
macies. 
Communication should focus here on the fact that in this way the high quality of German 
drinking water can be maintained. At the same time, the pharmacies themselves should be 
made to appreciate the point of the (‘new') regulation and to support the measure through 
their personal motivation. 
 
Implications for practical implementation 
￿  Expedition of negotiations between legislator, pharmaceutical companies, reverse logistics op-
erators and pharmacists concerning a new take-back system (via reverse logistics operators or 
local waste disposal companies along the lines of Berlin). 
￿  The co-ordination and design of communications for pharmacies should be the domain of the 
MeriWa committee (see Ch. 4.1). 
￿  The take-back system must then be uniformly conveyed to the general public  
(see Ch. 4.2 Population-specific strategy, Disposal module). 
 
Module 3 – Strengthening the consultancy role of pharmacists 
As mentioned earlier – pharmacists see themselves as a highly credible source of advice 
when it comes to purchasing medication, particularly given the competition from growing 
internet trade. They see no conflict between sales interests and giving advice that under 
certain  circumstances  may  also  recommend  not  taking  pharmaceutical  drugs.  From  the 
pharmacists' perspective, it can only boost their image and credibility if they increasingly 
advise people to apply fewer or alternative therapies. An important aspect of the advice they 
impart is geared to securing compliance and optimising therapy. Environmental aspects may 
also play a role, especially when advising ecologically aware customers. This, however, is 
only for the particularly committed and is more conceivable in terms of added value. 
 
Measure 
The publication strategy proposed in Module 1 can be extended in the medium to long term 
to include topics such as drug monitoring and evaluation, and environmental classification 
(cf. Sweden's classification system for pharmaceuticals, Stockholms läns landsting/Stock-Communication Strategies 
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holm County Council 2009). This will serve to strengthen pharmacists' know how with a 
view to advising customers accordingly if need be. 
 
Implications for strengthening the consulting role of pharmacists  
￿ Based on their know-how and understanding of their customers, pharmacists can touch on the 
  environmental aspects of drugs in sales talks with certain target groups. Communication Strategies 
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4.4  Specific strategy for doctors  
4.4.1  Background to the problem 
It became apparent during the qualitative interviews with doctors that the majority were 
not aware of any problem with active pharmaceutical ingredients in water. It plays no role 
in their professional everyday routine, neither with regard to the prescription of medication 
nor its disposal (cf. Deffner/Götz 2008). The doctors complained about the lack of hard 
scientific facts vis-à-vis the occurrence of individual active substances in water bodies. The 
same applies to the negative impacts on the animal and plant world. The interviews re-
vealed reservations about possible counteractive measures: the doctors are afraid of the 
spotlight switching from healing to other objectives
13, or of still more regulations restricting 
their room for manoeuvre. 
In the start project, it was concluded from the results of these interviews that the medical 
profession first needs to be made properly aware of the issue. Simply providing more in-
formation, however, is not the way to bring about adequate awareness of the problem. In-
stead it is important to take into account doctors' specific professional and scientific self-
image. A suitable communication strategy thus needs a modular design that allows doctors’ 
autonomy  in  reaching  their  own  conclusions  in  a  manner  consistent  with  their  scien-
tific/professional  role  and  perceived  status.  This  initially  calls  for  the  dissemination  of 
strictly factual information on drug residues in the environment, bearing in mind the initial 
aim to increase doctors' awareness of the issue. 
Specifically  from  a  communications  perspective,  the  interviews  with  various  specialist 
medical professionals carried out within start were reanalysed. In addition, a further focus 
group was conducted. This generated some relevant new insights: firstly it was confirmed 
that doctors can be divided into three groups based on their reactions to the problem of 
drug residues in the environment/water (see also fig. 7): 
1.  Active defence and refusal to address the problem 
2.  Detachment and relativisation 
3.  An open mind on and willingness to address the problem  
 
 
 
 
 
 
 
 
 
 
                                         
13
   This  becomes  apparent  from  the  following  quote:  "Conversely  we  could  ask  the  somewhat  provocative 
question: so we aren't allowed to prescribe any more drugs for fear of jeopardising the environment?" (Quo-
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Fig. 7: Reaction patterns amongst doctors 
 
Prevailing defensive response 
An additional focus group with doctors in the spring of 2009 revealed how the ‘Defence' 
pattern can dominate other reaction patterns and, by the way its arguments are presented, 
can block any constructive discussion of the issue. This defensive stance is probably very 
widespread in the medical profession, which is why it must be taken seriously and taken 
into account when planning a communication strategy. 
The reasoning behind this defensive response revolves around uncertainty about the actual 
extent and implications of the problem, although this is precisely what characterises the risk. 
The result is a call for scientific, causal evidence of the negative impacts, particularly the 
direct risk of harm and toxicity to human beings. The following quote demonstrates this: 
“They talk about a problem and the solution – but they haven't yet shown that a problem ex-
ists. They simply haven't shown anything at all. They haven't come up with a study to con-
vince us that there is any problem. Now we're already talking as if the problem were already 
upon us.” (Quotation Ma/GD 19.05.09) 
Although this attitude could in the first instance be interpreted as scientific reasoning, it is 
in fact a case of using scientific language to dismiss the issues at stake. This is apparent 
from the reaction to measures launched abroad. For instance, the environmental classifica-
tion of pharmaceuticals undertaken by Stockholm County Council is evidence of the fact 
that here the problem is recognised as such. In the focus group, people reacted to informa-
tion about this classification by assuming that interests other than environmental concerns 
lay behind the measure. This becomes clear from the remarks of one doctor: 
“Well, I simply don't believe that you can do something like this if [you] are independent. I 
[don't] think that a County Council like this can produce the kind of complexity present in 
the list. There must be other interests behind it. I just don't buy it. Forgive me for seeing this 
in a political light, but the assessment [sic] – how do they actually arrive at an assessment – 
on what are they actually drawing here? You really do have to put a question mark above it. Communication Strategies 
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A list like this isn't a bad thing in itself – but who comes up with something like this, why is 
it undertaken, who pays for it, in whose interest has it been done? I can sense a few problems 
in that respect." 
The various attempts at negating the problem are accompanied by the desire to prevent any 
discussion about the relevant role of doctors here. This stance proves very dominant in the 
course of discussion. It has a negative effect on the willingness of those doctors with a 
somewhat more neutral or open attitude to discuss the problems. 
 
Causes of the defensive response 
What are the causes of this defensive attitude, sometimes demonstrated quite aggressively 
by some doctors. The focus group uncovered several reasons: first of all, it is clear that 
doctors do not feel responsible if the problem in question is confined to the environment 
with no immediate impact on human health. They feel that other instances are then respon-
sible. The problem only takes on personal relevance for them when there is proof of an 
effect on health. Here, however, it is surprising to note the lack of thought given to preven-
tion. Since initial changes to aquatic life caused by active pharmaceutical ingredients have 
been proven, one could argue, that there is a need to counter any potential risk to human 
health, especial that of particularly vulnerable groups such as (unborn) children. And yet 
the opposite proves to be the case. The discussion about measures to reduce the input of 
active substances is blocked early on, and even declared taboo. In the course of the focus 
group, further causes became apparent: 
As a result of regulations perceived in terms of a ‘perpetual health reform', some doctors 
feel under constant pressure to rationalise and cut back on costs. They see this pressure as 
running counter to the task of healing and restricting both time and financial resources to 
a  minimum.  This  situation  is  frustrating  for  some  doctors  and  leads  to clock-watching 
‘conveyor belt' medicine. As they see it, there is virtually no time left to chat, listen and 
respond to their patients. The tight budgeting results in keeping consultations with patients 
who have state health insurance as brief as possible. This in turn exacerbates the existing 
practice of prescribing drugs as the quickest way of doctor and patient reaching an agree-
ment. The prescription is increasingly turning into a tool with which to ‘propel' patients out 
of the doctors' surgery again as quickly as possible: 
“Yes, it's also partly the point of visiting the doctor, especially for older people. They need 
some justification for going to the doctor. ‘I need a drug', when all they might really need is 
social contact. But basically speaking, this act, and writing a prescription is an act, is a very 
substantial part of what goes on at a doctor's surgery. It marks the end of the consultation 
and the doctor can bring things to a close […]. It's incredibly difficult to send the patient 
away without medication, because they want you to give them something." (Quotation St./GD 
am 10.05.09) 
Health system structures impose restrictions on the room for manoeuvre open to general 
practitioners and a strong dissonance emerges between wanting to do and being able to do 
– between a doctor's aspiration and the professional framework. The consequences are ag-
gression, feelings of guilt, cynicism and resignation, as becomes clear from the following 
quote: Communication Strategies 
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“[…] pointless, I've sat there working until burnout set in: it didn't do any good. I get the 
problems facing this country in my surgery. It's all about maintaining social rights, about 
pensions or the social security office; half the patients were addicted to drugs – sleeping tab-
lets – because they were elderly. You couldn't do anything. And so I simply dropped out […]” 
(quotation St/GD 19.05.09) 
Given this background, any discussion about drug residues in the environment triggers an 
affect. On the one hand people are afraid of an external (possibly governmental) player 
introducing non-medical arguments that interfere with their treating of patients. On the 
other hand, it addresses a conflict in which many doctors find themselves, but which is 
deemed a taboo; the one-sided nature of drug prescription practice. The issue of drug resi-
dues in water also latently implies the other, extremely sensitive topic of too many (unnec-
essary) drugs being prescribed because doctor-patient interaction has to a large extent (un-
intentionally) become reduced to the act of prescribing pharmaceutical drugs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: Background to the dominant defensive response from doctors 
 
The ’openness‘ response pattern 
There is, however, also a group of doctors who are prepared to treat the problem seriously. 
This became apparent in a further focus group with ‘discerning doctors'. Its participants 
were selected on the basis of whether or not they sympathised with either environmental 
medicine or naturopathy and took a critical view of pharmaceutical medical treatment.
14 
The hypothesis was that there are doctors who are prepared to look into the effects of 
medication on the environment and particularly at the doctor's role in this. This assump-
tion was largely confirmed.  
                                         
14
   The focus group was carried out in January 2010. Communication Strategies 
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This group is aware of pollution from active pharmaceutical ingredients and also consider it 
a real problem. Even so, knowledge still tends to be somewhat hazy and is not seen in the 
context of its own medical conduct, at least not at the beginning of the group discussion. 
“[…]  so  which  substances  are  traceable  in  drinking  water?  I'm  sadly  ignorant  on  that 
score."(Quotation Mo/GD 19.01.2010) 
Initially, no connection is made between the emission of active substances and personal 
prescription practice. Awareness of the environmental relevance of the drugs thus holds no 
relevance when it comes to medication and deciding what course to follow. 
“I actually felt a bit shocked myself just now. I never gave it a thought until hearing this 
question: gosh, how are you and your prescription pad polluting this water day after day? 
I've never thought about it when writing out a prescription. […] I know this problem exists, 
but I've never considered myself the polluter." (Quotation Ch/GD 19.01.2010) 
In the course of discussion, participants are, however, quick to get to grips with the topic 
and recognise the link between environmental pollution and their own behaviour, namely 
the contribution made by the way doctors prescribe medical drugs. As the discussion pro-
gresses it becomes clear that the doctors are becoming increasingly prepared to reflect upon 
their  prescribing  practice  from  the  specific  perspective  of  environmental pollution.  This 
means that any communication strategy not only has to convey facts, but must also explic-
itly make a logical link between water pollution and prescribing routines. 
This group of doctors actually finds it easier to declare their willingness to show restraint 
in prescribing pharmaceuticals since the majority of their patients are themselves critical of 
prescribed medication and demand a restrictive approach to the use of drugs. These doctors 
criticise what they see as the inappropriate prescription routines of their colleagues: as 
touched on in the previous section, they see the situation as the result of a strong tendency 
towards a conveyor belt medical system revolving around prescribing drugs and featuring 
insufficient communication with the patients.  
Describing the style of other doctors, one participant explains:  
“He manages his practice according to the ritual he considers best, and that includes prescrib-
ing lots of drugs. There's no other way of doing it, otherwise he can't get the people out of 
the door quickly enough." (Quotation Ch/GD 19.01.2010) 
Thus they criticise the excessive and unnecessary use of drugs from a perspective that has 
nothing to do with environmental relevance. The special focus here is on the marketing 
activities of the pharmaceutical industry, which increases an active need for medication 
amongst patients. This leads to an attitude of believing that patients need to be ‘served' 
with drugs, even in cases where not medically meaningful. 
“The  marketing  clearly  targets  the  patients  directly  by  creating  needs."(Quotation  Ma/GD 
19.01.2010) 
For the communication strategy it also becomes clear that the originators must be very 
carefully chosen. Some members of this group of doctors are very critical of professional 
associations and similar professional organs and their media. 
“For me, the [professional association] smacks very much of being ‘at the beck and call of the 
pharmaceutical industry'." (Quotation Ma/GD 19.01.2010) Communication Strategies 
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As for auxiliary measures to tackle the problem, this group shows an open mind on the 
subject. The idea of a pharmaceuticals classification based on their environmental proper-
ties is welcomed as long as it is easy to handle. This means it must lend itself to integration 
into existing practice software according to discipline. These doctors are in fact already 
prepared to consider non-drug forms of therapy and engage in ‘narrative-based medicine'. 
“There are lots of things that can be treated without medication, at least in my field, things 
that could be solved through physiotherapy if we had the appropriate health insurance budg-
ets to work with." (Quotation Ge/GD 19.01.2010) 
“[…] the fact that I tend to practice narrative-based medicine, and that sometimes helps cut 
down on drugs." (Quotation Ch/GD 19.01.2010) 
Although these doctors recognise the relevance of the problem and prove receptive to ap-
propriate measures, they are apparently doubtful as to whether this also applies to their 
colleagues. Thus they also think it important to increase awareness on the ‘demand side', 
i.e. amongst patients. However, none of this means that the subject of emission is relevant 
for the prescription-related decisions of these doctors. In this context, they argue along the 
same lines as all other groups of doctors surveyed, saying that the environmental issue is 
not what clinches their decision: 
“My filter when it comes to prescribing or not prescribing has […] nothing to do with this en-
vironmental issue. Instead I just look to see if the patient needs something, if it will do him 
some good, or else I say: It'll go away of its own accord after a while so you can try without, 
or not, whatever you wish. […] But I don't think this environmental thing would come into 
play in my individual decisions because I basically believe that to take nothing is always the 
best way if possible." (Quotation Mo/GD 19.01.2010) 
But it becomes clear that a restrictive approach towards pharmaceutical drugs is indeed pos-
sible and being practised. This means that there is not necessarily any automatic process for 
prescribing drugs, nor is there any pressure within the health systems to lapse into ‘con-
veyor belt and prescription-based medicine'. A further lesson to be learned from this group 
of doctors is that the attitude of the patient does indeed exert an influence. The restrictive 
stance of doctors together with their patients results in the positive side-effect of fewer 
pharmaceuticals ending up in the environment – regardless of the motives behind it. 
 
4.4.2  Communication strategy 
The strategy outlined here consists of four modules: firstly, that of anchoring the subject 
matter in medical boards; secondly, addressing strategic core target groups; thirdly, sensi-
tising the medical profession; and fourthly, conveying different opportunities for action. 
The strategic communication should enable several goals to be achieved: removing barriers 
preventing any discussion on the subject, imparting insights and knowledge via the appro-
priate content and language, and enabling doctors to form their own professional conclu-
sions. Furthermore, it is important to make a logical connection between doctors' (own) 
prescription practice and the problem of drug residues in the environment. In the long term 
this can help develop a willingness to view the reduced use of medication as a solution, to 
address the idea and ultimately put it into practice. 
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Module 1 – Anchoring the subject matter in the main medical boards and institutions  
Before public communication gets underway, the problem as such needs to be recognised 
within the medical profession. The structure of the medical profession is very hierarchical 
and thus calls for a top-down strategy. 
 
Measure 
One initial step would be to persuade the relevant medical institutions to participate in the 
‘MeriWa' steering committee described earlier. Once a commitment of this kind has been 
secured, it is made public, i.e. published in key medical media. This provides a signal that 
opinion leaders within the medical profession have taken the problem on board whilst cre-
ating  a  certain  top-down  pressure  on  institutions  to  follow  suit.  The  problem  thus  no 
longer attracts purely subjective evaluations. 
 
Implications for practical implementation  
￿  Setting the topic on a sound footing with important medical functionaries as a precondition for 
gradual acceptance of the problem (given the defensive stance) 
￿  Persuading the functionaries to participate in a round table still to be set up (MeriWa) 
￿  Such participation and thus recognition of the problem‘s relevance must be broadly communi-
cated to the medical profession. The overall communication process can benefit from the garner-
ing of support and backing by the medical representatives in this committee. 
 
Module 2 – Raising awareness within the medical profession 
This module is all about informing the doctors about drug residues in water on the basis of 
scientific facts. The aim is to attract initial attention in a general context. It is important 
here to go into all the relevant facts: for instance the quantitative statements on the ratio 
of different emission sources (human vs. veterinary medicine; hospitals vs. doctors' surger-
ies; disposal vs. excretion), the main active pharmaceutical ingredients traceable in water, 
the first proven negative impacts, etc. The link with doctors' everyday routines needs to be 
made, and any references to supposedly far more important sources of entry such as im-
proper disposal or agriculture/veterinary medicine refuted. This must, however, take place 
without any moralising allocation of responsibility. A key aspect here is to quote research 
findings  from  institutions  and  sources  that  enjoy  unequivocal  renown  and  recognition 
amongst doctors. 
Furthermore, the problem must be recognised within major medical associations and pro-
fessional bodies. The objective is to work out guidelines and to publish them in print media 
and on the internet. In the interviews with doctors, it became clear that recognition by the 
medical associations is the decisive factor in getting specialists in private practice to take 
note of the problem. Discussing the subject in the medical associations also involves liabil-
ity issues, for instance with regard to drug substitution (patients could make legal claims 
regarding their right to a certain medication). Communication Strategies 
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A communication strategy addressing critical issues of this kind must particularly consider 
doctors' professional self-image: they see themselves as science-based workers dedicated to 
the art of healing. This also implies that for many doctors the “medical evidence" or direct 
scientific proof of harmfulness to human beings is the precondition for acknowledging the 
problem as such in the first place. Moreover, given the existing uncertainty it is vital to use 
very precise reasoning when trying to justify preventative action. Ultimately, any possible 
responsibility on the part of doctors for an environmental problem must be proportionate 
to the profession's core tasks. The doctors must be able to identify a clear correlation with 
their medical work. In the absence of legislation on the subject, change to work practices is 
more likely to come about via self-education and the discourse within the profession. In the 
end this means: increased awareness of the problem in order to change prescription prac-
tice in the long term must stem primarily from doctors' personal insight and discretion. On 
no account can it come from outside, and certainly not from medical laypersons. The pub-
lishing of specialist articles on the situation surrounding water pollution and its conse-
quences in media highly respected by the medical profession can pave the way for such 
discursive self-education (see Measures). 
 
Measures 
The task of selecting suitable communication tools must be assigned to a PR agency, which 
then plans and implements the process from start to finish (cf. Issue Management 4.1). 
Conceivable publication routes are:  
·  Specialist articles in medical print and online media of different orientations. The media 
are used to disseminate facts and options for action, and thus create the greatest possi-
ble willingness to go into the subject at greater length. These media are:  
–  print  media  that  possess  credibility  and  renown  in  the  minds  of  doctors  (e.g. 
Deutsches Ärzteblatt, specialist media for environmental medicine practitioners, jour-
nals aimed at specialist doctors such as gynaecologists, psychiatrists, internists, on-
cologists, rheumatologists, radiologists); 
–  medical online journals and medical web platforms; 
·  Special-interest publications in which therapies, prescription practice, efficacy and side-
effects are critically examined (e.g. Das Arzneitelegramm); 
·  Papers at congresses and conferences, e.g. professional association congresses (directed 
at the practitioners!); 
·  Training modules at seminars for specialist journalists; 
·  Information portal on the internet containing retrievable e-learning materials and e-
lectures. 
Consultation sessions at the associations of national health insurance doctors (KV) consti-
tute a further measure beyond that of ‘awareness' communication. These sessions are ob-
ligatory when it comes to budget overruns in the doctors' surgeries. The KV advisors can be 
trained on the subject of pharmaceuticals in the environment and then inform the doctors 
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We presume that the parallel communication strategy for boosting awareness amongst the 
general public (cf. Chapter 4.2) will also be noticed by the doctors. This will in turn signal 
the relevance of the topic for the whole of society. 
 
Implications for practical implementation  
In planning a communication strategy it is important to consider how to deal with a potential defen-
sive reflex that, despite being emotionally charged, is rationally argued and could block any objec-
tive discussion of the issue. 
￿  When communicating to doctors, the problem of pharmaceuticals in water must be addressed in 
a way that avoids making them feel like the cause of the problem and taking offence. 
￿  Every effort to address doctors must take place while recognising their medical achievements. 
￿  It must be made clear that there is absolutely no intention of interfering with medically indicated 
prescriptions. 
￿  The language of communication must be adapted to the medical discourse. If possible, the in-
formation should be conveyed by doctors themselves. 
￿  In alluding to the taboo topic of ’prescription medicine‘, it is important to be aware of the conflict 
between cost reduction and healing – in other words the synergies between cost reduction and 
input reductions need to be made clear. 
￿  The problem should also be addressed via recognised medical institutions and media – in other 
words, always from the top down. 
￿  The originators must enjoy credibility and authority within the medical profession. 
A selection of print media directed at (specialist) doctors:  
–   Deutsches Ärzteblatt , Cologne 
–   Der niedergelassene Arzt, WPV Wirtschafts- und Praxisverlag GmbH, Cologne 
–   Fachärztliche (Online-)Depeschen-Dienste, for example: Praxis-Depesche, Gyn-Depesche,  
Onko-Depesche, Neuro-Depesche, published by: GFI. Gesellschaft für medizinische  
Information mbH 
 
Module 3 – Addressing strategic core target groups 
The segmentation presented in Chapter 4.4.1 shows that parts of the medical profession are 
open-minded about the problem. We expect such sub-groups to take note of both scientific 
facts and proposals for solution and, in some cases, act accordingly. This particularly ap-
plies when the proposals lead to reduced costs as a result of a more economic approach to 
prescribing medication. Practitioners of environmental medicine, critically minded doctors, 
and doctors in their own practice have been identified as such open-minded groups, whose 
clientele favour naturopathy and ‘talking medicine'. “Environmental medicine deals with 
the impact of environmental influences on the health risk to the individual and the public 
at large. This embraces the medical care of people with health issues and medical diagnoses 
arising from environmental influences." (European Academy for Environmental Medicine 
2010). In the interests of prevention, practitioners of environmental medicine are prepared 
to look seriously at the long-term potential effects of drug residues in water. It is therefore Communication Strategies 
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fair to assume that this group can act as a professional and discursive bridge to other medi-
cal professionals. On the other hand, one also finds ardent controversy within the medical 
profession when it comes to the results of environmental medicine. This being so, it does 
not suffice to merely get the specialists in this field on board. 
There is no firmly defined group behind the term ‘critically minded doctors'. It features 
different (information) networks that are open to differentiated knowledge input and could 
play an important part in the discussion. These are doctors with a critical view of prescrip-
tion medicine, who are reluctant to allow pharmaceutical manufacturers to influence the 
way they prescribe medication. One institution where this kind of discerning doctor can be 
found is MEZIS (‘Mein Essen zahl ich selbst’ – ‘I pay for my lunch myself’), whose members 
take no incentives from pharmaceutical companies whatsoever. They are amalgamated at 
international level in ‘Healthy Skepticism – Countering Misleading Drug Promotion'. This 
group also includes the website www.bittere-pillen.de. In their publications they not only 
favour a meaningful and economic use of medication but also report on the correct dis-
posal thereof and on the results of water pollution due to active pharmaceutical ingredi-
ents. However, due to their critical stance, these groups and networks cannot be misinter-
preted as opinion leaders or disseminators for the overall medical profession. 
 
Measures 
Apparently, groups of doctors do exist who are prepared to look into the environmental 
relevance of active pharmaceutical ingredients and acknowledge it. But in their case also, it 
is necessary to convey facts and tie in the problem with doctors' practical and prescription 
routines (see Module 2). 
   
Implications for practical implementation 
￿  The open-minded doctors form a group in their own right and can only be informed and made 
more aware via media and channels specifically geared to their specialist areas and networks. 
They take a very critical stand towards professional associations and similar organisations along 
with any affiliated media.  
￿  The open-minded doctors are evidence of the fact that there is no automatic mechanism in the 
health system that forces people into ’prescription medicine‘. A restrictive approach towards 
pharmaceutical drugs for medical and economic reasons is possible and can also have cost-
saving consequences for the health system. 
Examples of associations 
–  Deutscher Berufsverband der Umweltmediziner: www.dbu-online.de 
–  ’Mein Essen zahl ich selbst‘ (MEZIS e.V.): www.mezis.de 
–  Healthy Skepticism: www.healthyskepticism.org 
–  Bittere Pillen: www.bittere-pillen.de 
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Module 4 – Communicating practical options 
This section is all about conveying to doctors how they can change the way they write 
prescriptions and advise their patients. It is probably the most difficult part of the commu-
nication strategy and has attracted the following proposals for suitable approaches and 
measures: 
Stronger consideration of non-drug forms of therapy: the communication strategy should 
make doctors aware that it can prove effective within an overall treatment plan to prescribe 
general health-promoting measures. This includes therapies that do not use drugs but have 
a preventative effect, thus reducing the intake of medication. Examples of such prescrip-
tions that promote a healthy way of life are: going for walks, joining a sports club or gym, 
and changing one’s diet. Experiences in Sweden show that patients are very receptive to 
this kind of advice, particularly when handed out in ‘prescription form’. It is seen as some-
thing more binding than if the doctor were merely to recommend a change of behaviour. 
What is more, this way it is possible to cater for patients’ expectation of being given a pre-
scription when they visit the doctor: 
An environmental health professional: “The more pressed for time the doctor, the more they 
tend to prescribe a drug in order to minimise the time needed for discussion and explanation 
[…] “So you just give them something.” Oncologist: “It’s the same old topic as far as I’m con-
cerned. Doctors prescribe far too much to patients – certainly less than they used to, but when 
you go to a patient’s home on an emergency call and see the stocks of medication that some 
have, then it’s definitely an excessive amount […]” (Source: interviews with doctors in start)  
Pilot schemes practising this are already underway in Germany. Take, for example, the 
campaign by the Medical Council of the State of Hesse, ‘Fit and healthy with a “prescrip-
tion” for exercise’. Other initiatives to support prevention have been launched by health 
insurance companies (e.g. Barmer Ersatzkasse, TKK, etc.), in which they offer a bonus pro-
gramme: if insured persons take advantage of health-promoting offers, they are entitled to 
financial compensation or discounts. In order for doctors to be able use such tools as an 
alternative to medication, health insurance companies need to accept and authorise these 
forms of prescription. 
Caution in prescribing active ingredients classified as ecologically relevant: this assumes the 
existence of an environmental classification system integrated into the major works of ref-
erence/recommendation and medical practice software used by doctors.
15 Within the publi-
cation recommendation outlined in Module 2, ‘Awareness strategy’, we suggest informing 
people via studies that discuss from a medical point of view where and to what extent cau-
tious prescribing is possible. Some examples of such studies might be those on scientifically 
controversial therapies (cf. hormone therapy; WIdO 2005, for example), and on scientifi-
cally unjustifiable differences in prescribing practice (e.g. regional differences in the use of 
medication, cf. Knopf/Melchert 2003). 
Reflection on doctor-patient interaction: doctors should be encouraged to query the auto-
matic prescribing of drugs or at least question certain wishes on the part of patients. Em-
                                         
15
   Compare the policy paper: Options for reducing the input of pharmaceuticals for human use and their resi-
dues or metabolites into raw and drinking water. Joint recommendation from the German Federal Environ-
ment Agency and the Institute for Social-Ecological Research; Status: February 2010. Communication Strategies 
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pirical health research (e.g. Britten et al. 2000; Cockbourn/Pit 1997) proves that countless 
misunderstandings arise between patients and doctors during medical consultations. At the 
same time, doctor and patient reach a kind of implicit agreement to the effect that a medi-
cation will be prescribed at the end of the consultation. If the drug fails to achieve the de-
sired improvement, the patient ends up feeling frustrated; if the prescription is merely a 
way of satisfying the patient’s expectation, then the doctor feels frustrated in his or her 
professional capacity. The following quotation illustrates the misunderstandings that occur 
between doctor and patient, and the prescriptions resulting from them: 
“[…] because I keep having the same problem, and basically get prescribed antibiotics […] My 
mother suggested her stuff [natural remedies], but he [the doctor] didn’t mention it. And no 
matter how well educated you are – somehow you always trust the doctor. Maybe that’s the 
problem.” (Quotation from Focus Group 2, General Public, w, 30) 
What is more, fewer prescriptions can also help reduce costs. So there is much in favour of 
tackling this problem and integrating it into a communication strategy. Such a sensitive 
topic must however be dealt with due caution.  
 
Implications for practical implementation 
￿  All measures addressed in this section must be seen within the context of modifications in the 
health system (e.g. cost reductions). They cannot be triggered by the communication strategy pre-
sented here but merely represent synergy effects via which the environmental influences of 
pharmaceuticals can be reduced.  
There are, however, strong links with the Awareness Strategy (cf. Module 2) vis-à-vis 
-  the acceptance of non-drug forms of therapy by healthy funds and doctors, 
-  the critical, reflective approach towards the automatic prescribing of drugs, and  
-  the doctor-patient relationship. Communication Strategies 
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4.5  Specific strategy for hospitals and clinics
16 
4.5.1  Background to the problem 
Although the concentration of active ingredients is higher in sewage from hospitals than 
from domestic households, for example, the absolute quantity is virtually irrelevant. Studies 
show that emissions from clinics for the most active substances account for less than 3 to 
5% of the total load (e.g. Kümmerer 2008; Schuster et al. 2008). Similar is true for diagnos-
tics such as x-ray contrast agents. Since the pressure to rationalise is very much a driving 
force in hospitals, the unnecessary prescription of drugs tends to be less of an issue. More-
over, the clear-cut rules and work procedures in day-to-day hospital life mean that improper 
disposal of left-over drugs plays a minimal role, even if it cannot be ruled out altogether.  
Drug residues from hospitals and clinics do not therefore enter the sewage system to a lar-
ger extent than is the case with domestic or urban sewage. This means that a communica-
tion strategy does not need to make this its focus.  
 
Hospital network as a communication environment 
Hospitals are professional businesses; but at the same time they constitute a social envi-
ronment revolving around illness and health, and hence drugs. It is therefore easy to ad-
dress various groups of people there. Hospitals can be sources of information on active 
pharmaceutical ingredients in the environment and the proper disposal of (expired) drugs. 
This involves the patient and the visitor on the one hand, and the nursing staff on the 
other, but also includes all kinds of non-medical workers such as technical and office em-
ployees. 
 
Sustainability for the corporate image 
The discussion concerning the problem of water pollution also holds entrepreneurial poten-
tial for hospitals. In communicating with patients, visitors and the workforce, there is scope 
for hospitals to position themselves as establishments with a duty towards sustainability, 
with a so-called Green Corporate Identity. The University Clinic of Freiburg is an example 
of such a strategy being used to create added value. After all, the outward portrayal of en-
vironmental aspects is becoming increasingly important for hospitals, too. In increasing 
staff awareness, it is possible to create a certain amount of productive overlap, as the issue 
can be discussed from various perspectives such as environmental management and occu-
pational safety. 
 
Hierarchies and professional mentality  
The pronounced hierarchy existing in hospitals hampers the awareness-raising process and 
that of getting people to engage in the issue. Similar is true of the way that doctors are 
professionally organised. To date, it has been difficult to interest the medical profession in 
environmental issues for a number of reasons. One is that such topics do not exactly serve 
                                         
16
   The information is based on an expert discussion with Prof. Dr. Klaus Kümmerer from the Institute of Envi-
ronmental Medicine and Hospital Hygiene at the University Clinic of Freiburg in November 2009 along with 
focus groups with hospital doctors and hospital pharmacists, conducted in 2006 and 2009. Communication Strategies 
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to further a career. The enhancement to image described above is a possible starting point 
from which to reach executive levels or the environmental commission responsible. There is 
however the possibility that the problem would be even more vehemently dismissed than 
amongst those doctors working in their own practices. Clinicians have far more to do with 
life-threatening diseases and could well be more inclined to see the environmental rele-
vance of drugs as an inappropriate aspect extrinsic to the idea of healing.  
As institutions of research and teaching, the university clinics do, however, play an impor-
tant role. They are a multiplier capable of arousing scientific interest early on in people’s 
medical careers. In the long term, teaching modules on the environmental impact of drugs 
could become embedded in medical training, for instance in infectiology, oncology and 
environmental medicine.  
Hospitals provide a good platform for making the connection between the environmental 
relevance of active pharmaceutical ingredients and the handling of antibiotics. Appropriate 
deployment reduces the likelihood of resistance, something that is of fundamental impor-
tance to doctors and patients; in addition it reduces input into the environment. 
 
Discerning pharmaceutical expertise and drug selection 
In their working environment, hospital pharmacists often play the role of supplier rather 
than one of pharmaceutical expert. Moreover, many smaller hospitals no longer have their 
own clinical pharmacist and instead order from outside pharmacies. This reinforces the 
supplier aspect, making it even more difficult to communicate with pharmacists and in-
volve them in an expert capacity. While the role of service provider is at odds with the self-
image of independent pharmacists as described in Chapter 4.3., clinical pharmacists are 
probably less amenable to an active role as an advisor on the environmental effects of 
medication and the proper disposal thereof. They do not have the means of influencing 
hospital procedures in the desired direction – despite being aware and convinced of the 
need to do so. Another point of departure is that of including the issue in the study curric-
ula for clinical pharmacy
17.  
The  pharmaceuticals  prescribed  in  hospitals  are  selected  by  a  dedicated  pharmaceutical 
drugs commission. Its make-up varies depending on the hospital. This also applies to the 
binding character of the selection, i.e. whether doctors may be given other drugs on request 
or are indeed bound by the official list. Via these pharmaceutical drug commissions, one 
could get environmental aspects added to the current selection criteria such as cost reduc-
tion and drug variety. However, this is only possible if the members of the commissions are 
informed about the environmental properties of the individual drugs. This knowledge could 
                                         
17
   “Clinical pharmacy is the branch of pharmacy that, based on scientific pharmaceutical knowledge, is con-
cerned with optimising the use of drugs on and by the patient” (Definition of the German Pharmaceutical 
Society – DPhG, and the Federal Union of German Associations of Pharmacists – ABDA; see at http://www. 
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be imparted via a classification index
18 and through continuing training for doctors and 
pharmacists.
19  
Despite being repeatedly denied from various sides, the influence of the pharmaceutical 
industry on the selection of drugs remains significant, even in hospitals and clinics. How-
ever, many clinics are subjecting this exercising of influence to more stringent regulation 
by insisting that pharmaceutical representatives announce any visits and, in some cases, 
negotiate only with the hospital management itself. 
 
Nursing and non-medical staff  
The influence of nursing staff is somewhat minimal due to its position within the hospital 
hierarchy. On the other hand, it is the nurses who handle the drugs on a daily basis and who 
thus also contribute to the entry of active ingredients into the water system, albeit involun-
tarily. They hold a key position when it comes to everyday clinical measures for occupa-
tional safety and environmental management in the context of pharmaceuticals. We assume 
that nursing staff and pharmaceutical technicians are far less dismissive of the subject than 
doctors. These groups could, for instance, be made more aware of the issue via (internal) 
training schemes or information available on the intranet, etc. The top-down approach men-
tioned above (establishing the subject as an issue in the minds of the medical directors) can 
thus be supplemented by a bottom-up effect. 
 
4.5.2  Practical implications for hospitals and clinics 
As we see it, the following implications exist here: 
￿  ’Green‘ image enhancement via corporate identity (CI): the decision for or against active environ-
mental management as part of the CI represents an entrepreneurial positioning decision. It is 
unlikely to be influenced by awareness triggered by an actor such as the German Federal Ministry 
of the Environment or German Federal Environment Agency. Influencing opportunities are thus few 
and far between here. 
￿  Strong hierarchies: awareness can only be increased in the long term, as proposed in the ’Aware-
ness-raising of the medical profession‘ module (4.4.2). Clinicians do not differ in this respect from 
doctors in their own practices. 
￿  University clinics and teaching hospitals fulfil an important multiplier function: this is where medi-
cal specialists become professionally socialised; in other words it is important in the long term to 
integrate the subject of the environmental impact of pharmaceuticals into their vocational training. 
The prerequisite for this, however, is similar to that for the awareness strategy: getting the medi-
cal umbrella organisations involved.  
￿  Clinical pharmacists: their capacity for exerting influence is lower than independent pharmacists. 
By intensifying the clinical pharmacy side of pharmacy training, advice from clinical pharmacists 
can gain in importance. To this end, however, we recommend the same measures as for know-
ledge transfer and continuing education outlined in Chapter 4.3.2. 
                                         
18
   The  classification  under  discussion  here  can  of  course  only  be  of  an  informative,  voluntary  and  non-
binding nature. The basic form of such a classification would be the domain of the Drug Commission of the 
German Medical Association. 
19
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￿  The drugs commissions can be important actors when it comes to giving greater consideration to 
environmental aspects in selecting drugs from those available. Here we recommend first imple-
menting the measures for raising awareness in the medical profession as described in Chapter 
4.4.2. 
￿  Nursing and non-medical staff play a key role in the daily handling of drugs, and are therefore im-
portant when it comes to recognition of the issue as such (bottom-up effect). However, since this 
occupational group is generally acknowledged to be over-worked, it remains doubtful whether 
nursing staff could take responsibility for disseminating this subject matter in the interests of a 
more sustainable organisation of their workplace. 
Examples of contacts 
–   Verband der Leitenden Krankenhausärzte Germanys e.V., Düsseldorf  
–   Bundesverband Deutscher Krankenhausapotheker (ADKA) e.V., Stuttgart  
–   Krankenhauspharmazie, Zeitschrift des Bundesverbandes Deutscher Krankenhausapotheker  
(ADKA) e.V., Hg. Prof. Dr. Egid Strehl, Universitätsklinikum Freiburg 
–   Deutscher Berufsverband für Pflegeberufe (DBFK), Berlin  
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http://www.abfallwirtschaft.steiermark.at/cms/dokumente/11067638_45536/6c073bcf/Infoblatt_A 
ltmedikamente_Version1.pdf  
Annex_19-20_F (Sanovi Aventis)  
http://en.sanofi-aventis.com/binaries/Elimination_MNU_2008-10-30_EN_tcm28-23231.pdf  
                                         
20
   Neither the German Federal Environmental Agency nor ISOE assumes responsibility for the content of any 
third-party websites accessed via links. The linked content is viewed and evaluated on a spot-check basis 
only. The continuous checking of content is neither intended nor possible. The German Federal Environ-
mental Agency and ISOE expressly distance themselves from any content that might infringe against crimi-
nal or liability laws, or which violates public decency. 
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Annex_21-22_D (Umweltministerium Rheinland-Pfalz) 
http://lak-rlp.de/download/Oeffentlichkeitsarbeit/flyer+altmedik.pdf  
Annex_23-24_D (Umweltbundesamt & VKU)  
Annex_25-26_D (City of Gütersloh) 
http://www.guetersloh.de/servlet/it.d4cms.custom.std.download.DownloadServlet/005101023654Z 
W5zY09CNGlQQU1SQzB4QUUyY21WbjhYVkVKdFNDdE1lQzR3WGhadUl4TmlNekFNVkd3NUIza0 
ZZRWxRTlVGRWRCOThCbkptSFVwQ2V5NGhHQ0pURWloNkFYTVFFeE1UUkdKY1VHOXpVd2s9/ 
Arzneimittelflyer_aktuelle_Vers4.09.07.pdf?IE55_OR_SP1_BUG=.pdf  
Annex_27-28_D (Stadt Essen) 
http://www.essen.de/Deutsch/Rathaus/Aemter/Ordner_59/Flyer_Altmedikamente_endg%C3%BClti 
g.pdf  
Annex_29_D (Stadt Cochem)  
http://www.cochem-zell.de/umwelt_abfallwirtschaft/abfallwirtschaft/informationen_zur_abfallent 
sorgung_von_a_z/altmedikamente/medikamente.pdf  
Annex_30_D (Landratsamt Biberach) 
http://www.biberach.de/fileadmin/user_upload/Abfallwirtschaft/Files/PM_2007_010_Alte_Arznei 
mittel.pdf  
Annex_31-34_D (Landesapothekerverband Baden-Württemberg)  
http://www.um.baden-wuerttemberg.de/servlet/is/57730/Alte_Arzneimittel_richtig_entsorgen. 
pdf?command=downloadContent&filename=Alte_Arzneimittel_richtig_entsorgen.pdf  
Annex_35-40_D (Friedhelm Ost) Politik-, Kommunikations- und Wirtschaftsberatung, Friedhelm Ost 
Staatssekretär a.D., Bad Honnef  
Annex_41-42_D (BUND – Bund für Umwelt und Naturschutz Deutschland e.V.)  
http://www.bund-sh.de/uploads/media/Medikamente_Grundwasser_01.pdf  
Annex_43-44_D (Berliner Senatsverwaltung für Gesundheit, Umwelt und Verbraucherschutz) 
http://www.berlin.de/imperia/md/content/sen-gesundheit/notfallvorsorge/umweltbezogener_ ge-
sundheitsschutz/09_01_16_arzneimittel_entsorgen.pdf  
Annex_45-48_D (Badenova) 
https://www.badenova.de/mediapool/media/dokumente/produkte_1/wasser_abwasser/abwasser_2 
/505710_ArzneimittelWasserUmwelt_2008-10.pdf  
Annex_49_D (Abfallwirtschaftsbetrieb Rastatt)  
http://www.awb-landkreis-rastatt.de/pdf/Altmedikamente.pdf  
Annex_50-51_CH (Apotheke Wyss)  
http://apotheke-wyss.ch/etc/gesundheit/Umgang_mit_Arzneimitteln.pdf  
Annex_52-53_CH (Amt für Gesundheit und Soziales Kanton Schwyz, Flyer) 
http://www.sz.ch/documents/flyer_medikamente_2009.pdf  
Annex_54_CH (Amt für Gesundheit und Soziales Kanton Schwyz, Aushang) 
http://www.sz.ch/documents/flyer_entsorgung_v_medikamenten.pdf  
Annex_55_CAN (Vancouver Coastal Health Department) 
http://www.nscg.ca/who/pressdis.cfm?DocID=48  
Annex_56-57_AUS (Return Unwanted Medicines) 
http://www.returnmed.com.au/userfiles/file/RUM_Brochure.pdf  
 
  
Prescription Drug and Personal Care 
Product Disposal 
 Medication Collection Instructions:  
1.  Gather your unwanted medications.  
2.  Leave items in their original containers. Pill bottles, blister packs, ointment tubes, and leak-proof 
liquid containers are all acceptable.  
3.  Remove any personal information on the label, but make sure the drug name is still visible.  
4.  Take medications to a participating pharmacy, and deliver the medications to the pharmacy 
counter. 
Acceptable Items: 
Non-Controlled DEA Drugs  
Medication Samples  
Prescription Medications 
Over-the-counter Medications  
Medicated Ointments/Lotions 
Antibiotics  
Steroids 
Cold and Flu Medications  
Vitamins  
Medications for Pets  
Inhalers 
Unacceptable Items: 
Narcotics/DEA Scheduled/Controlled Drugs 
Sunscreen Products 
Insect Repellants 
Cosmetics 
Tobacco Products 
Hair Care Products 
Personal Care Products  
Radioactive Items 
Business Waste 
Hydrogen Peroxide, Rubbing Alcohol, etc. 
Aerosol Cans 
IV Bags 
Sharps/Needles (unless pharmacy approves) 
Bloody or Infectious Waste 
Empty Containers  
Participating Locations: 
Busch's Ann Arbor - Green Rd.  
Busch's – Dexter  
Busch's – Saline  
Dexter Pharmacy  
Pharmacy Solutions, Inc.   
St. Joseph Mercy Pharmacy – Reichert  
ChelseaCare Pharmacy/St. Joseph Mercy  
The Prescription Shop II  
Village Pharmacy II  
Wenk's - Prescription Shop 
Walgreens 
For more information, please visit: www.dontflushdrugs.com 
Washtenaw County Water 
Resources Commissioner’s Office 
 
Washtenaw County Environmental Health 
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Proper Disposal of Prescription Drugs 
Federal Guidelines: 
Do not flush prescription drugs down the toilet or drain unless the label or 
accompanying patient information specifically instructs you to do so. 
For information on drugs that should be flushed visit the FDA’s website. 
To dispose of prescription drugs not labeled to be flushed,  you may be able 
to take advantage of community drug take-back programs or other 
programs, such as household hazardous waste collection events,  that 
collect drugs at a central location for proper disposal.  Call your city or county 
government’s household trash and recycling service and ask if a drug 
take-back program is available in your community. 
If a drug take-back or collection program is not available: 
1.  Take your prescription drugs out of their original containers. 
2.  Mix drugs with an undesirable substance, such as cat litter or used coffee 
grounds. 
3.  Put this mixture into a disposable container with a lid, such as an empty 
margarine tub, or into a sealable bag. 
4.  Conceal or remove any personal information, including Rx number, on the 
empty containers by covering it with black permanent marker or duct tape, 
or by scratching it off. 
5.  Place the sealed container with the mixture, and the empty drug containers, 
in the trash. 
Office of National Drug Control Policy 
750 17th St. NW, Washington, D.C. 20503 
p (202) 395-6618  f (202) 395-6730 
www.WhiteHouseDrugPolicy.gov
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e
 
p
l
a
s
t
i
c
 
b
a
g
s
.
 
 
T
i
g
h
t
l
y
 
t
i
e
 
o
r
 
s
e
-
c
u
r
e
 
t
h
e
 
b
a
g
s
 
w
i
t
h
 
d
u
c
t
 
t
a
p
e
 
t
o
 
p
r
e
v
e
n
t
l
e
a
k
a
g
e
 
a
n
d
 
p
l
a
c
e
 
i
n
 
t
h
e
 
t
r
a
s
h
.
C
a
p
s
u
l
e
s
 
a
n
d
 
T
a
b
l
e
t
s
i
n
 
C
o
n
t
a
i
n
e
r
s
L
i
q
u
i
d
 
P
P
C
P
s
A
m
p
u
l
e
s
,
 
V
i
a
l
s
,
 
a
n
d
 
N
e
e
d
l
e
s
I
f
 
y
o
u
 
a
r
e
 
i
n
s
t
r
u
c
t
e
d
 
t
o
 
d
o
 
s
o
 
b
y
 
y
o
u
r
 
p
h
y
s
i
c
i
a
n
,
 
f
i
n
i
s
h
 
t
h
e
 
p
r
e
s
c
r
i
p
t
i
o
n
.
 
 
F
o
r
 
a
n
y
 
u
n
u
s
e
d
 
p
o
r
t
i
o
n
o
f
 
t
h
e
 
p
r
e
s
c
r
i
p
t
i
o
n
 
o
r
 
o
t
h
e
r
 
h
e
a
l
t
h
 
c
a
r
e
 
p
r
o
d
u
c
t
,
 
f
o
l
l
o
w
 
t
h
e
 
d
i
s
p
o
s
a
l
 
s
t
e
p
s
 
b
e
l
o
w
.
 
 
R
e
m
e
m
b
e
r
 
t
o
f
i
r
s
t
 
b
l
a
c
k
-
o
u
t
 
a
n
y
 
p
e
r
s
o
n
a
l
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
l
a
b
e
l
 
t
o
 
p
r
o
t
e
c
t
 
p
r
i
v
a
c
y
,
 
b
u
t
 
e
n
s
u
r
e
 
t
h
e
 
d
r
u
g
n
a
m
e
 
i
s
 
s
t
i
l
l
 
v
i
s
i
b
l
e
.
 
 
A
t
 
p
r
e
s
e
n
t
,
 
t
h
e
r
e
 
a
r
e
 
f
e
w
,
 
i
f
 
a
n
y
 
“
t
a
k
e
 
b
a
c
k
”
 
p
r
o
g
r
a
m
s
 
f
o
r
 
p
r
e
s
c
r
i
p
t
i
o
n
d
r
u
g
s
.
 
 
C
a
l
l
 
y
o
u
r
 
l
o
c
a
l
 
p
h
a
r
m
a
c
y
 
t
o
 
c
o
n
f
i
r
m
 
i
n
f
o
r
m
a
t
i
o
n
 
o
n
 
t
h
e
 
d
i
s
p
o
s
a
l
 
o
f
 
p
r
e
s
c
r
i
p
t
i
o
n
 
d
r
u
g
s
.
•
 
W
r
a
p
 
p
a
c
k
a
g
e
 
w
i
t
h
 
s
e
v
e
r
a
l
l
a
y
e
r
s
 
o
f
 
d
u
c
t
 
t
a
p
e
,
 
a
l
l
o
w
i
n
g
v
i
s
i
b
i
l
i
t
y
 
o
f
 
t
h
e
 
p
r
o
d
u
c
t
 
n
a
m
e
.
T
h
i
s
 
w
i
l
l
 
p
r
e
v
e
n
t
 
b
l
i
s
t
e
r
 
p
a
c
k
s
 
f
r
o
m
b
r
e
a
k
a
g
e
.
•
 
D
o
u
b
l
e
 
b
a
g
 
t
h
e
 
s
e
a
l
e
d
 
p
a
c
k
s
 
i
n
 
o
p
a
q
u
e
p
l
a
s
t
i
c
 
b
a
g
s
.
 
 
T
i
g
h
t
l
y
 
t
i
e
 
o
r
 
s
e
c
u
r
e
 
t
h
e
 
b
a
g
s
w
i
t
h
 
d
u
c
t
 
t
a
p
e
 
t
o
 
p
r
e
v
e
n
t
 
l
e
a
k
a
g
e
 
a
n
d
p
l
a
c
e
 
i
n
 
t
h
e
 
t
r
a
s
h
.
B
l
i
s
t
e
r
-
P
a
c
k
a
g
e
d
 
C
a
p
s
u
l
e
s
a
n
d
 
T
a
b
l
e
t
s
Annex - 6 -Annex - 7 -NYS Department of Environmental Conservation
NYS Education Department
Return to collection  
events where available
   or
Mix with something  
undesirable such as coffee 
grounds, cat litter or dirt
Tape up containers
Toss in your garbage
For full instructions or designated collection events visit:  
www.dontflushyourdrugs.net
Don’t Flush Unwanted Household  
Medications or Pour Them Down the Drain
IMPORTANT MESSAGE
Help Protect New York’s Waters
Annex - 8 -P
h
o
n
e
:
 
8
1
5
-
6
3
7
-
1
3
4
3
 
F
a
x
:
 
8
1
5
-
6
3
7
-
0
5
2
5
 
w
w
w
.
k
n
i
b
.
o
r
g
 
5
4
1
7
 
N
.
 
S
e
c
o
n
d
 
S
t
r
e
e
t
 
L
o
v
e
s
 
P
a
r
k
,
 
I
L
 
6
1
1
1
1
 
W
h
a
t
’
s
 
t
h
e
 
I
s
s
u
e
?
 
 
S
a
f
e
 
m
e
t
h
o
d
s
 
o
f
 
d
i
s
p
o
s
a
l
 
a
r
e
 
n
e
e
d
e
d
 
f
o
r
 
e
x
p
i
r
e
d
 
o
r
 
u
n
w
a
n
t
e
d
 
m
e
d
i
c
i
n
e
s
.
 
P
r
o
d
u
c
t
s
 
o
f
 
c
o
n
c
e
r
n
 
i
n
c
l
u
d
e
 
p
r
e
s
c
r
i
p
t
i
o
n
 
a
n
d
 
o
v
e
r
-
t
h
e
 
c
o
u
n
t
e
r
 
m
e
d
i
c
a
t
i
o
n
s
.
 
I
m
p
r
o
p
e
r
 
d
i
s
p
o
s
a
l
 
o
f
 
m
e
d
i
c
i
n
e
s
 
p
r
e
s
e
n
t
s
 
b
o
t
h
 
a
 
p
u
b
l
i
c
 
s
a
f
e
t
y
 
a
n
d
 
e
n
v
i
r
o
n
m
e
n
t
a
l
 
h
a
z
a
r
d
 
a
n
d
 
w
a
s
t
e
s
 
m
i
l
l
i
o
n
s
 
o
f
 
h
e
a
l
t
h
 
c
a
r
e
 
d
o
l
l
a
r
s
 
a
n
n
u
a
l
l
y
.
1
 
 
W
h
y
 
i
s
 
M
e
d
i
c
i
n
e
 
D
i
s
p
o
s
a
l
 
a
 
C
o
n
c
e
r
n
?
 
 
T
h
e
 
t
h
r
e
e
 
m
a
i
n
 
h
a
z
a
r
d
s
 
a
r
e
:
 
 
1
.
 
 
P
o
s
s
i
b
l
e
 
p
o
i
s
o
n
i
n
g
 
f
r
o
m
 
a
c
c
i
d
e
n
t
a
l
 
i
n
g
e
s
t
i
o
n
,
 
p
a
r
t
i
c
u
l
a
r
l
y
 
a
m
o
n
g
 
y
o
u
n
g
 
c
h
i
l
d
r
e
n
 
a
n
d
 
p
e
t
s
,
 
i
f
 
m
e
d
i
c
i
n
e
s
 
a
r
e
 
t
h
r
o
w
n
 
i
n
 
t
h
e
 
t
r
a
s
h
.
 
 
2
.
 
I
l
l
e
g
a
l
 
u
s
e
 
o
r
 
t
h
e
f
t
,
 
i
n
c
l
u
d
i
n
g
 
i
d
e
n
t
i
t
y
 
t
h
e
f
t
,
 
f
r
o
m
 
d
i
s
c
a
r
d
e
d
 
c
o
n
t
a
i
n
e
r
s
 
p
r
o
v
i
d
i
n
g
 
p
e
r
s
o
n
a
l
 
p
a
t
i
e
n
t
 
i
n
f
o
r
m
a
t
i
o
n
.
 
 
3
.
 
C
o
n
t
a
m
i
n
a
t
i
o
n
 
o
f
 
w
a
t
e
r
 
r
e
s
o
u
r
c
e
s
,
 
w
h
i
c
h
 
c
a
n
 
r
e
s
u
l
t
 
i
n
 
r
e
p
r
o
d
u
c
t
i
v
e
 
a
n
d
 
d
e
v
e
l
o
p
m
e
n
t
a
l
 
p
r
o
b
l
e
m
s
 
i
n
 
f
i
s
h
 
a
n
d
 
o
t
h
e
r
 
a
q
u
a
t
i
c
 
w
i
l
d
l
i
f
e
 
i
f
 
m
e
d
i
c
i
n
e
s
 
a
r
e
 
f
l
u
s
h
e
d
 
o
r
 
p
l
a
c
e
d
 
i
n
 
t
h
e
 
t
r
a
s
h
.
 
 
 
 
 
 
1
 
D
a
u
g
h
t
o
n
,
 
C
.
 
(
2
0
0
3
)
.
 
“
C
r
a
d
l
e
 
t
o
 
C
r
a
d
l
e
 
S
t
e
w
a
r
d
s
h
i
p
 
o
f
 
D
r
u
g
s
 
f
o
r
 
M
i
n
i
m
i
z
i
n
g
 
T
h
e
i
r
 
E
n
v
i
r
o
n
m
e
n
t
a
l
 
D
i
s
p
o
s
i
t
i
o
n
 
W
h
i
l
e
 
P
r
o
m
o
t
i
n
g
 
H
u
m
a
n
 
H
e
a
l
t
h
—
R
a
t
i
o
n
a
l
e
 
f
o
r
 
a
n
d
 
A
v
e
n
u
e
s
 
T
o
w
a
r
d
 
a
 
G
r
e
e
n
 
P
h
a
r
m
a
c
y
”
.
 
E
n
v
i
r
o
n
m
e
n
t
a
l
 
H
e
a
l
t
h
 
P
e
r
s
p
e
c
t
i
v
e
s
.
 
1
1
1
 
(
5
)
:
 
7
5
7
-
7
7
4
.
 
U n u s e d   a n d  
E x p i r e d  
M e d i c a t i o n s  
 
H
o
w
 
t
o
 
r
e
d
u
c
e
 
p
o
l
l
u
t
i
o
n
 
 
a
n
d
 
p
r
e
v
e
n
t
 
p
o
i
s
o
n
i
n
g
 
O
t
h
e
r
 
R
e
s
o
u
r
c
e
s
 
D
i
s
p
o
s
a
l
 
o
f
 
U
n
w
a
n
t
e
d
 
M
e
d
i
c
i
n
e
s
 
 
 
 
 
 
 
r
e
s
o
u
r
c
e
 
k
i
t
 
f
r
o
m
 
I
L
-
I
N
 
S
e
a
 
G
r
a
n
t
 
w
w
w
.
i
i
s
g
c
p
.
o
r
g
/
u
n
w
a
n
t
e
d
m
e
d
s
 
 
 
 
 
U
.
S
.
 
E
n
v
i
r
o
n
m
e
n
t
a
l
 
P
r
o
t
e
c
t
i
o
n
 
A
g
e
n
c
y
 
t
h
e
 
p
o
t
e
n
t
i
a
l
 
e
n
v
i
r
o
n
m
e
n
t
a
l
 
i
m
p
a
c
t
s
 
o
f
 
p
h
a
r
m
a
c
e
u
t
i
c
a
l
s
:
 
w
w
w
.
e
p
a
.
g
o
v
/
p
p
c
p
 
U
.
S
.
 
G
e
o
l
o
g
i
c
a
l
 
S
u
r
v
e
y
 
r
e
s
e
a
r
c
h
 
o
n
 
t
h
e
 
p
r
e
s
e
n
c
e
 
o
f
 
p
h
a
r
m
a
c
e
u
t
i
c
a
l
s
 
i
n
 
t
h
e
 
 
 
 
 
 
 
e
n
v
i
r
o
n
m
e
n
t
:
 
h
t
t
p
:
/
/
t
o
x
i
c
s
.
u
s
g
s
.
g
o
v
/
r
e
g
i
o
n
a
l
/
e
m
c
/
 
U
.
S
.
 
F
i
s
h
 
&
 
W
i
l
d
l
i
f
e
 
S
e
r
v
i
c
e
 
&
 
 
t
h
e
 
A
m
e
r
i
c
a
n
 
P
h
a
r
m
a
c
i
s
t
s
 
A
s
s
o
c
i
a
t
i
o
n
 
S
M
A
R
x
T
 
D
i
s
p
o
s
a
l
 
W
e
b
s
i
t
e
:
 
h
t
t
p
:
/
/
s
m
a
r
x
t
d
i
s
p
o
s
a
l
.
n
e
t
 
V
i
s
i
t
 
w
w
w
.
k
n
i
b
.
o
r
g
 
F
o
r
 
M
o
r
e
 
I
n
f
o
r
m
a
t
i
o
n
 
O
n
 
A
l
l
 
O
f
 
O
u
r
 
E
n
v
i
r
o
n
m
e
n
t
a
l
 
I
n
i
t
i
a
t
i
v
e
s
 
T
h
i
s
 
b
r
o
c
h
u
r
e
 
m
a
d
e
 
p
o
s
s
i
b
l
e
 
b
y
 
t
h
e
 
I
L
-
I
N
 
S
e
a
 
G
r
a
n
t
 
 
R
e
c
y
c
l
i
n
g
 
*
 
L
i
t
t
e
r
 
P
r
e
v
e
n
t
i
o
n
 
*
 
B
e
a
u
t
i
f
i
c
a
t
i
o
n
 
Annex- 9 -H
o
w
 
d
o
 
P
h
a
r
m
a
c
e
u
t
i
c
a
l
s
 
E
n
t
e
r
 
t
h
e
 
E
n
v
i
r
o
n
m
e
n
t
?
 
 
P
h
a
r
m
a
c
e
u
t
i
c
a
l
s
 
h
a
v
e
 
b
e
e
n
 
f
o
u
n
d
 
p
r
i
m
a
r
i
l
y
 
i
n
 
d
i
s
c
h
a
r
g
e
 
f
r
o
m
 
w
a
s
t
e
w
a
t
e
r
 
t
r
e
a
t
m
e
n
t
 
p
l
a
n
t
s
 
a
n
d
 
s
u
r
f
a
c
e
 
w
a
t
e
r
s
.
 
P
h
a
r
m
a
c
e
u
t
i
c
a
l
s
 
a
r
e
 
a
l
s
o
 
r
e
l
e
a
s
e
d
 
i
n
t
o
 
w
a
t
e
r
w
a
y
s
 
v
i
a
 
r
u
n
o
f
f
 
f
r
o
m
 
c
o
m
m
e
r
c
i
a
l
 
a
n
i
m
a
l
 
f
e
e
d
i
n
g
 
o
p
e
r
a
t
i
o
n
s
 
a
n
d
 
a
q
u
a
c
u
l
t
u
r
e
,
 
a
n
d
 
f
r
o
m
 
f
i
e
l
d
s
 
w
h
e
r
e
 
m
a
n
u
r
e
 
a
n
d
 
b
i
o
s
o
l
i
d
s
 
h
a
v
e
 
b
e
e
n
 
a
p
p
l
i
e
d
.
 
 
H
o
w
 
C
a
n
 
M
e
d
i
c
a
t
i
o
n
s
 
 
I
m
p
a
c
t
 
t
h
e
 
E
n
v
i
r
o
n
m
e
n
t
?
 
 
E
x
p
i
r
e
d
 
o
r
 
u
n
w
a
n
t
e
d
 
m
e
d
i
c
i
n
e
s
,
 
i
f
 
f
l
u
s
h
e
d
 
d
o
w
n
 
t
h
e
 
t
o
i
l
e
t
 
o
r
 
d
r
a
i
n
,
 
a
r
e
 
a
 
s
o
u
r
c
e
 
o
f
 
p
o
l
l
u
t
i
o
n
 
i
n
 
w
a
s
t
e
w
a
t
e
r
.
 
B
e
c
a
u
s
e
 
s
e
w
a
g
e
 
t
r
e
a
t
m
e
n
t
 
p
l
a
n
t
s
 
a
r
e
 
n
o
t
 
d
e
s
i
g
n
e
d
 
t
o
 
d
e
a
l
 
w
i
t
h
 
d
r
u
g
s
,
 
t
h
e
s
e
 
c
h
e
m
i
c
a
l
s
 
c
a
n
 
b
e
 
r
e
l
e
a
s
e
d
 
i
n
t
o
 
s
t
r
e
a
m
s
,
 
l
a
k
e
s
,
 
a
n
d
 
g
r
o
u
n
d
w
a
t
e
r
 
a
n
d
 
a
f
f
e
c
t
 
f
i
s
h
 
a
n
d
 
o
t
h
e
r
 
a
q
u
a
t
i
c
 
w
i
l
d
l
i
f
e
.
 
 
 
 
Y
o
u
 
m
i
g
h
t
 
i
m
a
g
i
n
e
 
t
h
a
t
 
a
n
y
 
s
u
b
s
t
a
n
c
e
 
s
a
f
e
 
e
n
o
u
g
h
 
f
o
r
 
h
u
m
a
n
s
 
a
n
d
 
p
e
t
s
 
t
o
 
i
n
g
e
s
t
 
a
s
 
m
e
d
i
c
a
t
i
o
n
 
c
a
n
’
t
 
c
a
u
s
e
 
e
n
v
i
r
o
n
m
e
n
t
a
l
 
h
a
r
m
.
 
 
B
u
t
 
t
h
a
t
 
m
a
y
 
n
o
t
 
b
e
 
t
h
e
 
c
a
s
e
.
 
I
f
 
o
u
r
 
m
e
d
i
c
i
n
e
s
 
a
r
e
 
r
e
a
c
h
i
n
g
 
s
t
r
e
a
m
s
,
 
r
i
v
e
r
s
,
 
a
n
d
 
l
a
k
e
s
,
 
o
r
g
a
n
i
s
m
s
 
l
i
v
i
n
g
 
i
n
 
t
h
e
s
e
 
h
a
b
i
t
a
t
s
 
m
a
y
 
b
e
 
c
o
n
t
i
n
u
o
u
s
l
y
 
e
x
p
o
s
e
d
 
t
o
 
t
h
e
s
e
 
d
r
u
g
s
.
 
S
o
m
e
 
a
q
u
a
t
i
c
 
o
r
g
a
n
i
s
m
s
 
l
i
v
i
n
g
 
i
n
 
w
a
t
e
r
s
 
d
o
w
n
s
t
r
e
a
m
 
f
r
o
m
 
w
a
s
t
e
w
a
t
e
r
 
t
r
e
a
t
m
e
n
t
s
 
p
l
a
n
t
s
 
a
r
e
 
s
h
o
w
i
n
g
 
s
i
g
n
s
 
o
f
 
d
e
v
e
l
o
p
m
e
n
t
a
l
 
a
n
d
 
r
e
p
r
o
d
u
c
t
i
v
e
 
p
r
o
b
l
e
m
s
.
 
R
e
s
e
a
r
c
h
e
r
s
 
a
r
e
 
w
o
r
k
i
n
g
 
t
o
 
d
e
t
e
r
m
i
n
e
 
w
h
e
t
h
e
r
 
p
h
a
r
m
a
c
e
u
t
i
c
a
l
s
 
a
r
e
 
c
a
u
s
i
n
g
 
t
h
e
s
e
 
e
f
f
e
c
t
s
.
 
 
 
 
 
 
 
M
e
d
i
c
a
t
i
o
n
 
C
o
l
l
e
c
t
i
o
n
 
D
r
i
v
e
 
D
i
d
 
Y
o
u
 
K
n
o
w
?
 
 
9
0
%
 
o
f
 
c
o
n
s
u
m
e
r
s
 
d
i
s
p
o
s
e
 
o
f
 
u
n
u
s
e
d
 
m
e
d
i
c
i
n
e
s
 
d
o
w
n
 
t
h
e
 
t
o
i
l
e
t
 
o
r
 
i
n
 
t
h
e
 
t
r
a
s
h
.
 
P
r
e
s
c
r
i
p
t
i
o
n
 
d
r
u
g
s
 
a
r
e
 
n
o
w
 
t
h
e
 
n
u
m
b
e
r
 
o
n
e
 
d
r
u
g
 
u
s
e
d
 
b
y
 
t
e
e
n
a
g
e
r
s
.
 
7
8
,
0
0
0
 
c
h
i
l
d
r
e
n
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Most drugs can be thrown in the household trash, but 
consumers should take certain precautions before tossing 
them out, according to the Food and Drug Administration 
(FDA). A few drugs should be ﬂushed down the toilet. 
And a growing number of community-based “take-back” 
programs offer another safe disposal alternative.
Guidelines for Drug Disposal
FDA worked with the White House Ofﬁce of National 
Drug Control Policy (ONDCP) to develop the first 
consumer guidance for proper disposal of prescription 
drugs. Issued by ONDCP in February 2007, the federal 
guidelines are summarized here:
s   &OLLOW ANY SPECIlC DISPOSAL INSTRUCTIONS ON THE DRUG 
label or patient information that accompanies the 
medication. Do not ﬂush prescription drugs down 
the toilet unless this information speciﬁcally instructs 
you to do so.
s   )F NO INSTRUCTIONS ARE GIVEN THROW THE DRUGS IN THE 
household trash, but ﬁrst:
s     Take them out of their original containers and mix 
them with an undesirable substance, such as used 
coffee grounds or kitty litter. The medication will 
be less appealing to children and pets, and unrec-
ognizable to people who may intentionally go 
through your trash.
s     Put them in a sealable bag, empty can, or other 
container to prevent the medication from leaking 
or breaking out of a garbage bag.
I
s your medicine cabinet ﬁlled with expired 
drugs or medications you no longer use? 
How should you dispose of them?
How to Dispose of
Unused Medicines
Take drugs out of their original containers and mix them with 
an undesirable substance, such as used coffee grounds …
Photo Illustration: FDA/Michael Ermarth
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s   4AKE ADVANTAGE OF COMMUNITY DRUG 
take-back programs that allow the 
public to bring unused drugs to a 
central location for proper disposal. 
Call your city or county govern-
ment’s household trash and recy-
cling service (see blue pages in phone 
book) to see if a take-back program is 
available in your community.
FDA’s Director of Pharmacy Affairs, 
Ilisa Bernstein, Pharm.D., J.D., offers 
some additional tips:
s   "EFORE THROWING OUT A MEDICINE 
container, scratch out all identify-
ing information on the prescription 
label to make it unreadable. This 
will help protect your identity and 
the privacy of your personal health 
information.
s   $O NOT GIVE MEDICATIONS TO FRIENDS 
Doctors prescribe drugs based on 
a person’s speciﬁc symptoms and 
medical history. A drug that works 
for you could be dangerous for 
someone else.
s   7HEN IN DOUBT ABOUT PROPER DIS-
posal, talk to your pharmacist.
Bernstein says the same disposal meth-
ods for prescription drugs could apply 
to over-the-counter drugs as well.
Why the Precautions?
Disposal instructions on the label are 
part of FDA’s “risk mitigation” strat-
egy, says Capt. Jim Hunter, R.Ph., 
M.P.H., Senior Program Manager on 
FDA’s Controlled Substance Staff. 
When a drug contains instructions 
to ﬂush it down the toilet, he says, 
it’s because FDA, working with the 
manufacturer, has determined this 
method to be the most appropriate 
route of disposal that presents the 
least risk to safety.
About a dozen drugs, such as pow-
erful narcotic pain relievers and other 
controlled substances, carry instruc-
tions for ﬂushing to reduce the danger 
of unintentional use or overdose and 
illegal abuse.
For example, the fentanyl patch, an 
adhesive patch that delivers a potent 
pain medicine through the skin, comes 
with instructions to ﬂush used or left-
over patches. Too much fentanyl can 
cause severe breathing problems and 
lead to death in babies, children, pets, 
and even adults, especially those who 
have not been prescribed the drug. 
“Even after a patch is used, a lot of 
the drug remains in the patch,” says 
Hunter, “so you wouldn’t want to throw 
something in the trash that contains a 
powerful and potentially dangerous 
narcotic that could harm others.” 
Environmental Concerns
Despite the safety reasons for ﬂushing 
drugs, some people are questioning 
the practice because of concerns about 
trace levels of drug residues found in 
surface water, such as rivers and lakes, 
and in some community drinking 
water supplies. However, the main 
way drug residues enter water systems 
is by people taking medications 
and then naturally passing them 
through their bodies, says Raanan 
Bloom, Ph.D., an Environmental 
Assessment Expert in FDA’s Center for 
Drug Evaluation and Research. “Most 
drugs are not completely absorbed or 
metabolized by the body, and enter 
the environment after passing through 
waste water treatment plants.”
A company that wants FDA to 
approve its drug must submit an 
application package to the agency. 
FDA requires, as part of the applica-
tion package, an assessment of how 
the drug’s use would affect the envi-
ronment. Some drug applications 
are excluded from the assessment 
requirement, says Bloom, based on 
previous agency actions.
“For those drugs for which envi-
ronmental assessments have been 
required, there has been no indication 
of environmental effects due to ﬂush-
ing,” says Bloom. In addition, accord-
ing to the Environmental Protection 
Agency, scientists to date have found 
no evidence of adverse human health 
effects from pharmaceutical residues in 
the environment. 
Nonetheless, FDA does not want 
to add drug residues into water sys-
tems unnecessarily, says Hunter. The 
agency is in the process of reviewing 
all drug labels with disposal direc-
tions to assure that the recommended 
methods for disposal are still appro-
priate.
Another environmental concern 
lies with inhalers used by people who 
have asthma or other breathing prob-
lems, such as chronic obstructive pul-
monary disease. Traditionally, many 
inhalers have contained chloroﬂuo-
rocarbons (CFC’s), a propellant that 
damages the protective ozone layer. 
The CFC inhalers are being phased 
out and replaced with more environ-
mentally friendly inhalers. 
Depending on the type of prod-
uct and where you live, inhalers and 
aerosol products may be thrown into 
household trash or recyclables, or 
may be considered hazardous waste 
and require special handling. Read 
the handling instructions on the 
label, as some inhalers should not 
be punctured or thrown into a ﬁre or 
incinerator. To ensure safe disposal, 
contact your local trash and recycling 
facility. 
This article appears on FDA’s 
Consumer Health Information 
Web page (www.fda.gov/consumer), 
which features the latest on all FDA-
regulated products. Sign up for free 
e-mail subscriptions at www.fda.gov/
consumer/consumerenews.html.
For More Information
Proper Disposal of Prescription 
Drugs Fact Sheet and Video Clip
www.ondcp.gov/drugfact/factsht/
proper_disposal.html
SMARxT Disposal Campaign
www.smarxtdisposal.net
Albuterol Inhalers: Time to 
Transition
www.fda.gov/consumer/updates/
albuterol053008.html
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Please use these practical guidelines when disposing of prescription and over-the-counter medicines:
 For Pills and Liquids:
1. Keep the medicines in the original container. This will help 
    identify the contents if they are accidentally ingested. 
2. Mark out your name and prescription number for safety.
3. For pills: add some water or soda to start dissolving them
    For liquids: add something inedible like cat litter, dirt or 
    cayenne pepper. 
4. Close the lid and secure with duct or packing tape.
5. Place the bottle(s) inside an opaque (non see-through) 
    container like a coffee can or plastic laundry bottle.
6. Tape that container closed.
7. Hide the container in the trash. Do not put in the recycle bin.
Expired or unwanted prescription and over-the-counter medications from households should never be disposed of 
by flushing them down the toilet or a drain. Although this method of disposal prevents accidental ingestion, it can 
cause contamination to Florida’s aquatic environment because wastewater treatment systems are not designed to 
remove many of these medications. 
• DO NOT give drugs 
  to anyone else.
• DO NOT flush drugs 
           down the toilet.
• DO NOT put drugs in the trash 
   without disguising them – human or 
   animal scavengers may find them 
   and misuse them.
Florida Department of Environmental Protection
3900 Commonwealth Boulevard
Tallahassee, Florida 32399
850.245.8707
www.dep.state.fl.us
Seven Steps to Safety Seven Steps to Safety
Don’t Flush That
Leftover Medicine
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Annex - 16 -sorgt werden. In den Altstoff- und Problem-
stoffsammelstellen der Gemeinden können
gefährliche Altmedikamente nicht von den in
Haushalten üblichen nicht gefährlichen Alt-
medikamenten unterschieden werden (keine
Kennzeichnung). Die richtige Zuordnung
kann nur vom Arzt oder Apotheker vorge-
nommen werden!
TIPP: Nutzen Sie diese Möglichkeiten
und befragen Sie Ihren Arzt oder Apo-
theker bereits bei Rezeptausstellung
oder Medikamentenübernahme über
die richtige Entsorgung! !
Fachabteilung 19D
Abfall- und Stoffflusswirtschaft
Das Land
Steiermark
Vorsicht!
Altmedikamente (Medikamente, die als Ab-
fall anfallen, wie z.B. Salben, Tropfen, Tablet-
ten) können grundsätzlich Substanzen ent-
halten, die bei unsachgemäßer Entsorgung
zu einer Gefährdung von Menschen und Um-
welt führen. Während in der Vergangenheit
vor allem Schwermetalle enthalten waren
(z.B. blei- oder zinkhaltige Salben, quecksil-
berhaltige Tropfen) werden heute in der Che-
motherapie Medikamente mit Zellgiften (Zy-
tostatika), eingesetzt.
Die Sammlung!
Altmedikamente müssen getrennt gesam-
melt werden und dürfen keinesfalls in den
Restmüll gelangen! Während Altmedikamen-
te aus medizinischen Einrichtungen (z.B. Spi-
täler, Arztpraxen, Pflegeeinrichtungen) direkt
über dazu berechtigte Abfallsammler ent-
sorgt werden müssen, werden Altmedika-
mente aus Haushalten (Medikamente, die im
Haushalt als Abfall anfallen) grundsätzlich
über die Altstoff- und Problemstoffsammel-
stellen der Gemeinden oder über die Apothe-
ken gesammelt. 
Falls Altmedikamente mit gefahrenrelevan-
ten Eigenschaften im Haushalt anfallen
(schwermetallhaltige Medikamente oder Zy-
tostatika), müssen diese über die Apotheken
oder andere medizinische Einrichtungen ent-
Altmedikamente
Information zur „richtigen
Sammlung und Entsorgung“
© ShoTiMo / PIXELIO´
Entsorgung über die 
Restmülltonne verboten!
Rückgabe bei den
Altstoff- und Problemstoffsammelstellen
oder Apotheken.
Entsorgung über die 
Kanalisation verboten!
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Bei den Altstoff- und Problemstoffsam-
melstellen der Gemeinden:
● Die Übernahme erfolgt ausschließlich während
der Öffnungszeiten; keine Sammlung über öf-
fentlich zugängliche Sammelbehälter (z.B. Sam-
melinseln); keine Sammlung mit dem Restmüll!
● Anlieferung ohne Kartonschachteln und Bei  -
packtexte (Entsorgung als Altpapier). Das Sam-
melstellenpersonal nimmt keine weitere Sortie-
rung der Altmedikamente vor!
● Lagerung in flüssigkeitsdichten und verschließ-
baren Gebinden (z.B. Kunststofffässer mit Spann-
ring).
● Kennzeichnung der Gebinde mit der Abfall-
Schlüssel-Nummer  53501 und der Abfallbe-
zeichnung  Arzneimittel, nicht wassergefähr-
dend, ohne Zytostatika.
● Weitergabe als nicht gefährlicher Abfall an einen
befugten Abfallsammler (Entsorger). Dabei hat
der übernehmende Entsorger auf dem Übergabe-
nachweis (z.B. Lieferschein) die Übernahme zur
thermischen Behandlung in einer dafür geneh-
migten Verbrennungsanlage zu bestätigen. 
● Bei Übernahme von Altmedikamenten aus der
Apothekensammlung ist ein Übergabenachweis
auszustellen (siehe nachfolgendes Beispiel).
Bei den Apotheken:
● Die Übernahme erfolgt ausschließlich während
der Öffnungszeiten; keine Sammlung über öf-
fentlich zugängliche Sammelbehälter (z.B. Sam-
melinseln)!
● Aussortierung und getrennte Lagerung der Alt-
medikamente, die aufgrund ihrer Inhaltsstoffe
gefahrenrelevante Eigenschaften aufweisen! Da-
zu kann auch die Medikamentenbezeichnung
bzw. der Beipacktext herangezogen werden!
● Entfernung der Kartonschachteln und Bei  -
packtexte (Altpapier)!
● Getrennte Lagerung der Altmedikamente mit
bzw. ohne gefahrenrelevante Eigenschaften in
flüssigkeitsdichten und verschließbaren Gebin-
den (z.B. Kunststofffässer mit Spannring).
● Kennzeichnung der Gebinde mit der Abfall-
Schlüssel-Nummer 53501 und der Abfallbezeich-
nung  Arzneimittel, nicht wassergefährdend,
ohne Zytostatika bzw. der Abfall-Schlüssel-
Nummer 53510 und der Abfallbezeichnung Arz-
neimittel, wassergefährdend, schwermetallhal-
tig (z.B. Blei, Cadmium, Zink, Quecksilber, Se-
len), Zytostatika und unsortierte Arzneimittel.
● Weitergabe als nicht gefährlicher bzw. gefähr-
licher Abfall an einen befugten Abfallsammler
(Entsorger). Dabei hat der übernehmende Entsor-
ger auf dem Übergabenachweis (z.B. Lieferschein
bzw. Begleitschein) die Übernahme zur thermi-
schen Behandlung in einer dafür genehmigten
Verbrennungsanlage zu bestätigen.
Die Sammlung und Entsorgung von Altmedikamenten aus privaten Haushalten!
H I N W E I S : 
Apotheken können aus privaten Haushalten übernommene und
vorsortierte Altmedikamente, die der Abfallschlüsselnummer
53501 (nicht gefährliche Abfälle) entsprechen, an die Gemein-
den übergeben. Im Sinne der bereits bisher üblichen Praxis be-
steht auch zukünftig die Empfehlung des Landes Steiermark,
dass die Betreiber der Altstoff- und Problemstoffsammelzentren
diese Altmedikamente aus privaten Haushalten kostenlos über-
nehmen. Dabei hat die Apotheke auf dem ÜBERGABENACHWEIS
(z.B. Lieferschein) die ausschließliche Herkunft der Altmedika-
mente aus Haushaltsvorsammlungen, die Vorsortierung und de-
ren Zuordnung zu den nicht gefährlichen Abfällen (SN 53501)
zu bestätigen! Altbestände an Altmedikamenten der Apotheken
werden von den Altstoff- und Problemstoffsammelzentren je-
denfalls nicht übernommen (diese sind von der Apotheke über
einen privaten Abfallsammler direkt zu entsorgen)!
Ü B E R G A B E N A C H W E I S :
(nach den Anforderungen der Abfallnachweisverordnung 
BGBl. II Nr. 618/2003)
Die Gemeinde (Name und Anschrift der Gemeinde), als Betreiber
des Altstoff- und Problemstoffsammelzentrums (Anschrift des
Altstoff- und Problemstoffsammelzentrums), bestätigt die
Übernahme von (Menge der Altmedikamente) kg Altmedika-
mente (SN 53501 Arzneimittel, nicht wassergefährdend, oh-
ne Zytostatika nach den Vorgaben der ÖNORM S 2100) von
(Name und Anschrift der Apotheke). 
Der Übergeber bestätigt die Herkunft der Altmedikamente aus
privaten Haushalten, die Vorsortierung und deren Zuordnung zu
den nicht gefährlichen Abfällen!
_____________________________________
Stempel und Unterschrift des Übergebers!
_____________________________________
Stempel und Unterschrift des Übernehmers!
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c
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n
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c
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b
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c
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c
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c
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c
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l
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b
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c
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e
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m
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t
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k
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c
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b
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.
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c
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c
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c
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c
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b
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d
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d
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i
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d
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c
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d
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d
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A
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a
l
t
e
 
o
d
e
r
 
n
i
c
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c
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c
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c
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.
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b
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b
e
r
e
i
c
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T
e
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.
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b
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c
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d
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b
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.
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c
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b
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.
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d
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c
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b
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l
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e
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b
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b
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l
l
e
 
I
h
r
e
r
 
S
t
a
d
t
 
o
d
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b
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b
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b
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b
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b
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u
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c
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b
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d
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b
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b
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u
c
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b
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c
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n
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n
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b
e
r
 
d
e
n
 
R
e
s
t
m
ü
l
l
z
u
l
ä
s
s
t
,
 
e
m
p
f
e
h
l
e
n
 
d
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i
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c
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c
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b
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b
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c
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i
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e
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c
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i
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b
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b
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b
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b
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.
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b
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b
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i
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.
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c
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b
u
n
d
m
a
t
e
r
i
a
l
i
e
n
(
B
l
i
s
t
e
r
v
e
r
p
a
c
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b
e
n
t
u
-
b
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b
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c
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p
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c
h
f
e
s
t
e
n
,
 
v
e
r
s
c
h
l
i
e
ß
b
a
r
e
n
 
B
e
-
h
ä
l
t
n
i
s
 
g
e
s
a
m
m
e
l
t
 
w
e
r
d
e
n
 
u
n
d
 
k
ö
n
n
e
n
v
e
r
d
e
c
k
t
 
ü
b
e
r
 
d
i
e
 
R
e
s
t
m
ü
l
l
t
o
n
n
e
 
e
n
t
s
o
r
g
t
w
e
r
d
e
n
.
 
S
o
l
c
h
e
 
g
e
b
r
a
u
c
h
t
e
n
 
M
e
d
i
k
a
l
p
r
o
-
d
u
k
t
e
 
w
e
r
d
e
n
 
a
u
s
 
h
y
g
i
e
n
i
s
c
h
e
n
 
G
r
ü
n
d
e
n
w
e
d
e
r
 
i
n
 
d
e
n
 
A
p
o
t
h
e
k
e
n
 
n
o
c
h
 
a
n
 
d
e
n
m
e
i
s
t
e
n
 
S
a
m
m
e
l
s
t
e
l
l
e
n
 
a
n
g
e
n
o
m
m
e
n
!
!
!
B
e
i
s
p
i
e
l
e
 
f
ü
r
 
s
t
i
c
h
f
e
s
t
e
 
B
e
h
ä
l
t
n
i
s
s
e
 
 
 
W
e
i
t
e
r
e
 
I
n
f
o
r
m
a
t
i
o
n
e
n
 
e
r
h
a
l
t
e
n
 
S
i
e
 
i
n
 
d
e
r
 
A
p
o
t
h
e
k
e
o
d
e
r
 
b
e
i
 
d
e
r
 
A
b
f
a
l
l
b
e
r
a
t
u
n
g
•
 
G
e
b
r
a
u
c
h
t
e
 
V
e
r
b
ä
n
d
e
,
 
P
f
l
a
s
t
e
r
 
u
n
d
M
u
l
l
b
i
n
d
e
n
 
g
e
h
ö
r
e
n
 
e
b
e
n
f
a
l
l
s
 
i
n
 
d
e
n
H
a
u
s
m
ü
l
l
.
 
V
o
n
 
d
i
e
s
e
n
 
g
e
h
e
n
 
i
n
 
d
e
r
 
R
e
g
e
l
k
e
i
n
e
 
G
e
f
a
h
r
e
n
 
a
u
s
.
 
N
u
r
 
b
e
i
 
i
n
f
e
k
t
i
ö
s
e
m
M
a
t
e
r
i
a
l
 
m
ü
s
s
e
n
 
d
i
e
s
e
 
g
e
m
ä
ß
 
d
e
r
 
A
n
w
e
i
-
s
u
n
g
 
I
h
r
e
s
 
A
r
z
t
e
s
 
u
n
d
 
u
n
t
e
r
 
E
i
n
h
a
l
t
u
n
g
b
e
s
t
i
m
m
t
e
r
 
H
y
g
i
e
n
e
v
o
r
s
c
h
r
i
f
t
e
n
 
e
n
t
s
o
r
g
t
w
e
r
d
e
n
.
•
 
U
m
v
e
r
p
a
c
k
u
n
g
e
n
,
 
w
i
e
 
z
.
B
.
 
K
a
r
t
o
n
s
u
n
d
 
a
u
c
h
 
d
i
e
 
B
e
i
p
a
c
k
z
e
t
t
e
l
 
v
o
n
 
A
r
z
n
e
i
-
e
n
,
 
v
o
r
 
d
e
r
 
A
b
g
a
b
e
 
i
n
 
d
e
r
 
A
p
o
t
h
e
k
e
 
o
d
e
r
S
a
m
m
e
l
s
t
e
l
l
e
 
e
n
t
f
e
r
n
e
n
 
u
n
d
 
d
i
e
s
e
 
m
i
t
d
e
m
 
A
l
t
p
a
p
i
e
r
 
e
n
t
s
o
r
g
e
n
Annex - 26 -T
i
p
p
s
 
z
u
r
 
r
i
c
h
t
i
g
e
n
 
u
n
d
 
u
m
w
e
l
t
g
e
r
e
c
h
t
e
n
E
n
t
s
o
r
g
u
n
g
 
a
l
t
e
r
 
M
e
d
i
k
a
m
e
n
t
e
U
m
w
e
l
t
a
m
t
 
d
e
r
 
S
t
a
d
t
 
E
s
s
e
n
i
n
 
K
o
o
p
e
r
a
t
i
o
n
 
m
i
t
d
e
m
 
G
e
s
u
n
d
h
e
i
t
s
a
m
t
 
d
e
r
 
S
t
a
d
t
 
E
s
s
e
n
,
d
e
m
 
Ö
k
o
l
o
g
i
e
-
A
r
b
e
i
t
s
k
r
e
i
s
d
e
s
 
K
r
a
n
k
e
n
h
a
u
s
v
e
r
b
a
n
d
e
s
 
E
s
s
e
n
,
d
e
m
 
E
s
s
e
n
e
r
 
A
p
o
t
h
e
k
e
r
v
e
r
b
a
n
d
,
d
e
r
 
E
n
t
s
o
r
g
u
n
g
s
b
e
t
r
i
e
b
e
 
E
s
s
e
n
 
G
m
b
H
 
u
n
d
d
e
r
 
N
O
W
E
D
A
 
e
G
A
p
o
t
h
e
k
e
r
g
e
n
o
s
s
e
n
s
c
h
a
f
t
,
 
E
s
s
e
n
G
e
s
t
a
l
t
u
n
g
,
 
D
r
u
c
k
 
u
n
d
 
V
e
r
t
e
i
l
u
n
g
:
N
O
W
E
D
A
 
e
G
H
e
r
a
u
s
g
e
b
e
r
/
I
m
p
r
e
s
s
u
m
U
m
w
e
l
t
a
m
t
 
d
e
r
 
S
t
a
d
t
 
E
s
s
e
n
C
l
a
u
d
i
a
 
K
ö
l
l
n
e
r
T
e
l
.
:
 
0
2
0
1
 
8
8
-
5
9
1
2
5
c
l
a
u
d
i
a
.
k
o
e
l
l
n
e
r
@
u
m
w
e
l
t
a
m
t
.
e
s
s
e
n
.
d
e
A
p
o
t
h
e
k
e
r
v
e
r
b
a
n
d
 
E
s
s
e
n
U
l
r
i
c
h
 
S
c
h
w
i
e
r
T
e
l
.
:
 
0
2
0
1
 
3
2
3
5
9
1
i
n
f
o
@
k
a
i
s
e
r
-
w
i
l
h
e
l
m
-
a
p
o
t
h
e
k
e
.
d
e
G
e
s
u
n
d
h
e
i
t
s
a
m
t
 
d
e
r
 
S
t
a
d
t
 
E
s
s
e
n
C
l
a
u
d
i
a
 
S
t
e
i
n
T
e
l
.
:
 
0
2
0
1
 
8
8
-
5
3
1
2
7
c
l
a
u
d
i
a
.
s
t
e
i
n
@
g
e
s
u
n
d
h
e
i
t
s
a
m
t
.
e
s
s
e
n
.
d
e
Ö
k
o
l
o
g
i
e
-
A
r
b
e
i
t
s
k
r
e
i
s
 
d
e
s
K
r
a
n
k
e
n
h
a
u
s
v
e
r
b
a
n
d
e
s
 
E
s
s
e
n
D
r
.
 
J
o
h
a
n
n
e
s
 
W
a
t
t
e
r
o
t
t
T
e
l
.
:
 
0
2
0
1
 
1
7
4
-
1
5
0
0
8
j
.
w
a
t
t
e
r
o
t
t
@
k
l
i
n
i
k
e
n
-
e
s
s
e
n
-
m
i
t
t
e
.
d
e
E
n
t
s
o
r
g
u
n
g
s
b
e
t
r
i
e
b
e
 
E
s
s
e
n
 
G
m
b
H
H
e
i
n
e
r
 
B
a
h
r
e
n
b
e
r
g
T
e
l
.
:
 
0
2
0
1
 
8
5
4
-
2
7
2
0
h
b
a
h
r
e
n
b
e
r
g
@
e
b
e
-
e
s
s
e
n
.
d
e
K
o
n
t
a
k
t
E
i
n
 
P
l
a
t
z
 
f
ü
r
a
l
t
e
 
P
i
l
l
e
n
!
D
i
e
 
r
i
c
h
t
i
g
e
 
E
n
t
s
o
r
g
u
n
g
a
l
t
e
r
 
A
r
z
n
e
i
m
i
t
t
e
l
 
i
s
t
 
I
h
r
 
B
e
i
t
r
a
g
z
u
m
 
U
m
w
e
l
t
s
c
h
u
t
z
!
S
T
A
D
T
E
S
S
E
N
U
m
w
e
l
t
a
m
t
Annex - 27 -B
e
w
u
s
s
t
 
e
i
n
k
a
u
f
e
n
 
s
t
a
t
t
 
u
n
b
e
n
u
t
z
t
 
e
n
t
s
o
r
g
e
n
!
•
 
A
r
z
n
e
i
m
i
t
t
e
l
 
k
ö
n
n
e
n
 
n
i
c
h
t
 
u
m
g
e
t
a
u
s
c
h
t
 
 
 
 
w
e
r
d
e
n
!
•
 
L
a
s
s
e
n
 
S
i
e
 
s
i
c
h
 
v
o
r
 
d
e
m
 
K
a
u
f
 
v
o
n
 
I
h
r
e
m
 
A
r
z
t
 
u
n
d
 
A
p
o
t
h
e
k
e
r
 
b
e
r
a
t
e
n
.
•
 
V
i
e
l
e
 
E
s
s
e
n
e
r
 
A
p
o
t
h
e
k
e
n
 
b
i
e
t
e
n
 
e
i
n
e
 
k
o
s
t
e
n
f
r
e
i
e
 
B
e
r
a
t
u
n
g
 
u
n
d
 
K
o
n
t
r
o
l
l
e
 
I
h
r
e
r
 
H
a
u
s
a
p
o
t
h
e
k
e
 
a
n
.
W
o
h
i
n
 
m
i
t
 
a
l
t
e
n
 
A
r
z
n
e
i
m
i
t
t
e
l
n
?
A
u
f
 
k
e
i
n
e
n
 
F
a
l
l
 
i
n
 
d
i
e
 
T
o
i
l
e
t
t
e
 
b
z
w
.
i
n
s
 
A
b
w
a
s
s
e
r
 
g
e
b
e
n
!
J
e
d
e
 
T
a
b
l
e
t
t
e
 
u
n
d
 
j
e
d
e
r
 
T
r
o
p
f
e
n
 
A
r
z
n
e
i
s
a
f
t
,
d
e
r
 
n
i
c
h
t
 
i
n
 
d
a
s
 
A
b
w
a
s
s
e
r
 
u
n
d
 
d
a
m
i
t
 
i
n
 
d
e
n
W
a
s
s
e
r
k
r
e
i
s
l
a
u
f
 
g
e
l
a
n
g
t
,
 
e
n
t
l
a
s
t
e
t
 
u
n
s
e
r
e
U
m
w
e
l
t
 
e
r
h
e
b
l
i
c
h
,
 
d
e
n
n
 
M
e
d
i
k
a
m
e
n
t
e
 
s
i
n
d
o
f
t
 
n
u
r
 
l
a
n
g
s
a
m
 
o
d
e
r
 
g
a
r
 
n
i
c
h
t
 
b
i
o
l
o
g
i
s
c
h
 
a
b
b
a
u
b
a
r
.
A
l
t
e
,
 
n
i
c
h
t
 
m
e
h
r
 
b
e
n
ö
t
i
g
t
e
 
A
r
z
n
e
i
m
i
t
t
e
l
g
e
h
ö
r
e
n
 
i
n
 
d
e
n
 
H
a
u
s
m
ü
l
l
!
D
e
r
 
u
m
w
e
l
t
v
e
r
t
r
ä
g
l
i
c
h
s
t
e
 
u
n
d
 
e
i
n
f
a
c
h
s
t
e
 
W
e
g
,
n
i
c
h
t
 
m
e
h
r
 
b
e
n
ö
t
i
g
t
e
 
M
e
d
i
k
a
m
e
n
t
e
 
z
u
 
e
n
t
s
o
r
g
e
n
,
i
s
t
 
d
i
e
 
g
r
a
u
e
 
T
o
n
n
e
.
I
n
 
d
e
n
 
M
ü
l
l
v
e
r
b
r
e
n
n
u
n
g
s
a
n
l
a
g
e
n
 
w
e
r
d
e
n
 
a
r
z
n
e
i
l
i
c
h
e
 
W
i
r
k
s
t
o
f
f
e
 
s
o
 
z
e
r
s
t
ö
r
t
,
 
d
a
s
s
 
k
e
i
n
 
E
i
n
t
r
a
g
 
i
n
 
d
i
e
 
U
m
w
e
l
t
 
m
e
h
r
 
e
r
f
o
l
g
e
n
 
k
a
n
n
.
 
D
a
r
ü
b
e
r
 
h
i
n
a
u
s
 
k
ö
n
n
e
n
 
A
l
t
m
e
d
i
k
a
m
e
n
t
e
 
s
a
m
t
 
V
e
r
p
a
c
k
u
n
g
 
i
n
 
v
i
e
l
e
n
A
p
o
t
h
e
k
e
n
 
i
n
 
d
i
e
 
r
o
t
e
 
T
o
n
n
e
 
g
e
g
e
b
e
n
 
w
e
r
d
e
n
.
 
S
o
 
l
e
i
s
t
e
n
 
S
i
e
 
e
i
n
e
n
 
w
i
c
h
t
i
g
e
n
 
B
e
i
t
r
a
g
 
f
ü
r
 
d
e
n
 
U
m
w
e
l
t
s
c
h
u
t
z
.
A
r
z
n
e
i
m
i
t
t
e
l
 
g
e
h
ö
r
e
n
 
n
i
c
h
t
i
n
 
K
i
n
d
e
r
h
ä
n
d
e
!
K
i
n
d
e
r
 
k
ö
n
n
e
n
 
T
a
b
l
e
t
t
e
n
 
f
ü
r
 
b
u
n
t
e
 
B
o
n
b
o
n
s
h
a
l
t
e
n
.
 
A
u
c
h
 
d
e
s
h
a
l
b
 
i
s
t
 
e
s
 
r
a
t
s
a
m
,
 
A
r
z
n
e
i
m
i
t
t
e
l
m
i
t
 
d
e
m
 
a
n
d
e
r
e
n
 
H
a
u
s
m
ü
l
l
 
z
u
 
v
e
r
m
i
s
c
h
e
n
.
A
u
c
h
 
d
u
r
c
h
 
E
i
n
w
i
c
k
e
l
n
 
i
n
 
Z
e
i
t
u
n
g
s
p
a
p
i
e
r
 
k
ö
n
n
e
n
 
A
r
z
n
e
i
m
i
t
t
e
l
 
„
v
e
r
s
t
e
c
k
t
“
 
w
e
r
d
e
n
.
 
S
p
r
i
t
z
e
n
 
o
d
e
r
 
K
a
n
ü
l
e
n
 
s
o
l
l
t
e
n
 
d
a
g
e
g
e
n
 
e
n
t
w
e
d
e
r
 
i
n
 
s
t
i
c
h
f
e
s
t
e
n
G
e
f
ä
ß
e
n
 
g
e
s
a
m
m
e
l
t
 
u
n
d
 
ü
b
e
r
 
d
e
n
 
H
a
u
s
m
ü
l
l
e
n
t
s
o
r
g
t
 
o
d
e
r
 
i
n
 
d
e
r
 
A
p
o
t
h
e
k
e
 
a
b
g
e
g
e
b
e
n
 
w
e
r
d
e
n
.
W
e
r
 
g
a
n
z
 
s
i
c
h
e
r
 
g
e
h
e
n
 
m
ö
c
h
t
e
,
 
s
o
l
l
t
e
 
d
i
e
„
g
e
t
a
r
n
t
e
n
“
 
A
l
t
m
e
d
i
k
a
m
e
n
t
e
 
e
r
s
t
 
k
u
r
z
 
v
o
r
 
d
e
m
A
b
f
u
h
r
t
e
r
m
i
n
 
i
n
 
d
i
e
 
g
r
a
u
e
 
T
o
n
n
e
 
l
e
g
e
n
.
 
I
n
 
d
e
r
 
r
o
t
e
n
T
o
n
n
e
 
i
n
 
d
e
n
 
A
p
o
t
h
e
k
e
n
 
s
i
n
d
 
A
r
z
n
e
i
m
i
t
t
e
l
 
a
m
 
s
i
c
h
e
r
s
t
e
n
 
g
e
g
e
n
 
M
i
s
s
b
r
a
u
c
h
 
g
e
s
c
h
ü
t
z
t
.
V
e
r
p
a
c
k
u
n
g
e
n
 
e
n
t
f
e
r
n
e
n
?
A
r
z
n
e
i
m
i
t
t
e
l
r
e
s
t
e
 
(
T
a
b
l
e
t
t
e
n
,
 
D
r
a
g
e
e
s
 
u
s
w
.
)
 
s
o
l
l
t
e
n
i
n
 
d
e
n
 
K
u
n
s
t
s
t
o
f
f
v
e
r
p
a
c
k
u
n
g
e
n
 
(
B
l
i
s
t
e
r
)
o
d
e
r
 
F
l
ä
s
c
h
c
h
e
n
 
v
e
r
b
l
e
i
b
e
n
 
u
n
d
 
i
n
 
d
i
e
s
e
n
 
e
n
t
s
o
r
g
t
 
w
e
r
d
e
n
.
 
L
e
e
r
e
 
K
a
r
t
o
n
s
 
g
e
h
ö
r
e
n
 
i
n
 
d
i
e
 
P
a
p
i
e
r
t
o
n
n
e
n
,
l
e
e
r
e
 
K
u
n
s
t
s
t
o
f
f
v
e
r
p
a
c
k
u
n
g
e
n
 
i
n
 
d
i
e
 
g
e
l
b
e
 
T
o
n
n
e
.
K
e
i
n
 
P
l
a
t
z
 
f
ü
r
a
l
t
e
 
P
i
l
l
e
n
!
H
i
e
r
 
l
i
e
g
e
n
 
s
i
e
 
r
i
c
h
t
i
g
!
Annex - 28 -Stadt Cochem/Verbandsgemeinde Cochem-Land  - 3 -  4/2008
Der Sachverständigenrat für Umweltfragen (wissenschaftliches Beratungsgremium der Bundesregierung) hat sich in 
2007 mit dem Thema Arzneimittel in der Umwelt befasst, Risiken bewertet und Handlungsmöglichkeiten aufgezeigt. 
Aktuelle Umfragen haben ergeben, dass einige Verbraucherinnen und Verbraucher ihre Altmedikamente umweltge-
fährdend über die Toilette entsorgen. Dies zum Anlass genommen informiert diese Seite über die Entsorgung der 
Altmedikamente.
Die richtige Entsorgung der Altmedikamente ist ein wichtiger Beitrag, die Belastung von 
Gewässern und Böden durch Arzneimittelrückstände zu reduzieren.
Arzneimittel sicher aufbewahren
Arzneimittel müssen geeignet und sicher gelagert werden, d.h. evtl. kühl, lichtgeschützt, trocken. Sie gehören nicht in 
Kinderhände und sollten so aufbewahrt werden, dass Unbefugte keinen Zugriff haben.
Bewusst einkaufen statt unbenutzt entsorgen
Arzneimittel können nicht umgetauscht werden! Informieren Sie sich vor dem Kauf sorgfältig über Inhaltsstoffe und 
Nebenwirkungen (Beipackzettel) und beraten Sie sich mit Ihrem Arzt oder Apotheker.
Arzneimittel in der Umwelt
Viele Arzneimittel sind kaum oder nur schwer biologisch abbaubar. Wer Medikamente einnimmt, scheidet automatisch 
Arzneimittel oder deren Abbauprodukte in Spuren aus, die über die Toilette in das Abwasser gelangen. Dadurch kön-
nen geringste Rückstände (z. B. Antibiotika) in Gewässer oder in den Boden gelangen. Dies hat möglicherweise einen 
Einfluss auf die Resistenzbildung von Krankheitserregern beim Menschen.
Wohin mit den alten Arzneimitteln?
- Abgabe bei Apotheken und beim Umweltmobil
Verbraucher können ihre alten Arzneimittel bei Apotheken oder beim Umweltmobil 
(Termine und Informationen s. S. 4-6) entsorgen. Dort ist nicht nur eine sichere Lage-
rung, sondern auch der Weg in die Verbrennung gewährleistet. 
Verpackung entfernen?
Leere Verpackungen von Medikamenten können verwertet werden, z.B. 
Kartonage-Verpackung zum Altpapier (blaues Fach der Wertstofftonne !). 
Arzneimittelreste (Tabletten, Dragees usw.) sollten in der Verpackung (Bli-
ster, Fläschchen usw.) verbleiben und in dieser entsorgt werden (s. oben). 
Diese Abfälle nicht abgeben:
Gebrauchte Spritzen (z. B. von Diabetikern), Dialysebestecke (z. B. von 
der Heimdialyse), Blutkonserven oder sonstige mit Blut, Sekreten oder Ex-
kreten kontaminierte Abfälle. Fragen zur Entsorgung von Abfällen aus der 
häuslichen Pflege, der Heimtherapie sowie zur Entsorgung von Abfällen aus medizinischen Einrichtungen beantwortet 
die Kreisverwaltung Cochem-Zell, Abteilung Abfallwirtschaft, Telefon: 02671/61-165.
Quelle: Ministerium für Umwelt, Forsten und Verbraucherschutz: Altmedikamente entsorgen, Verbraucherinformation
Entsorgung von Altmedikamenten
Nicht in die Restmülltonne, Toilette oder ins Abwasser geben!
Weitere Informationen z. B. über die Entsorgung von Abfällen aus medizinischen Einrichtungen:
www.mufv.rlp.de/ifag-startseite Arbeitskreis IFAG – Informations Forum Abfallwirtschaft im Gesundheitswesen 
in Rheinland-Pfalz: Abfall-ABC, Praxistipps usw.
www.bgw-online.de Berufsgenossenschaft für Gesundheitsdienst und Wohlfahrtspflege: Broschüre Abfallent-
sorgung, Broschüre M 620 – Umgang mit Zytostatika usw.
Umweltdaten:
www.umweltatlas.rlp.de Umweltatlas des Landes Rheinland-Pfalz zu verschiedenen Themen mit entsprechen-
den Karten
www.geoportal-wasser.rlp.de Kartenbasierte Daten zum Thema Wasser 
www.umweltrat.de Sachverständigenrat für Umweltfragen
Annex - 29 -Das Umwelt- und Abfallwirtschaftsamt informiert:
Alte Arzneimittel gehören in die Mülltonne 
Oftmals landen alte Arzneimittel einfach in der Toilette. In der Folge wurden in 
den letzten Jahren immer häufiger Arzneimittelwirkstoffe in Flüssen 
nachgewiesen. Das Umwelt- und Abfallwirtschaftsamt im Landratsamt weist 
deshalb darauf hin, dass alte Arzneimittel oder nicht mehr benötigte Medikamente 
über die Hausmülltonne schadlos entsorgt werden können. Es ist lediglich dafür 
Sorge zu tragen, dass Kinder die bunten Pillen und Fläschchen nicht aus dem 
Mülleimer fischen.
Auch werden Altmedikamente bei der Problemstoffsammlung des Landkreises 
angenommen. Eine generelle Rücknahmepflicht der Apotheken besteht nicht. 
Keinesfalls sollten Altmedikamente über die Toilette entsorgt werden. Die 
„Entsorgung“ über das häusliche Abwasser belastet unnötig Kläranlagen und 
Gewässer. 
Bei Fragen: Umwelt- und Abfallwirtschaftsamt, Tel 07351/52-370. 
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h
u
t
z
e
s
U
m
 
E
i
n
t
r
ä
g
e
 
v
o
n
 
M
e
d
i
k
a
m
e
n
t
e
n
 
i
n
 
d
i
e
 
 
G
e
w
ä
s
-
s
e
r
 
z
u
 
v
e
r
r
i
n
g
e
r
n
,
 
m
ü
s
s
e
n
 
m
ö
g
l
i
c
h
e
 
A
u
s
w
i
r
-
k
u
n
g
e
n
 
p
h
a
r
m
a
k
o
l
o
g
i
s
c
h
e
r
 
S
u
b
s
t
a
n
z
e
n
 
a
u
f
 
d
i
e
U
m
w
e
l
t
 
s
t
ä
r
k
e
r
e
 
B
e
r
ü
c
k
s
i
c
h
t
i
g
u
n
g
 
b
e
i
 
d
e
r
 
Z
u
-
l
a
s
s
u
n
g
 
 
f
i
n
d
e
n
.
 
B
e
i
 
e
r
h
e
b
l
i
c
h
e
n
 
U
m
w
e
l
t
a
u
s
-
w
i
r
k
u
n
g
e
n
 
m
u
s
s
 
e
i
n
e
 
Z
u
l
a
s
s
u
n
g
 
v
e
r
s
a
g
t
 
w
e
r
-
d
e
n
,
 
d
e
n
n
:
 
V
o
r
s
o
g
e
n
d
e
r
 
G
e
w
ä
s
s
e
r
s
c
h
u
t
z
 
i
s
t
s
c
h
l
i
e
ß
l
i
c
h
 
a
u
c
h
 
G
e
s
u
n
d
h
e
i
t
s
s
c
h
u
t
z
.
I
m
 
G
e
g
e
n
s
a
t
z
 
z
u
 
H
u
m
a
n
a
r
z
n
e
i
m
i
t
t
e
l
n
 
b
e
s
t
e
h
t
b
e
i
 
T
i
e
r
a
r
z
n
e
i
m
i
t
t
e
l
n
 
d
i
e
 
M
ö
g
l
i
c
h
k
e
i
t
,
 
d
i
e
 
Z
u
l
a
s
-
s
u
n
g
 
z
u
 
v
e
r
s
a
g
e
n
,
 
s
o
f
e
r
n
 
s
c
h
ä
d
l
i
c
h
e
 
A
u
s
w
i
r
-
k
u
n
g
e
n
 
a
u
f
 
d
i
e
 
U
m
w
e
l
t
 
f
e
s
t
g
e
s
t
e
l
l
t
 
w
e
r
d
e
n
.
 
F
u
t
-
t
e
r
m
i
t
t
e
l
z
u
s
a
t
z
s
t
o
f
f
e
 
w
i
e
 
A
n
t
i
b
i
o
t
i
k
a
 
u
n
d
 
W
a
c
h
s
-
t
u
m
s
f
ö
r
d
e
r
e
r
 
u
n
t
e
r
l
i
e
g
e
n
 
a
l
l
e
r
d
i
n
g
s
 
n
i
c
h
t
 
d
e
r
A
r
z
n
e
i
m
i
t
t
e
l
g
e
s
e
t
z
g
e
b
u
n
g
.
F
ü
r
 
d
i
e
 
b
i
s
h
e
r
 
f
e
s
t
g
e
s
t
e
l
l
t
e
n
 
B
e
l
a
s
t
u
n
g
e
n
 
d
e
r
G
e
w
ä
s
s
e
r
 
s
i
n
d
 
z
u
m
 
G
r
o
ß
t
e
i
l
 
n
u
r
 
A
r
z
n
e
i
m
i
t
t
e
l
v
e
r
a
n
t
w
o
r
t
l
i
c
h
,
 
d
i
e
 
v
o
r
 
I
n
k
r
a
f
t
t
r
e
t
e
n
 
d
e
r
 
n
e
u
e
n
R
i
c
h
t
l
i
n
i
e
 
z
u
r
 
U
m
w
e
l
t
p
r
ü
f
u
n
g
 
v
o
n
 
M
e
d
i
k
a
m
e
n
-
t
e
n
 
b
e
r
e
i
t
s
 
i
m
 
V
e
r
k
e
h
r
 
w
a
r
e
n
.
 
F
ü
r
 
M
e
d
i
k
a
m
e
n
-
t
e
 
ä
l
t
e
r
e
r
 
Z
u
l
a
s
s
u
n
g
 
(
v
o
r
 
2
0
0
8
)
 
s
i
n
d
 
l
e
i
d
e
r
 
k
e
i
-
n
e
 
U
m
w
e
l
t
p
r
ü
f
u
n
g
e
n
 
v
o
r
g
e
s
e
h
e
n
.
 
D
e
s
h
a
l
b
 
u
n
-
t
e
r
s
t
ü
t
z
e
n
 
S
i
e
 
d
i
e
 
F
o
r
d
e
r
u
n
g
:
 
 
A
u
c
h
 
l
a
n
g
e
 
v
e
r
-
m
a
r
k
t
e
t
e
 
 
A
r
z
n
e
i
m
i
t
t
e
l
 
b
e
d
ü
r
f
e
n
 
e
i
n
e
r
 
n
a
c
h
t
r
ä
g
-
l
i
c
h
e
n
,
 
a
u
s
s
a
g
e
k
r
ä
f
t
i
g
e
n
 
S
t
o
f
f
r
i
s
i
k
o
b
e
w
e
r
t
u
n
g
h
i
n
s
i
c
h
t
l
i
c
h
 
i
h
r
e
r
 
U
m
w
e
l
t
a
u
s
w
i
r
k
u
n
g
e
n
.
B
u
n
d
 
f
ü
r
 
U
m
w
e
l
t
 
u
n
d
 
N
a
t
u
r
s
c
h
u
t
z
 
D
e
u
t
s
c
h
l
a
n
d
 
(
B
U
N
D
)
L
a
n
d
e
s
v
e
r
b
a
n
d
 
S
c
h
l
e
s
w
i
g
-
H
o
l
s
t
e
i
n
 
e
.
 
V
.
L
e
r
c
h
e
n
s
t
r
a
ß
e
 
2
2
2
4
1
0
3
 
K
i
e
l
T
e
l
.
:
 
0
4
3
1
-
6
 
6
0
 
6
0
-
0
F
a
x
:
 
0
4
3
1
-
6
 
6
0
 
6
0
-
3
3
E
m
a
i
l
:
 
b
u
n
d
-
s
h
@
b
u
n
d
-
s
h
.
d
e
w
w
w
.
b
u
n
d
-
s
h
.
d
e
U
n
t
e
r
s
t
ü
t
z
e
n
 
S
i
e
 
u
n
s
e
r
e
 
A
r
b
e
i
t
f
ü
r
 
d
e
n
 
U
m
w
e
l
t
-
 
u
n
d
 
N
a
t
u
r
s
c
h
u
t
z
o
d
e
r
 
w
e
r
d
e
n
 
S
i
e
 
M
i
t
g
l
i
e
d
.
M
i
t
g
l
i
e
d
 
w
e
r
d
e
n
w
w
w
.
b
u
n
d
.
n
e
t
w
w
w
.
b
u
n
d
-
s
h
.
d
e
0
4
3
1
/
 
6
 
6
0
 
6
0
 
0
S
p
e
n
d
e
n
k
o
n
t
o
F
ö
r
d
e
-
S
p
a
r
k
a
s
s
e
 
K
i
e
l
K
t
o
-
N
r
.
 
9
2
 
0
0
6
 
0
0
6
,
 
B
L
Z
 
2
1
0
 
5
0
1
 
7
0A
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u
m
 
u
m
w
e
l
t
g
e
r
e
c
h
t
e
n
 
U
m
g
a
n
g
 
m
i
t
M
e
d
i
k
a
m
e
n
t
e
n

M
e
d
i
k
a
m
e
n
t
e
 
k
e
i
n
e
s
f
a
l
l
s
 
ü
b
e
r
 
d
i
e
 
T
o
i
l
e
t
t
e
o
d
e
r
 
d
a
s
 
W
a
s
c
h
b
e
c
k
e
n
 
e
n
t
s
o
r
g
e
n
.

A
b
g
e
l
a
u
f
e
n
e
 
u
n
d
 
n
i
c
h
t
 
m
e
h
r
 
b
e
n
ö
t
i
g
t
e
 
M
e
-
d
i
k
a
m
e
n
t
e
 
s
i
n
d
 
a
n
 
d
i
e
 
 
A
p
o
t
h
e
k
e
 
z
u
r
ü
c
k
z
u
-
g
e
b
e
n
.

E
t
w
a
 
d
r
e
i
v
i
e
r
t
e
l
 
d
e
r
 
d
e
u
t
s
c
h
e
n
 
A
p
o
t
h
e
k
e
n
s
i
n
d
 
a
n
 
e
i
n
 
S
a
m
m
e
l
s
y
s
t
e
m
 
f
ü
r
 
A
l
t
a
r
z
n
e
i
m
i
t
-
t
e
l
 
a
n
g
e
s
c
h
l
o
s
s
e
n
.
 
S
t
e
l
l
e
n
 
S
i
e
 
s
i
c
h
e
r
,
 
d
a
s
s
I
h
r
e
 
A
p
o
t
h
e
k
e
 
a
n
 
d
i
e
s
e
s
 
S
a
m
m
e
l
s
y
s
t
e
m
 
a
n
-
g
e
s
c
h
l
o
s
s
e
n
 
i
s
t
.
 
W
e
c
h
s
e
l
n
 
S
i
e
 
i
m
 
Z
w
e
i
f
e
l
s
-
f
a
l
l
 
d
i
e
 
 
A
p
o
t
h
e
k
e
.

F
ü
h
r
e
n
 
S
i
e
 
e
i
n
e
 
L
i
s
t
e
 
ü
b
e
r
 
I
h
r
e
n
 
a
k
t
u
e
l
l
e
n
 
M
e
-
d
i
k
a
m
e
n
t
e
n
b
e
s
t
a
n
d
.
 
N
e
h
m
e
n
 
S
i
e
 
d
i
e
s
e
 
L
i
s
t
e
m
i
t
 
z
u
 
I
h
r
e
m
 
A
r
z
t
b
e
s
u
c
h
.
 
S
o
 
l
a
s
s
e
n
 
s
i
c
h
 
u
n
-
n
ö
t
i
g
e
 
V
e
r
s
c
h
r
e
i
b
u
n
g
e
n
 
 
v
e
r
m
e
i
d
e
n
 
u
n
d
 
d
e
r
M
e
d
i
k
a
m
e
n
t
e
n
v
e
r
b
r
a
u
c
h
 
w
i
r
d
 
g
e
s
e
n
k
t
.

R
e
d
e
n
 
S
i
e
 
m
i
t
 
I
h
r
e
m
 
A
r
z
t
 
ü
b
e
r
 
e
i
n
e
 
m
ö
g
l
i
-
c
h
e
 
U
m
w
e
l
t
-
P
r
o
b
l
e
m
a
t
i
k
 
v
o
n
 
M
e
d
i
k
a
m
e
n
t
e
n
.
W
e
n
n
 
e
i
n
e
 
B
e
h
a
n
d
l
u
n
g
 
m
i
t
 
M
e
d
i
k
a
m
e
n
t
e
n
n
i
c
h
t
 
 
z
u
 
u
m
g
e
h
e
n
 
i
s
t
,
 
f
r
a
g
e
n
 
S
i
e
 
n
a
c
h
 
e
i
-
n
e
r
 
V
e
r
s
c
h
r
e
i
b
u
n
g
 
u
m
w
e
l
t
f
r
e
u
n
d
l
i
c
h
e
r
 
o
d
e
r
p
f
l
a
n
z
l
i
c
h
e
r
 
P
r
o
d
u
k
t
e
.
 
F
r
a
g
e
n
 
S
i
e
 
a
u
c
h
 
n
a
c
h
a
n
 
d
e
n
 
t
a
t
s
ä
c
h
l
i
c
h
e
n
 
B
e
d
a
r
f
 
a
n
g
e
p
a
ß
t
e
n
P
a
c
k
u
n
g
s
g
r
ö
ß
e
n
.
Z
u
v
i
e
l
 
M
e
d
i
k
a
m
e
n
t
e
n
r
ü
c
k
s
t
ä
n
d
e
b
e
l
a
s
t
e
n
 
u
n
s
e
r
e
 
G
e
w
ä
s
s
e
r
M
e
d
i
k
a
m
e
n
t
e
 
e
r
l
e
i
c
h
t
e
r
n
 
i
m
 
B
e
d
a
r
f
s
f
a
l
l
 
d
a
s
L
e
b
e
n
.
 
G
u
t
,
 
d
a
ß
 
e
s
 
s
i
e
 
g
i
b
t
.
 
 
A
l
l
e
r
d
i
n
g
s
 
w
e
r
d
e
n
s
i
e
 
z
u
m
 
N
a
c
h
t
e
i
l
 
f
ü
r
 
M
e
n
s
c
h
,
 
U
m
w
e
l
t
 
u
n
d
 
G
e
-
w
ä
s
s
e
r
 
i
n
 
z
u
 
g
r
o
ß
e
n
 
M
e
n
g
e
n
 
e
i
n
g
e
s
e
t
z
t
.
I
n
 
D
e
u
t
s
c
h
l
a
n
d
 
w
e
r
d
e
n
 
p
r
o
 
J
a
h
r
 
3
8
.
0
0
0
 
T
o
n
-
n
e
n
 
H
u
m
a
n
p
h
a
r
m
a
k
a
 
u
n
d
 
 
2
.
5
0
0
 
T
o
n
n
e
n
 
T
i
e
r
-
a
r
z
n
e
i
m
i
t
t
e
l
 
v
e
r
b
r
a
u
c
h
t
.
 
V
o
n
 
d
e
n
 
e
t
w
a
 
3
.
0
0
0
A
r
z
n
e
i
m
i
t
t
e
l
-
I
n
h
a
l
t
s
s
t
o
f
f
e
n
 
d
i
e
 
e
s
 
g
i
b
t
,
 
k
ö
n
n
e
n
e
t
w
a
 
1
8
0
 
S
t
o
f
f
e
 
a
n
a
l
y
s
i
e
r
t
 
w
e
r
d
e
n
.
 
 
D
a
v
o
n
 
 
w
u
r
-
d
e
n
 
b
i
s
h
e
r
 
m
e
h
r
 
a
l
s
 
1
2
0
 
W
i
r
k
s
t
o
f
f
e
 
b
z
w
.
 
d
e
r
e
n
A
b
b
a
u
p
r
o
d
u
k
t
e
 
i
m
 
 
A
b
w
a
s
s
e
r
,
 
O
b
e
r
f
l
ä
c
h
e
n
w
a
s
-
s
e
r
,
 
G
r
u
n
d
w
a
s
s
e
r
 
o
d
e
r
 
T
r
i
n
k
w
a
s
s
e
r
 
 
n
a
c
h
g
e
w
i
e
-
s
e
n
.
 
E
i
n
 
G
r
u
n
d
:
 
E
i
n
 
G
r
o
ß
t
e
i
l
 
d
e
r
 
M
e
d
i
k
a
m
e
n
t
e
w
i
r
d
 
u
n
g
e
n
u
t
z
t
 
w
i
e
d
e
r
 
a
u
s
g
e
s
c
h
i
e
d
e
n
 
u
n
d
 
g
e
-
l
a
n
g
t
 
m
i
t
 
d
e
m
 
A
b
w
a
s
s
e
r
 
i
n
 
d
i
e
 
K
l
ä
r
a
n
l
a
g
e
 
u
n
d
v
o
n
 
d
o
r
t
 
i
n
 
d
e
n
 
W
a
s
s
e
r
k
r
e
i
s
l
a
u
f
.
D
o
c
h
 
n
i
c
h
t
 
a
l
l
e
i
n
 
a
u
f
 
d
i
e
s
e
m
 
W
e
g
e
 
f
i
n
d
e
t
 
e
i
n
 
E
i
n
-
t
r
a
g
 
s
t
a
t
t
.
 
V
o
r
 
a
l
l
e
m
 
e
i
n
e
 
n
i
c
h
t
 
f
a
c
h
g
e
r
e
c
h
t
e
 
E
n
t
-
s
o
r
g
u
n
g
 
a
l
t
e
r
 
o
d
e
r
 
n
i
c
h
t
 
 
m
e
h
r
 
b
e
n
ö
t
i
g
t
e
r
 
M
e
d
i
-
k
a
m
e
n
t
e
 
t
r
ä
g
t
 
e
r
h
e
b
l
i
c
h
 
z
u
r
 
G
e
w
ä
s
s
e
r
b
e
l
a
s
t
u
n
g
b
e
i
.
 
U
m
f
r
a
g
e
n
 
z
u
f
o
l
g
e
 
e
n
t
s
o
r
g
t
 
 
e
i
n
 
b
e
a
c
h
t
l
i
c
h
e
r
A
n
t
e
i
l
 
d
e
r
 
B
e
v
ö
l
k
e
r
u
n
g
 
ü
b
r
i
g
 
g
e
b
l
i
e
b
e
n
e
 
T
a
b
l
e
t
-
t
e
n
 
ü
b
e
r
 
d
i
e
 
T
o
i
l
e
t
t
e
 
-
 
i
n
s
b
e
s
o
n
d
e
r
e
 
f
l
ü
s
s
i
g
e
 
M
e
-
d
i
k
a
m
e
n
t
e
.
 
D
i
e
s
 
b
e
l
a
s
t
e
t
 
u
n
s
e
r
e
 
U
m
w
e
l
t
 
u
n
n
ö
-
t
i
g
 
u
n
d
 
m
u
ß
 
v
e
r
m
i
e
d
e
n
 
w
e
r
d
e
n
.
D
i
e
 
K
o
n
z
e
n
t
r
a
t
i
o
n
e
n
 
v
o
n
 
M
e
d
i
k
a
m
e
n
t
e
n
w
i
r
k
s
t
o
f
-
f
e
n
 
i
m
 
T
r
i
n
k
w
a
s
s
e
r
 
w
e
r
d
e
n
 
g
e
m
ä
ß
 
U
m
w
e
l
t
b
u
n
-
d
e
s
a
m
t
 
(
U
B
A
)
 
a
l
s
 
n
i
c
h
t
 
b
e
s
o
r
g
n
i
s
e
r
r
e
g
e
n
d
 
e
i
n
-
g
e
s
c
h
ä
t
z
t
,
 
l
i
e
g
e
n
 
s
i
e
 
d
o
c
h
 
u
m
 
m
e
h
r
e
r
e
 
Z
e
h
n
e
r
-
p
o
t
e
n
z
e
n
 
u
n
t
e
r
 
d
e
n
 
G
e
h
a
l
t
e
n
 
e
i
n
e
r
 
t
h
e
r
a
p
e
u
t
i
-
s
c
h
e
n
 
D
o
s
i
s
.
 
 
D
e
n
n
o
c
h
 
b
e
s
t
e
h
t
 
H
a
n
d
l
u
n
g
s
b
e
-
d
a
r
f
:
 
Z
u
m
 
e
i
n
e
n
 
s
i
n
d
 
d
i
e
 
 
A
u
s
w
i
r
k
u
n
g
e
n
 
g
e
r
i
n
g
e
r
K
o
n
z
e
n
t
r
a
t
i
o
n
e
n
 
v
o
n
 
M
e
d
i
k
a
m
e
n
t
e
n
r
ü
c
k
s
t
ä
n
d
e
n
a
u
f
 
d
i
e
 
m
e
n
s
c
h
l
i
c
h
e
 
G
e
s
u
n
d
h
e
i
t
 
u
n
d
 
d
i
e
 
U
m
w
e
l
t
w
e
i
t
g
e
h
e
n
d
 
u
n
b
e
k
a
n
n
t
.
 
Z
u
m
 
a
n
d
e
r
e
n
 
w
i
r
d
 
d
i
e
 
B
e
-
v
ö
l
k
e
r
u
n
g
 
i
n
 
D
e
u
t
s
c
h
l
a
n
d
 
i
m
m
e
r
 
ä
l
t
e
r
 
u
n
d
 
d
a
m
i
t
w
i
r
d
 
a
u
c
h
 
d
e
r
 
M
e
d
i
k
a
m
e
n
t
e
n
v
e
r
b
r
a
u
c
h
 
w
e
i
t
e
r
 
a
n
-
s
t
e
i
g
e
n
.
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            Annex - 48 -Abfallwirtschaftsbetrieb des Landkreises Rastatt  
Informationen zur Entsorgung von 
Altmedikamenten
Seite 1 von 1 
In jedem Haushalt sind sie zu finden, alte 
Medikamente, die nicht mehr gebraucht 
werden. Spätestens wenn die Hausapothe-
ke einmal kritisch gesichtet wird, stellt sich 
die Frage nach der richtigen Entsorgung 
der alten Pillen, Salben oder Säfte.  
Nicht mehr benötigte Medikamente können 
gemeinsam mit den Restabfällen entsorgt wer-
den. Die Wirkstoffe in den Medikamenten sind 
so dosiert, dass die Beseitigung in Verbren-
nungsanlagen für Hausmüll erfolgen kann. 
Dieser Entsorgungsweg ist sowohl für feste als 
auch für flüssige Altmedikamente geeignet. 
Eine ordnungsgemäße Entsorgung von Altme-
dikamenten ist also über den Restabfallbehäl-
ter (graue Tonne) möglich. Lediglich besonde-
re Medikamente, die z.B. erbgutverändernde 
Substanzen beinhalten (vor allem Zytostatika), 
sind gesondert zu entsorgen. Diese Medika-
mente werden allerdings normalerweise nicht 
an Patienten zur häuslichen Behandlung ver-
schrieben.  
Ein mögliches Gefahrenpotential bei der Ent-
sorgung von Altmedikamenten besteht in der 
Zeit zwischen dem Einwerfen in die graue 
Tonne und der Entleerung der Behälter ins 
Müllfahrzeug. Es ist nicht auszuschließen, 
dass ein auf dem Gehweg bereit gestellter 
Restabfallbehälter umfällt. Wenn nun alte Me-
dikamente enthalten sind und die „schönen 
bunten Pillen“ auf dem Gehweg liegen, könn-
ten Kinder diese als „Bonbons“ ansehen.   
Um dieses Risiko zu minimieren, empfiehlt der 
Abfallwirtschaftsbetrieb für die Entsorgung von 
Altmedikamenten:  
- Kleine Mengen alter Medikamente sollten 
in einem zugebundenen Müllbeutel mit 
dem Hausmüll vermischt in die graue Ton-
ne gegeben werden.  
- Größere Mengen Altmedikamente, die bei 
Räumung oder Auflösung einer Hausapo-
theke anfallen, sind bei der Problemstoff-
sammlung sicherer aufgehoben. Die Alt-
medikamente werden von dort aus zur 
Hausmüllverbrennung gegeben. Ein unbe-
fugter Zugriff durch Dritte ist bei der Wahl 
dieses Weges ausgeschlossen.  
- Die Schachteln und Beipackzettel sind 
getrennt von den Altmedikamenten über 
die Wertstofftonne zu entsorgen. Pillen und 
Tabletten sollten nicht aus ihren direkten 
Verpackungen (Pillenträgerpapier, so ge-
nannte Blister) herausgedrückt werden, um 
einen unmittelbaren Kontakt mit den Medi-
kamenten zu vermeiden.  
Auch einige Apotheken nehmen alte und über-
lagerte Medikamente an. Allerdings ist dies 
eine Freiwilligkeitsleistung dieser Apotheken. 
Eine gesetzliche Verpflichtung zur Rücknahme 
gibt es nicht. 
  
Altmedikamente dürfen nicht in die Toilette 
Auf gar keinen Fall dürfen Altmedikamente wie 
Tropfen oder Säfte sowie Pillen und Tabletten 
in die Spüle oder Toilette gegeben werden. 
Leider scheint dieser unzulässige Entsor-
gungsweg auch eine gängige Praxis der Ent-
ledigung alter Medikamente zu sein, da sich 
Arzneimittelrückstände inzwischen immer häu-
figer in Flüssen und im Grundwasser nachwei-
sen lassen.  
Auskünfte zum Thema erteilt die Abfallbera-
tung unter der Telefonnummer 07222/381-
5555 oder können übers Internet unter 
www.awb-landkreis-rastatt.de abgerufen wer-
den. 
Annex - 49 -Richtiger Umgang mit Arzneimitteln 
Hand aufs Herz: sind Sie sicher, dass Sie Ihre Arzneimittel richtig einnehmen und lagern, um 
eine optimale Wirkung zu gewährleisten? 
Richtige Einnahme 
Feste Arzneiformen, wie Kapseln oder Tabletten sollten mit genügend Flüssigkeit 
eingenommen werden. Gewisse Flüssigkeiten wie Kaffee, Tee, Milch oder Fruchtsaft können 
mit bestimmten Arzneistoffen Wechselwirkungen (Interaktionen) eingehen. So kann die 
Wirkung von einigen Antibiotika stark abnehmen, wenn man sie mit einem Schluck Milch 
hinunterspült. Auch Eisenpräparate verlieren einen grossen Teil ihrer Wirkung, wenn sie mit 
Kaffee oder Tee eingenommen werden. Andererseits können Alkohol oder Grapefruitsaft die 
Wirkung verschiedener Medikamente verstärken. 
Nehmen Sie also Ihre Medikamente mit mindestens einem 
Deziliter Trinkwasser ein. So können Sie sicher sein, dass die 
Arzneimittel keinerlei Beeinträchtigung durch störende Stoffe 
erfahren. Achten Sie darauf, dass Sie beim Schlucken eine 
aufrechte Haltung einnehmen, und ausreichend grosse Schlucke 
trinken, damit das Arzneimittel gut rutscht und 
Schleimhautschäden an der Speiseröhre vermieden werden. 
Richtiger Zeitpunkt der Einnahme 
Der richtige Zeitpunkt der Einnahme ist sehr wichtig für die optimale Wirkung des 
Arzneimittels. Gewisse Medikamente werden nüchtern, das heisst 1 Stunde vor oder 
2 Stunden nach einer Mahlzeit eingenommen, damit sie besser und schneller aufgenommen 
werden und der Wirkstoff nicht durch Nahrungsbestandteile beeinflusst wird.
Andere Arzneimittel müssen zum Essen eingenommen werden, 
damit der Magen nicht unnötig gereizt wird oder weil sie sich im 
fetthaltigen Milieu einer Mahlzeit besser auflösen. 
Bei gewissen Arzneimitteln ist auch die Einnahme zu 
bestimmten Tageszeiten erforderlich: Cortisonpräparate werden 
immer am frühen Morgen eingenommen, da dies der natürlichen 
Ausschüttung im Körper entspricht. 
Bei Antibiotika ist auch der zeitliche Abstand zwischen den einzelnen Tabletten wichtig, 
damit der Wirkstoffspiegel des Medikaments im Blut immer gleich hoch bleibt. Einnahme: alle 
12 bzw. alle 8 Stunden. 
Annex - 50 -Wechselwirkungen zwischen Arzneimitteln 
Wechselwirkungen zwischen Arzneimitteln kommen häufig vor. Nicht nur bei Medikamenten, 
welche vom Arzt verordnet sind, sondern auch bei Medikamenten, die Sie rezeptfrei in der 
Apotheke kaufen oder sogar bei Nahrungsergänzungsmitteln. 
Die Wirkung von Medikamenten kann durch gleichzeitige Einname mit gewissen 
Nahrungsmitteln und Getränken beeinflusst werden.  
In der Apotheke prüfen wir jedes Ihrer Rezepte auf Verträglichkeit mit den bereits 
verordneten Medikamenten. Fragen Sie uns auch bei nicht rezeptpflichtigen Medikamenten, 
die Sie selber kaufen, ob diese mit Ihrer Dauermedikation zusammen eingenommen werden 
dürfen. 
Richtige Lagerung von Medikamenten 
Medikamente sollten möglichst dunkel, bei Raumtemperatur 
(ca. 20 Grad Celsius) und trocken aufbewahrt werden. 
Badezimmer und Küche sind ungeeignete Orte, Medikamente 
zu lagern, da grosse Temperaturschwankungen und hohe 
Luftfeuchtigkeit herrschen. Die Medikamente müssen so 
platziert sein, dass sie für Kinder nicht erreichbar sind. 
Arzneimittel sollten immer in der Originalverpackung inklusive 
Beipackzettel aufbewahrt werden. Nur so können Ablaufdatum und Bestimmung des 
Medikaments überprüft werden.  
Gewisse Arzneimittel (z.B. Augentropfen, Sirupe) sind, einmal geöffnet nur begrenzt haltbar. 
Hier empfiehlt es sich, das Anbruchsdatum mit Kugelschreiber auf der Packung zu 
vermerken.  
Richtige Entsorgung von Medikamenten 
Kontrollieren Sie zweimal im Jahr Ihre Hausapotheke auf 
abgelaufene oder nicht mehr benötigte Medikamente. 
Werfen Sie alte Medikamente auf keinen Fall in die Toilette. Sie 
gelangen sonst in den Wasserkreislauf und belasten die Umwelt. 
Medikamente, welche verfallen sind, oder die Sie nicht mehr 
benötigen, können Sie uns in die Apotheke bringen. Wir entsorgen 
sie dann für Sie kostenlos und fachgerecht. 
Möchten Sie regelmässig von uns über Themen der Gesundheit informiert werden, können 
Sie sich auch im Internet unter www.apotheke-wyss.ch registrieren lassen. 
Apotheke  Wyss  am  Bahnhof     Apotheke  Wyss  im  Täfernhof 
Bahnhofstr.  36     Mellingerstr.  207 
5400  Baden       5405  Baden-Dättwil 
056 222 48 63            056 202 30 30 
info@apotheke-wyss.ch     daettwil@apotheke-wyss.ch
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Entsorgung von Medikamenten
Bitte geben Sie abgelaufene Medi-
kamente oder solche, die Sie nicht 
mehr brauchen, Ihrer Abgabestelle
(Arztpraxis oder Apotheke) zur fach-
gerechten Entsorgung zurück.
Medikamente
gehören nicht in 
den Hauskehricht.
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WANTED: ALL YOUR DRUGS!!! 
 
(November 20
th, 2003) Leftover and expired medications can be dangerous not only to your health, 
but also to the environment when disposed of improperly. That’s why Vancouver Coastal Health 
(VCH) wants your unused and expired prescriptions and over-the-counter medications. 
 
Lions Gate Hospital (LGH) is holding its third annual Rxsponsible Drug Disposal Program on 
Tuesday, November 25
th and Wednesday, November 26
th between 8:00 am and 4:00 pm in the main 
lobby of the hospital located at 231 East 15
th Street in North Vancouver. This program is free of 
charge and provides staff, physicians and the public with a safe way to dispose of any unused 
medications that have been sitting around the home or office. 
 
Organized by the BC Community Drug Utilization Program (BC CDUP) with the support of VCH 
and several pharmaceutical companies, the two-day initiative is aimed at encouraging safe and 
responsible disposal of unused and expired medications. 
 
“Drugs have an expiry date for a reason,” says pharmacist Dr. Anne Nguyen.  “At best, drugs lose 
their potency over time, rendering them ineffective.  At worst, expired medications are harmful.”  For 
example, kidney damage has occurred when tetracycline (an antibiotic) is used past its expiry date.  
Expired aspirin (ASA) can be transformed into a new compound that is only used externally for its 
ability to break down skin, making it dangerous when swallowed.   
 
“Unfortunately, many people get rid of their old drugs by either throwing them into the garbage 
where they end up in a landfill, or flushing them down the toilet,” says Nguyen.  Both disposal 
methods are harmful to the environment.  A recent US study of medications in streams found a 
number of substances including antibiotics, steroids and other prescription and non-prescription 
drugs.  
 
The program’s aim is to encourage people to return their old prescription and over-the-counter 
medications for safe disposal. In just two years, the program at LGH has prevented more than 100 
kilograms of drug waste from entering landfills and sewage systems. 
 
All medications handed over for disposal will be treated confidentially and incinerated within 
biomedical waste guidelines.  Needles and other medical supplies will not be accepted.  People unable 
to make it to LGH are reminded that they can always take their old drugs to their local pharmacy, 
which will arrange safe and responsible disposal. 
  
For media inquiries, please contact:    
Dr. Anne Nguyen  
BC Community Drug Utilization Program 
Telephone: 604-984-3791 
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